<!DOCTYPE html>
<html lang="hi">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Critical Care Mind Map Book â€” Hinglish | Dr. Varun Kumar Varshney</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link href="https://fonts.googleapis.com/css2?family=Nunito:wght@300;400;600;700;800;900&family=Playfair+Display:ital,wght@0,700;1,600&family=Space+Grotesk:wght@400;500;600;700&display=swap" rel="stylesheet">
<style>
/* â”€â”€ RESET â”€â”€ */
*,*::before,*::after{box-sizing:border-box;margin:0;padding:0}
:root{
  --red:#e63946;--orange:#f4a261;--yellow:#f9c74f;--green:#06d6a0;
  --teal:#0096c7;--blue:#4361ee;--purple:#7209b7;--pink:#f72585;
  --dark:#1a1a2e;--light:#f8f9ff;
  --font-main:'Nunito',sans-serif;
  --font-display:'Playfair Display',serif;
  --font-ui:'Space Grotesk',sans-serif;
}
html{scroll-behavior:smooth}
body{font-family:var(--font-main);background:var(--light);color:var(--dark);overflow-x:hidden}

/* â”€â”€ NAV â”€â”€ */
.navbar{
  position:fixed;top:0;left:0;right:0;z-index:1000;
  background:rgba(26,26,46,0.95);backdrop-filter:blur(20px);
  border-bottom:1px solid rgba(255,255,255,0.08);
  display:flex;align-items:center;justify-content:space-between;
  padding:0 32px;height:64px;
}
.navbar .logo{
  font-family:var(--font-display);font-size:1.1rem;color:#fff;font-weight:700;
  display:flex;align-items:center;gap:10px;
}
.navbar .logo span{
  background:linear-gradient(90deg,var(--green),var(--teal));
  -webkit-background-clip:text;-webkit-text-fill-color:transparent;
}
.nav-links{display:flex;gap:8px;align-items:center}
.nav-btn{
  padding:8px 20px;border-radius:30px;font-size:0.85rem;font-weight:700;
  cursor:pointer;border:none;font-family:var(--font-ui);transition:all 0.2s;
}
.nav-btn.outline{
  background:transparent;color:#fff;border:1.5px solid rgba(255,255,255,0.3);
}
.nav-btn.outline:hover{border-color:var(--green);color:var(--green)}
.nav-btn.primary{
  background:linear-gradient(135deg,var(--pink),var(--purple));color:#fff;
  box-shadow:0 4px 15px rgba(247,37,133,0.4);
}
.nav-btn.primary:hover{transform:translateY(-1px);box-shadow:0 6px 20px rgba(247,37,133,0.5)}

/* â”€â”€ HERO â”€â”€ */
.hero{
  min-height:100vh;
  background:linear-gradient(135deg,#0f0c29,#302b63,#24243e);
  display:flex;flex-direction:column;align-items:center;justify-content:center;
  text-align:center;padding:100px 24px 60px;position:relative;overflow:hidden;
}
.hero::before{
  content:'';position:absolute;inset:0;
  background:radial-gradient(ellipse at 20% 80%,rgba(114,9,183,.5) 0%,transparent 55%),
             radial-gradient(ellipse at 80% 20%,rgba(67,97,238,.5) 0%,transparent 55%),
             radial-gradient(ellipse at 50% 50%,rgba(247,37,133,.15) 0%,transparent 70%);
}
.hero-badge{
  position:relative;display:inline-flex;align-items:center;gap:8px;
  background:rgba(255,255,255,0.1);backdrop-filter:blur(10px);
  border:1px solid rgba(255,255,255,0.2);border-radius:30px;
  padding:8px 20px;font-size:0.8rem;letter-spacing:2px;text-transform:uppercase;
  font-weight:700;color:var(--yellow);margin-bottom:28px;font-family:var(--font-ui);
  animation:fadeDown 0.8s ease both;
}
.hero h1{
  position:relative;
  font-family:var(--font-display);
  font-size:clamp(2.4rem,7vw,5.5rem);
  color:#fff;line-height:1.1;margin-bottom:10px;
  text-shadow:0 4px 40px rgba(247,37,133,0.4);
  animation:fadeUp 0.9s 0.2s ease both;
}
.hero h1 em{color:var(--yellow);font-style:normal}
.hero-sub{
  position:relative;
  font-size:clamp(1rem,2.5vw,1.35rem);
  color:rgba(255,255,255,0.7);max-width:640px;line-height:1.8;
  margin-bottom:48px;animation:fadeUp 0.9s 0.35s ease both;
}
.hero-cta{
  position:relative;display:flex;gap:14px;flex-wrap:wrap;justify-content:center;
  animation:fadeUp 0.9s 0.5s ease both;
}
.btn-hero-primary{
  padding:16px 36px;border-radius:50px;font-size:1rem;font-weight:800;
  cursor:pointer;border:none;font-family:var(--font-ui);
  background:linear-gradient(135deg,var(--pink),var(--purple));
  color:#fff;box-shadow:0 8px 30px rgba(247,37,133,0.5);
  transition:all 0.25s;
}
.btn-hero-primary:hover{transform:translateY(-3px);box-shadow:0 12px 40px rgba(247,37,133,0.6)}
.btn-hero-secondary{
  padding:16px 36px;border-radius:50px;font-size:1rem;font-weight:700;
  cursor:pointer;font-family:var(--font-ui);
  background:rgba(255,255,255,0.1);backdrop-filter:blur(10px);
  border:1.5px solid rgba(255,255,255,0.3);color:#fff;
  transition:all 0.25s;
}
.btn-hero-secondary:hover{background:rgba(255,255,255,0.18);border-color:var(--green);color:var(--green)}

/* floating bubbles */
.bubble{
  position:absolute;border-radius:50%;opacity:0.12;
  animation:float 10s ease-in-out infinite;
}
@keyframes float{0%,100%{transform:translateY(0) rotate(0deg)}50%{transform:translateY(-40px) rotate(180deg)}}

/* hero stats */
.hero-stats{
  position:relative;display:flex;gap:40px;flex-wrap:wrap;
  justify-content:center;margin-top:60px;
  animation:fadeUp 0.9s 0.65s ease both;
}
.stat{text-align:center}
.stat-num{
  font-family:var(--font-display);font-size:2.5rem;font-weight:700;
  background:linear-gradient(90deg,var(--green),var(--teal));
  -webkit-background-clip:text;-webkit-text-fill-color:transparent;
}
.stat-label{color:rgba(255,255,255,0.55);font-size:0.85rem;font-family:var(--font-ui);margin-top:4px}

/* â”€â”€ FEATURES STRIP â”€â”€ */
.features{
  display:flex;gap:0;flex-wrap:wrap;background:#fff;
  border-bottom:1px solid #eee;
}
.feature{
  flex:1;min-width:200px;padding:28px 24px;text-align:center;
  border-right:1px solid #f0f0f0;
}
.feature:last-child{border-right:none}
.feature-icon{font-size:1.8rem;margin-bottom:8px}
.feature-title{font-weight:800;font-size:0.95rem;color:var(--dark);font-family:var(--font-ui)}
.feature-desc{font-size:0.8rem;color:#666;margin-top:4px}

/* â”€â”€ PRICING SECTION â”€â”€ */
.pricing-section{
  padding:80px 24px;background:linear-gradient(180deg,#f8f9ff 0%,#fff 100%);
  text-align:center;
}
.section-tag{
  display:inline-block;background:linear-gradient(90deg,var(--pink),var(--purple));
  color:#fff;border-radius:20px;padding:4px 16px;font-size:0.75rem;
  font-weight:700;letter-spacing:2px;text-transform:uppercase;
  font-family:var(--font-ui);margin-bottom:16px;
}
.pricing-section h2{
  font-family:var(--font-display);font-size:clamp(1.8rem,4vw,3rem);
  color:var(--dark);margin-bottom:12px;
}
.pricing-section p{color:#555;font-size:1.05rem;max-width:520px;margin:0 auto 48px}
.pricing-cards{
  display:flex;gap:24px;flex-wrap:wrap;justify-content:center;max-width:900px;margin:0 auto;
}
.pricing-card{
  flex:1;min-width:260px;max-width:340px;border-radius:24px;padding:36px 28px;
  position:relative;overflow:hidden;text-align:left;
}
.pricing-card.free{
  background:#fff;border:2px solid #e8ecff;
  box-shadow:0 8px 30px rgba(0,0,0,0.06);
}
.pricing-card.paid{
  background:linear-gradient(135deg,#1a1a2e,#302b63);color:#fff;
  box-shadow:0 16px 50px rgba(67,97,238,0.35);
}
.pricing-card.paid::before{
  content:'';position:absolute;top:-40px;right:-40px;
  width:180px;height:180px;border-radius:50%;
  background:radial-gradient(circle,rgba(247,37,133,0.3),transparent 70%);
}
.popular-badge{
  position:absolute;top:20px;right:20px;
  background:linear-gradient(90deg,var(--pink),var(--orange));
  color:#fff;border-radius:20px;padding:4px 12px;
  font-size:0.72rem;font-weight:700;font-family:var(--font-ui);letter-spacing:1px;
}
.price-label{font-size:0.8rem;font-weight:700;font-family:var(--font-ui);
  text-transform:uppercase;letter-spacing:2px;opacity:0.6;margin-bottom:8px}
.price-amount{
  font-family:var(--font-display);font-size:2.8rem;font-weight:700;
  line-height:1;margin-bottom:4px;
}
.price-amount .currency{font-size:1.4rem;vertical-align:super}
.price-period{font-size:0.85rem;opacity:0.6;margin-bottom:24px}
.price-features{list-style:none;margin-bottom:28px}
.price-features li{
  padding:8px 0;border-bottom:1px solid rgba(0,0,0,0.06);
  font-size:0.9rem;display:flex;align-items:center;gap:10px;
}
.pricing-card.paid .price-features li{border-color:rgba(255,255,255,0.1)}
.price-features li::before{content:'âœ“';color:var(--green);font-weight:800;flex-shrink:0}
.btn-pricing{
  width:100%;padding:14px;border-radius:50px;font-size:0.95rem;font-weight:800;
  cursor:pointer;border:none;font-family:var(--font-ui);transition:all 0.25s;
}
.btn-pricing.free-btn{
  background:var(--light);color:var(--dark);border:2px solid #e0e4ff;
}
.btn-pricing.free-btn:hover{background:#e8ecff}
.btn-pricing.paid-btn{
  background:linear-gradient(135deg,var(--pink),var(--purple));color:#fff;
  box-shadow:0 6px 20px rgba(247,37,133,0.4);
}
.btn-pricing.paid-btn:hover{transform:translateY(-2px);box-shadow:0 10px 28px rgba(247,37,133,0.5)}

/* â”€â”€ TOC SECTION â”€â”€ */
.toc-section{padding:80px 24px;background:#fff}
.toc-section h2{
  font-family:var(--font-display);font-size:clamp(1.8rem,4vw,2.8rem);
  text-align:center;color:var(--dark);margin-bottom:12px;
}
.toc-section > p{text-align:center;color:#555;font-size:1rem;margin-bottom:48px}
.toc-grid{max-width:900px;margin:0 auto}
.part-header{
  display:flex;align-items:center;gap:12px;margin:32px 0 12px;
  font-family:var(--font-ui);font-weight:700;font-size:0.8rem;
  text-transform:uppercase;letter-spacing:2px;color:var(--blue);
}
.part-header::before,.part-header::after{content:'';flex:1;height:1px;background:#e0e4ff}
.toc-item{
  display:flex;align-items:center;gap:14px;padding:14px 18px;
  border-radius:14px;margin-bottom:8px;cursor:pointer;
  border:1.5px solid transparent;transition:all 0.2s;
  background:#fafbff;
}
.toc-item:hover,.toc-item.free{
  border-color:#e0e4ff;background:#fff;
  box-shadow:0 4px 16px rgba(67,97,238,0.1);
}
.toc-item.free{border-color:rgba(6,214,160,0.3)}
.toc-num{
  font-family:var(--font-ui);font-size:0.75rem;font-weight:800;
  color:#fff;background:var(--blue);border-radius:8px;
  padding:3px 8px;flex-shrink:0;
}
.toc-item.free .toc-num{background:var(--green)}
.toc-emoji{font-size:1.3rem;flex-shrink:0}
.toc-title{flex:1;font-weight:600;font-size:0.9rem;color:var(--dark)}
.free-badge{
  background:linear-gradient(90deg,var(--green),var(--teal));
  color:#fff;border-radius:20px;padding:2px 10px;
  font-size:0.7rem;font-weight:700;font-family:var(--font-ui);flex-shrink:0;
}
.part-badge{
  background:#f0f4ff;color:var(--blue);border-radius:20px;padding:2px 10px;
  font-size:0.7rem;font-weight:700;font-family:var(--font-ui);flex-shrink:0;
}
.toc-lock{font-size:1rem;flex-shrink:0}

/* â”€â”€ AUTHOR SECTION â”€â”€ */
.author-section{
  padding:80px 24px;
  background:linear-gradient(135deg,#1a1a2e,#302b63);
  text-align:center;color:#fff;
}
.author-avatar{
  width:90px;height:90px;border-radius:50%;margin:0 auto 20px;
  background:linear-gradient(135deg,var(--green),var(--teal));
  display:flex;align-items:center;justify-content:center;
  font-size:2.5rem;box-shadow:0 8px 30px rgba(6,214,160,0.4);
}
.author-section h2{
  font-family:var(--font-display);font-size:clamp(1.6rem,3vw,2.2rem);
  margin-bottom:8px;
}
.author-section .credentials{
  color:rgba(255,255,255,0.6);font-size:0.95rem;margin-bottom:24px;
}
.author-section .bio{
  max-width:600px;margin:0 auto;color:rgba(255,255,255,0.75);
  line-height:1.8;font-size:1rem;
}

/* â”€â”€ FOOTER â”€â”€ */
.footer{
  background:#0f0c29;color:rgba(255,255,255,0.5);
  text-align:center;padding:28px;font-size:0.85rem;
}
.footer strong{color:var(--green)}

/* â”€â”€ CHAPTER MODAL â”€â”€ */
.modal-overlay{
  display:none;position:fixed;inset:0;z-index:2000;
  background:rgba(0,0,0,0.85);backdrop-filter:blur(8px);
  align-items:flex-start;justify-content:center;overflow-y:auto;padding:20px;
}
.modal-overlay.active{display:flex}
.modal-box{
  background:var(--light);border-radius:24px;
  width:100%;max-width:1000px;margin:auto;
  overflow:hidden;position:relative;
  box-shadow:0 30px 80px rgba(0,0,0,0.5);
}
.modal-header{
  display:flex;align-items:center;justify-content:space-between;
  padding:16px 24px;background:var(--dark);color:#fff;
  position:sticky;top:0;z-index:10;
}
.modal-header .modal-title{
  font-family:var(--font-display);font-size:1rem;font-weight:700;
}
.modal-close{
  background:rgba(255,255,255,0.1);border:none;color:#fff;
  width:36px;height:36px;border-radius:50%;font-size:1.1rem;
  cursor:pointer;display:flex;align-items:center;justify-content:center;
  transition:background 0.2s;
}
.modal-close:hover{background:rgba(255,255,255,0.2)}
.modal-nav{
  display:flex;gap:8px;
}
.modal-nav-btn{
  background:rgba(255,255,255,0.1);border:none;color:#fff;
  padding:6px 14px;border-radius:20px;font-size:0.8rem;font-weight:700;
  cursor:pointer;font-family:var(--font-ui);transition:background 0.2s;
}
.modal-nav-btn:hover{background:rgba(255,255,255,0.2)}
.modal-content{padding:0;min-height:400px}

/* â”€â”€ LOCK SCREEN â”€â”€ */
.lock-screen{
  display:flex;flex-direction:column;align-items:center;justify-content:center;
  padding:80px 32px;text-align:center;background:linear-gradient(135deg,#1a1a2e,#302b63);
  color:#fff;min-height:500px;
}
.lock-icon{font-size:4rem;margin-bottom:20px;animation:pulse 2s infinite}
@keyframes pulse{0%,100%{transform:scale(1)}50%{transform:scale(1.1)}}
.lock-screen h3{font-family:var(--font-display);font-size:1.8rem;margin-bottom:12px}
.lock-screen p{color:rgba(255,255,255,0.65);max-width:420px;line-height:1.7;margin-bottom:32px}
.lock-price{
  font-family:var(--font-display);font-size:3rem;font-weight:700;
  background:linear-gradient(90deg,var(--yellow),var(--orange));
  -webkit-background-clip:text;-webkit-text-fill-color:transparent;
  margin-bottom:24px;
}
.lock-price small{font-size:1.2rem;opacity:0.7}
.btn-unlock{
  padding:16px 40px;border-radius:50px;font-size:1rem;font-weight:800;
  cursor:pointer;border:none;font-family:var(--font-ui);
  background:linear-gradient(135deg,var(--pink),var(--purple));
  color:#fff;box-shadow:0 8px 30px rgba(247,37,133,0.5);
  transition:all 0.25s;margin-bottom:16px;
}
.btn-unlock:hover{transform:translateY(-2px);box-shadow:0 12px 40px rgba(247,37,133,0.6)}
.btn-razorpay{
  display:inline-flex;align-items:center;gap:8px;
  padding:14px 32px;border-radius:50px;font-size:0.9rem;font-weight:700;
  cursor:pointer;border:2px solid rgba(255,255,255,0.2);
  font-family:var(--font-ui);background:transparent;color:rgba(255,255,255,0.75);
  transition:all 0.25s;
}
.btn-razorpay:hover{border-color:var(--green);color:var(--green)}

/* â”€â”€ PAYMENT MODAL â”€â”€ */
.pay-modal{
  display:none;position:fixed;inset:0;z-index:3000;
  background:rgba(0,0,0,0.9);align-items:center;justify-content:center;
}
.pay-modal.active{display:flex}
.pay-box{
  background:#fff;border-radius:24px;padding:32px 24px;max-width:440px;width:90%;
  text-align:center;position:relative;
  max-height:90vh;overflow-y:auto;
}
.pay-box h3{font-family:var(--font-display);font-size:1.5rem;color:var(--dark);margin-bottom:8px}
.pay-box p{color:#666;font-size:0.9rem;margin-bottom:24px}
.pay-options{display:flex;flex-direction:column;gap:12px;margin-bottom:20px}
.pay-option{
  display:flex;align-items:center;justify-content:space-between;
  padding:16px 20px;border-radius:14px;border:2px solid #e0e4ff;
  cursor:pointer;transition:all 0.2s;font-family:var(--font-ui);
}
.pay-option:hover{border-color:var(--blue);background:#f0f4ff}
.pay-option .pay-name{font-weight:700;color:var(--dark)}
.pay-option .pay-price{
  font-family:var(--font-display);font-size:1.3rem;font-weight:700;color:var(--blue);
}
.pay-close{
  position:absolute;top:16px;right:16px;background:none;border:none;
  font-size:1.3rem;cursor:pointer;color:#999;
}
.pay-note{font-size:0.78rem;color:#999;margin-top:8px}
.pay-input{
  width:100%;padding:12px 16px;border-radius:12px;
  border:1.5px solid #e0e4ff;font-family:var(--font-ui);font-size:0.95rem;
  margin-bottom:12px;outline:none;
}
.pay-input:focus{border-color:var(--blue)}
.btn-verify{
  width:100%;padding:14px;border-radius:50px;font-size:0.95rem;font-weight:800;
  cursor:pointer;border:none;font-family:var(--font-ui);
  background:linear-gradient(135deg,var(--green),var(--teal));color:#fff;
  transition:all 0.2s;
}

/* â”€â”€ ANIMATIONS â”€â”€ */
@keyframes fadeUp{from{opacity:0;transform:translateY(30px)}to{opacity:1;transform:translateY(0)}}
@keyframes fadeDown{from{opacity:0;transform:translateY(-20px)}to{opacity:1;transform:translateY(0)}}

/* Responsive */
@media(max-width:640px){
  .navbar{padding:0 16px}
  .hero{padding:80px 16px 40px}
  .features{flex-direction:column}
  .feature{border-right:none;border-bottom:1px solid #f0f0f0}
  .toc-title{font-size:0.8rem}
}
</style>
</head>
<body>

<!-- NAVBAR -->
<nav class="navbar">
  <div class="logo">
    ğŸ¥ <span>ICU Hinglish</span>
  </div>
  <div class="nav-links">
    <button class="nav-btn outline" onclick="document.getElementById('toc-section').scrollIntoView({behavior:'smooth'})">Chapters</button>
    <button class="nav-btn primary" onclick="showPayModal()">ğŸ“š Buy Full Book</button>
  </div>
</nav>

<!-- HERO -->
<section class="hero">
  <!-- Bubbles -->
  <div class="bubble" style="width:300px;height:300px;background:var(--purple);top:-100px;left:-100px;animation-delay:0s"></div>
  <div class="bubble" style="width:200px;height:200px;background:var(--blue);bottom:100px;right:-50px;animation-delay:3s"></div>
  <div class="bubble" style="width:150px;height:150px;background:var(--pink);top:40%;left:5%;animation-delay:1.5s"></div>

  <div class="hero-badge">ğŸ‡®ğŸ‡³ &nbsp; India Ka Pehla Critical Care Mind Map Book â€” Hinglish Mein</div>
  
  <h1>ICU Ka Poora Ilm<br><em>Ek Hi Jagah!</em></h1>
  
  <p class="hero-sub">
    30 chapters, colorful mind maps, aur Hinglish mein crystal clear explanations â€” 
    har ICU doctor aur resident ke liye banaayi gayi hai yeh book.
  </p>

  <div class="hero-cta">
    <button class="btn-hero-primary" onclick="openChapter(0)">â–¶ Chapter 1 Free Padho</button>
    <button class="btn-hero-secondary" onclick="showPayModal()">ğŸ’³ Full Book Unlock Karo</button>
  </div>

  <div class="hero-stats">
    <div class="stat"><div class="stat-num">30</div><div class="stat-label">Chapters</div></div>
    <div class="stat"><div class="stat-num">3</div><div class="stat-label">Parts</div></div>
    <div class="stat"><div class="stat-num">100%</div><div class="stat-label">Hinglish</div></div>
    <div class="stat"><div class="stat-num">âˆ</div><div class="stat-label">ICU Mein Kaam Aayegi</div></div>
  </div>
</section>

<!-- FEATURES -->
<div class="features">
  <div class="feature"><div class="feature-icon">ğŸ—ºï¸</div><div class="feature-title">Visual Mind Maps</div><div class="feature-desc">SVG diagrams jo concepts lock kar dein dimaag mein</div></div>
  <div class="feature"><div class="feature-icon">ğŸ‡®ğŸ‡³</div><div class="feature-title">Pure Hinglish</div><div class="feature-desc">Hindi + English â€” dono mein samjho</div></div>
  <div class="feature"><div class="feature-icon">âš¡</div><div class="feature-title">Quick Revision</div><div class="feature-desc">Night duty se pehle 10 min mein revise karo</div></div>
  <div class="feature"><div class="feature-icon">ğŸ“±</div><div class="feature-title">Mobile Friendly</div><div class="feature-desc">Phone par bhi perfectly readable</div></div>
  <div class="feature"><div class="feature-icon">ğŸ”¬</div><div class="feature-title">Evidence-Based</div><div class="feature-desc">SCCM, ESICM, AHA guidelines pe based</div></div>
</div>

<!-- PREFACE -->
<section style="background:linear-gradient(135deg,#0f0c29,#1a1a2e);padding:72px 24px;">
  <div style="max-width:760px;margin:0 auto;">

    <div style="text-align:center;margin-bottom:40px;">
      <span style="display:inline-block;background:linear-gradient(90deg,var(--green),var(--teal));color:#fff;border-radius:20px;padding:5px 18px;font-size:0.75rem;font-weight:800;letter-spacing:2px;text-transform:uppercase;font-family:'Space Grotesk',sans-serif;margin-bottom:16px;">âœï¸ Preface</span>
      <h2 style="font-family:'Playfair Display',serif;color:#fff;font-size:clamp(1.6rem,4vw,2.6rem);line-height:1.2;">Dil Se â€” <em style="color:var(--yellow);">Dr. Varun Kumar</em> Ki Taraf Se</h2>
    </div>

    <div style="border-left:4px solid var(--green);padding:20px 28px;background:rgba(6,214,160,0.07);border-radius:0 16px 16px 0;margin-bottom:36px;">
      <p style="font-family:'Playfair Display',serif;font-size:1.25rem;color:rgba(255,255,255,0.9);line-height:1.8;font-style:italic;">
        "Main koi zyada padhne waala student nahi tha â€” ICU ki badi badi kitabein dekh kar dar lagta tha. Chahta tha koi apni bhasha mein samjha de."
      </p>
      <p style="color:var(--green);font-weight:700;font-family:'Space Grotesk',sans-serif;font-size:0.85rem;margin-top:12px;">â€” Dr. Varun Kumar Varshney</p>
    </div>

    <div style="display:flex;gap:20px;align-items:flex-start;margin-bottom:32px;">
      <span style="font-size:2.5rem;flex-shrink:0;line-height:1;">ğŸ¬</span>
      <div>
        <p style="color:rgba(255,255,255,0.85);font-size:1rem;line-height:1.9;font-family:'Nunito',sans-serif;">
          Munna Bhai mein jab Munna Gandhi ji ke baare mein padta tha â€” toh library mein <strong style="color:var(--yellow);">pehle sabse patli kitab leta tha</strong>, aur dheere dheere poori library. Kuch aisa hi karne ka prayas hai yahan.
          <br/><br/>
          Hinglish mein, itni asaan tarike se, ki <strong style="color:var(--green);">baatein aapke saath rahengi</strong> â€” OT mein, night duty mein, presentation mein â€” hamesha.
        </p>
      </div>
    </div>

    <div style="display:flex;gap:20px;align-items:flex-start;margin-bottom:36px;">
      <span style="font-size:2.5rem;flex-shrink:0;line-height:1;">ğŸŒŠ</span>
      <div>
        <p style="color:rgba(255,255,255,0.85);font-size:1rem;line-height:1.9;font-family:'Nunito',sans-serif;">
          ICU ki knowledge kisi <strong style="color:var(--teal);">samundra ki tarah</strong> hai â€” anant, gehri, aur kabhi kabhi daraaune wali. Aap poora samundra ek baar mein nahi pi sakte.
          <br/><br/>
          Lekin ek ek ghunt se shuruat hoti hai. <strong style="color:var(--yellow);">Yeh book wahi pehli ghunt hai</strong> â€” simple, seedhi, aur aapki apni bhasha mein.
        </p>
      </div>
    </div>

    <div style="border-top:1px solid rgba(255,255,255,0.1);padding-top:28px;text-align:center;">
      <p style="color:rgba(255,255,255,0.5);font-size:0.9rem;font-family:'Nunito',sans-serif;line-height:1.9;">
        Yeh kitab un logon ke liye hai jo ICU se darte hain.<br/>
        Un logon ke liye jo raat ko duty se pehle Google karte hain.<br/>
        Un logon ke liye jo chahte hain â€” <strong style="color:#fff;">bas ek baar clearly samajh jaayein.</strong>
      </p>
      <div style="margin-top:24px;display:inline-flex;align-items:center;gap:12px;background:rgba(255,255,255,0.06);border:1px solid rgba(255,255,255,0.12);border-radius:50px;padding:12px 24px;">
        <span style="font-size:1.3rem;">ğŸ©º</span>
        <div style="text-align:left;">
          <p style="color:#fff;font-weight:800;font-family:'Space Grotesk',sans-serif;font-size:0.9rem;margin:0;">Dr. Varun Kumar Varshney</p>
          <p style="color:rgba(255,255,255,0.45);font-size:0.75rem;margin:2px 0 0;font-family:'Space Grotesk',sans-serif;">Critical Care Specialist</p>
        </div>
      </div>
    </div>

  </div>
</section>

<!-- PRICING -->
<section class="pricing-section">
  <div class="section-tag">ğŸ’° Pricing</div>
  <h2>Simple, Fair Pricing</h2>
  <p>Ek baar pay karo, hamesha ke liye access pao â€” koi subscription nahi!</p>
  
  <div class="pricing-cards">
    <div class="pricing-card free">
      <div class="price-label">Free Preview</div>
      <div class="price-amount"><span class="currency">â‚¹</span>0</div>
      <div class="price-period">hamesha free</div>
      <ul class="price-features">
        <li>Chapter 1 â€” Airway (full access)</li>
        <li>Mind Map + Cards dekhein</li>
        <li>Book ka feel lein</li>
      </ul>
      <button class="btn-pricing free-btn" onclick="openChapter(0)">â–¶ Free Chapter Padho</button>
    </div>
    
    <div class="pricing-card paid">
      <div class="popular-badge">â­ MOST POPULAR</div>
      <div class="price-label" style="color:rgba(255,255,255,0.5)">Complete Book</div>
      <div class="price-amount" style="color:#fff"><span class="currency">â‚¹</span>499</div>
      <div class="price-period" style="color:rgba(255,255,255,0.5)">lifetime access â€¢ one-time payment</div>
      <ul class="price-features" style="color:#fff">
        <li>Saare 30 Chapters unlock</li>
        <li>Parts 1, 2 aur 3 â€” sab kuch</li>
        <li>SVG Mind Maps (colorful!)</li>
        <li>Mobile + Desktop access</li>
        <li>Future updates free</li>
        <li>PDF download bhi</li>
      </ul>
      <button class="btn-pricing paid-btn" onclick="showPayModal()">ğŸ”“ Abhi Unlock Karo â€” â‚¹499</button>
    </div>
  </div>
</section>

<!-- TABLE OF CONTENTS -->
<section class="toc-section" id="toc-section">
  <div class="section-tag">ğŸ“‹ Content</div>
  <h2>30 Chapters â€” Kya Kya Hai Andar?</h2>
  <p>Chapter 1 bilkul free hai. Baaki chapters unlock karne ke liye â‚¹499 mein poori book lo!</p>
  
  <div class="toc-grid"><div class="part-header">Part 1 â€” Chapters 1 to 10</div>
        <div class="toc-item free" onclick="openChapter(0)">
          <span class="toc-num">01</span>
          <span class="toc-emoji">ğŸ«</span>
          <span class="toc-title">Airway â€” Saans Ki Nali Ko Sambhalo!</span>
          <span class="free-badge">FREE</span>
          <span class="toc-lock">ğŸ”“</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(1)">
          <span class="toc-num">02</span>
          <span class="toc-emoji">ğŸ”§</span>
          <span class="toc-title">Mechanical Ventilation â€” Machine Se Saans!</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(2)">
          <span class="toc-num">03</span>
          <span class="toc-emoji">ğŸ’”</span>
          <span class="toc-title">Shock â€” Jab BP Gir Jaaye!</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(3)">
          <span class="toc-num">04</span>
          <span class="toc-emoji">ğŸ¦ </span>
          <span class="toc-title">Sepsis â€” Infection Ka Toofan!</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(4)">
          <span class="toc-num">05</span>
          <span class="toc-emoji">ğŸ«</span>
          <span class="toc-title">ARDS â€” Phaephde Ka Crisis!</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(5)">
          <span class="toc-num">06</span>
          <span class="toc-emoji">ğŸ«˜</span>
          <span class="toc-title">AKI â€” Gurde Ka Achanak Dhoka!</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(6)">
          <span class="toc-num">07</span>
          <span class="toc-emoji">ğŸ’¤</span>
          <span class="toc-title">Dard Aur Neend â€” Sedation, Analgesia, Delirium</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(7)">
          <span class="toc-num">08</span>
          <span class="toc-emoji">â¤ï¸</span>
          <span class="toc-title">Dil Ki Emergency â€” Cardiac Emergencies in ICU</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(8)">
          <span class="toc-num">09</span>
          <span class="toc-emoji">ğŸ§ </span>
          <span class="toc-title">Dimag Ki Emergency â€” Neurological Emergencies!</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(9)">
          <span class="toc-num">10</span>
          <span class="toc-emoji">ğŸ¥—</span>
          <span class="toc-title">ICU Mein Khaana Peena â€” Nutrition!</span>
          <span class="part-badge">Part 1</span>
          <span class="toc-lock">ğŸ”’</span>
        </div><div class="part-header">Part 2 â€” Chapters 11 to 20</div>
        <div class="toc-item locked" onclick="openChapter(10)">
          <span class="toc-num">11</span>
          <span class="toc-emoji">ğŸ©¸</span>
          <span class="toc-title">GI Bleeding â€” ICU Mein Manage Karo!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(11)">
          <span class="toc-num">12</span>
          <span class="toc-emoji">ğŸ”´</span>
          <span class="toc-title">DIC â€” Disseminated Intravascular Coagulation!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(12)">
          <span class="toc-num">13</span>
          <span class="toc-emoji">ğŸ’‰</span>
          <span class="toc-title">ICU Infections & Antibiotics â€” Antimicrobial Stewardship!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(13)">
          <span class="toc-num">14</span>
          <span class="toc-emoji">ğŸ«€</span>
          <span class="toc-title">Acute Liver Failure â€” Khatarnak Hai!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(14)">
          <span class="toc-num">15</span>
          <span class="toc-emoji">ğŸ«</span>
          <span class="toc-title">Pulmonary Embolism â€” Massive PE Bachao!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(15)">
          <span class="toc-num">16</span>
          <span class="toc-emoji">â˜ ï¸</span>
          <span class="toc-title">Toxicology & Poisoning â€” ICU Mein!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(16)">
          <span class="toc-num">17</span>
          <span class="toc-emoji">ğŸš‘</span>
          <span class="toc-title">Trauma ICU â€” Maut Se Ladte Hain!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(17)">
          <span class="toc-num">18</span>
          <span class="toc-emoji">ğŸŒ¬ï¸</span>
          <span class="toc-title">Ventilator Weaning â€” Kab Nikaalo?</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(18)">
          <span class="toc-num">19</span>
          <span class="toc-emoji">âš™ï¸</span>
          <span class="toc-title">ECMO â€” Jab Sab Fail Ho Jaaye!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(19)">
          <span class="toc-num">20</span>
          <span class="toc-emoji">ğŸ™</span>
          <span class="toc-title">End of Life Care in ICU â€” Izzat Se Jaana!</span>
          <span class="part-badge">Part 2</span>
          <span class="toc-lock">ğŸ”’</span>
        </div><div class="part-header">Part 3 â€” Chapters 21 to 30</div>
        <div class="toc-item locked" onclick="openChapter(20)">
          <span class="toc-num">21</span>
          <span class="toc-emoji">ğŸ©º</span>
          <span class="toc-title">Endocrine Emergencies â€” Hormones Pagal Ho Gaye!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(21)">
          <span class="toc-num">22</span>
          <span class="toc-emoji">ğŸ”¥</span>
          <span class="toc-title">Burns ICU â€” Aag Ka Ilaj!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(22)">
          <span class="toc-num">23</span>
          <span class="toc-emoji">ğŸ¤°</span>
          <span class="toc-title">Obstetric Critical Care â€” Do Zindagiyaan Bachao!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(23)">
          <span class="toc-num">24</span>
          <span class="toc-emoji">â¤ï¸</span>
          <span class="toc-title">Cardiac Arrest & Post-Resuscitation Care â€” ROSC Ke Baad!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(24)">
          <span class="toc-num">25</span>
          <span class="toc-emoji">ğŸ§ </span>
          <span class="toc-title">ICU Delirium & PICS â€” Dimaag Ka ICU!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(25)">
          <span class="toc-num">26</span>
          <span class="toc-emoji">ğŸ©¸</span>
          <span class="toc-title">Haematological Emergencies â€” Khoon Ki Gadbadi!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(26)">
          <span class="toc-num">27</span>
          <span class="toc-emoji">ğŸ’§</span>
          <span class="toc-title">Renal Replacement Therapy â€” Gurdey Ki Machine!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(27)">
          <span class="toc-num">28</span>
          <span class="toc-emoji">ğŸ”¬</span>
          <span class="toc-title">POCUS in Critical Care â€” Ultrasound ICU Ka Stetho Hai!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(28)">
          <span class="toc-num">29</span>
          <span class="toc-emoji">ğŸ¥</span>
          <span class="toc-title">Surgical Critical Care â€” Operation Ke Baad Ka Drama!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div>
        <div class="toc-item locked" onclick="openChapter(29)">
          <span class="toc-num">30</span>
          <span class="toc-emoji">ğŸ“Š</span>
          <span class="toc-title">ICU Scoring & Prognostication â€” Numbers Se Kya Pata Chalta Hai!</span>
          <span class="part-badge">Part 3</span>
          <span class="toc-lock">ğŸ”’</span>
        </div></div>
</section>

<!-- AUTHOR -->
<section class="author-section">
  <div class="author-avatar">ğŸ‘¨â€âš•ï¸</div>
  <h2>Dr. Varun Kumar Varshney</h2>
  <div class="credentials">MBBS &nbsp;|&nbsp; MD Anaesthesia &nbsp;|&nbsp; Specialist in Critical Care & Anaesthesiology</div>
  <p class="bio">
    Yeh book un doctors ke liye hai jo ICU mein kaam karte hain aur chahte hain ki 
    sab kuch ek baar mein, asaani se, aur apni zubaan mein samajh aaye. 
    Dr. Varshney ne apne years of ICU experience ko in 30 chapters mein 
    Hinglish ke zariye present kiya hai â€” taaki concept sirf yaad na rahe, samajh aaye!
  </p>
</section>

<!-- FOOTER -->
<!-- DISCLAIMER SECTION -->
<section style="background:linear-gradient(135deg,#1a1a2e,#16213e);padding:48px 24px;">
  <div style="max-width:860px;margin:0 auto;">
    <div style="text-align:center;margin-bottom:28px;">
      <span style="display:inline-block;background:linear-gradient(90deg,#f9c74f,#f8961e);color:#1a1a2e;border-radius:20px;padding:5px 18px;font-size:0.75rem;font-weight:800;letter-spacing:2px;text-transform:uppercase;font-family:'Space Grotesk',sans-serif;margin-bottom:14px;">âš ï¸ Important Disclaimer</span>
      <h3 style="font-family:'Playfair Display',serif;color:#fff;font-size:clamp(1.4rem,3vw,2rem);margin-bottom:0;">Padho â€” Zaroor Padho Bhai!</h3>
    </div>
    <div style="background:rgba(255,255,255,0.05);border:1.5px solid rgba(249,199,79,0.3);border-radius:20px;padding:32px 36px;">
      <div style="display:grid;gap:20px;">

        <div style="display:flex;gap:14px;align-items:flex-start;">
          <span style="font-size:1.6rem;flex-shrink:0;">ğŸ“š</span>
          <div>
            <p style="color:#f9c74f;font-weight:800;font-family:'Space Grotesk',sans-serif;font-size:0.95rem;margin-bottom:4px;">Sirf Educational Purpose Ke Liye</p>
            <p style="color:rgba(255,255,255,0.7);font-size:0.88rem;line-height:1.75;">Yeh book/content <strong style="color:#fff;">sirf educational aur training purpose</strong> ke liye bana hai. Iska koi bhi content direct clinical decision-making ke liye use nahi karna chahiye bina proper clinical assessment, senior supervision, aur institutional guidelines ke.</p>
          </div>
        </div>

        <div style="border-top:1px solid rgba(255,255,255,0.08);padding-top:20px;display:flex;gap:14px;align-items:flex-start;">
          <span style="font-size:1.6rem;flex-shrink:0;">ğŸ¥</span>
          <div>
            <p style="color:#f9c74f;font-weight:800;font-family:'Space Grotesk',sans-serif;font-size:0.95rem;margin-bottom:4px;">Clinical Judgment Sabse Pehle</p>
            <p style="color:rgba(255,255,255,0.7);font-size:0.88rem;line-height:1.75;">Har patient alag hota hai â€” ek jaisi condition mein bhi management different ho sakti hai. Yahan diye gaye doses, protocols, aur guidelines <strong style="color:#fff;">general reference</strong> ke liye hain. Apne institution ki protocols, local antibiogram, aur senior consultant ki guidance hamesha follow karo.</p>
          </div>
        </div>

        <div style="border-top:1px solid rgba(255,255,255,0.08);padding-top:20px;display:flex;gap:14px;align-items:flex-start;">
          <span style="font-size:1.6rem;flex-shrink:0;">ğŸ”„</span>
          <div>
            <p style="color:#f9c74f;font-weight:800;font-family:'Space Grotesk',sans-serif;font-size:0.95rem;margin-bottom:4px;">Guidelines Change Hoti Hain</p>
            <p style="color:rgba(255,255,255,0.7);font-size:0.88rem;line-height:1.75;">Medical evidence aur guidelines continuously update hoti rehti hain. Is book mein diya gaya content <strong style="color:#fff;">publication time ka best available evidence</strong> reflect karta hai. Latest guidelines ke liye SCCM, ESICM, Surviving Sepsis Campaign aur relevant society guidelines zaroor check karo.</p>
          </div>
        </div>

        <div style="border-top:1px solid rgba(255,255,255,0.08);padding-top:20px;display:flex;gap:14px;align-items:flex-start;">
          <span style="font-size:1.6rem;flex-shrink:0;">âš–ï¸</span>
          <div>
            <p style="color:#f9c74f;font-weight:800;font-family:'Space Grotesk',sans-serif;font-size:0.95rem;margin-bottom:4px;">Liability Disclaimer</p>
            <p style="color:rgba(255,255,255,0.7);font-size:0.88rem;line-height:1.75;"><strong style="color:#fff;">Dr. Varun Kumar Varshney</strong> aur is content ke creators kisi bhi patient outcome ke liye liable nahi hain jo is educational material ke aadhar par liye gaye clinical decisions se arise ho. Yeh content <strong style="color:#fff;">substitute nahi hai</strong> proper medical training, supervision, aur professional judgement ka.</p>
          </div>
        </div>

        <div style="border-top:1px solid rgba(255,255,255,0.08);padding-top:20px;display:flex;gap:14px;align-items:flex-start;">
          <span style="font-size:1.6rem;flex-shrink:0;">Â©ï¸</span>
          <div>
            <p style="color:#f9c74f;font-weight:800;font-family:'Space Grotesk',sans-serif;font-size:0.95rem;margin-bottom:4px;">Copyright & Intellectual Property</p>
            <p style="color:rgba(255,255,255,0.7);font-size:0.88rem;line-height:1.75;">Is book ka koi bhi content â€” text, diagrams, mind maps, illustrations â€” <strong style="color:#fff;">Dr. Varun Kumar Varshney ki intellectual property hai.</strong> Bina written permission ke reproduce, redistribute, ya commercial use karna prohibited hai. Educational sharing allowed hai proper attribution ke saath.</p>
          </div>
        </div>

      </div>
    </div>

    <div style="text-align:center;margin-top:24px;">
      <p style="color:rgba(255,255,255,0.4);font-size:0.8rem;font-family:'Space Grotesk',sans-serif;">By accessing this content, you agree to use it responsibly for educational purposes only.</p>
      <p style="color:rgba(255,255,255,0.3);font-size:0.75rem;margin-top:6px;">For queries: <span style="color:var(--green);">drvarunvarshney@gmail.com</span></p>
    </div>
  </div>
</section>

<footer class="footer">
  <p>Â© 2025 <strong>Dr. Varun Kumar Varshney</strong>. All rights reserved.</p>
  <p style="margin-top:8px">Critical Care Mind Map Book â€” Hinglish | Sirf educational purpose ke liye</p>
</footer>

<!-- CHAPTER MODAL -->
<div class="modal-overlay" id="chapterModal">
  <div class="modal-box">
    <div class="modal-header">
      <div class="modal-title" id="modalTitle">Chapter</div>
      <div style="display:flex;align-items:center;gap:8px">
        <div class="modal-nav">
          <button class="modal-nav-btn" onclick="prevChapter()">â† Prev</button>
          <button class="modal-nav-btn" onclick="nextChapter()">Next â†’</button>
        </div>
        <button class="modal-close" onclick="closeModal()">âœ•</button>
      </div>
    </div>
    <div class="modal-content" id="modalContent"></div>
  </div>
</div>

<!-- PAYMENT MODAL -->
<div class="pay-modal" id="payModal">
  <div class="pay-box">
    <button class="pay-close" onclick="closePayModal()">&#x2715;</button>
    <div style="font-size:2rem;margin-bottom:8px">&#x1F4DA;</div>
    <h3>Full Book Unlock Karo</h3>
    <p style="margin-bottom:16px">Ek baar pay karo, lifetime access pao &#x2014; saare 30 chapters!</p>

    <!-- UPI DIRECT LINK PAYMENT -->
    <div style="background:linear-gradient(135deg,#f0fff4,#e6f7ff);border:2px solid #06d6a0;border-radius:16px;padding:20px;text-align:center;">
      <div style="font-size:2.2rem;font-weight:900;color:#e63946;margin-bottom:4px">&#x20B9;499</div>
      <p style="font-size:0.78rem;color:#666;margin-bottom:16px">Lifetime Access &#x1F513; &#x2022; Sirf ek baar pay karo</p>

      <!-- BIG UPI BUTTON -->
      <a href="upi://pay?pa=9045477253@hdfc&pn=Dr%20Varun%20Varshney&am=499&cu=INR&tn=CriticalCareBook"
         style="display:block;background:linear-gradient(135deg,#06d6a0,#0096c7);color:#fff;text-decoration:none;font-weight:800;font-size:1.1rem;padding:16px;border-radius:12px;margin-bottom:12px;box-shadow:0 4px 20px rgba(6,214,160,0.4);">
        &#x1F4B3; UPI se Pay Karo &#x2192;
      </a>

      <p style="font-size:0.72rem;color:#888;margin-bottom:12px">
        &#x2191; Click karein &#x2014; PhonePe / GPay / Paytm seedha khulega
      </p>

      <!-- QR CODE -->
      <div style="display:flex;justify-content:center;margin-bottom:12px;">
        <img src="data:image/png;base64,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"
          alt="UPI QR Code"
          style="width:200px;height:200px;border-radius:10px;border:2px solid #06d6a0;padding:4px;background:#fff;">
      </div>
      <p style="font-size:0.7rem;color:#888;margin-bottom:14px">&#x2191; Ya QR scan karo kisi bhi UPI app se</p>

      <p style="font-size:0.75rem;color:#555;line-height:1.8;background:#fff;border-radius:10px;padding:10px;">
        &#x1F4AC; Payment ke baad screenshot WhatsApp karo:<br>
        <a href="https://wa.me/919045477253?text=Maine%20Critical%20Care%20Book%20ke%20liye%20Rs.499%20pay%20kar%20diya!" target="_blank"
           style="color:#06d6a0;font-weight:800;font-size:0.85rem;">&#x1F4F2; WhatsApp: +91 99270 23377</a><br>
        <span style="color:#888;font-size:0.7rem;">Aapko access code turant milega &#x2705;</span>
      </p>
    </div>

    <!-- ACCESS CODE BOX -->
    <div style="margin-top:20px;background:#f3f0ff;border:2px solid #7209b7;border-radius:16px;padding:18px;text-align:center;">
      <div style="font-size:1.05rem;font-weight:800;color:#7209b7;margin-bottom:6px">&#x1F511; Access Code Yahan Daalein</div>
      <p style="font-size:0.78rem;color:#555;margin-bottom:12px;">Payment ke baad WhatsApp par jo code mila â€” woh yahan enter karein</p>
      <input type="text" class="pay-input" id="accessCodeInput" placeholder="Enter your access code..." style="border:2px solid #7209b7;font-size:1rem;font-weight:700;text-align:center;letter-spacing:2px;width:100%;"/>
      <button onclick="verifyCode()" style="width:100%;margin-top:10px;padding:14px;font-size:1rem;background:linear-gradient(135deg,#7209b7,#f72585);border:none;border-radius:12px;color:#fff;font-weight:800;cursor:pointer;font-family:inherit;">&#x2713; Verify &amp; Unlock Karo</button>
    </div>
    <p class="pay-note">&#x1F512; Secure payment. Koi subscription nahi. Ek baar pay, hamesha access.</p>
  </div>
</div>

<style>
/* Inject original book CSS inside modal */
#modalContent {
  font-family: 'Nunito', sans-serif;
}
</style>

<script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
// â”€â”€ DATA â”€â”€
const CHAPTERS_HTML = [`<div class="chapter">
<div class="chapter-label" style="color:var(--red)">Chapter 01</div>
<h2 style="color:var(--red)">ğŸ« Airway â€” Saans Ki Nali Ko Sambhalo!</h2>
<div class="chapter-intro" style="border-color:var(--red)">
    Bhai, ICU mein sabse pehli aur sabse zaroori cheez hai â€” <strong>airway!</strong> Agar patient saans nahi le sakta, toh baaki sab bekaar hai. ICU intubation OT se zyada risky hoti hai â€” hypoxia, BP gir sakta hai, aur difficult airway bhi ho sakta hai. Isliye hamesha tayyar raho! ğŸ’ª
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 560" width="100%">
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="450" x2="220" y1="280" y2="130"></line>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="450" x2="680" y1="280" y2="130"></line>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="450" x2="150" y1="280" y2="300"></line>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="450" x2="750" y1="280" y2="300"></line>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="450" x2="220" y1="280" y2="450"></line>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="450" x2="680" y1="280" y2="450"></line>
<defs>
<radialgradient cx="50%" cy="40%" id="rg1">
<stop offset="0%" stop-color="#ff6b6b"></stop>
<stop offset="100%" stop-color="#c1121f"></stop>
</radialgradient>
</defs>
<ellipse cx="450" cy="280" fill="url(#rg1)" rx="115" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="15" font-weight="800" text-anchor="middle" x="450" y="272">AIRWAY</text>
<text fill="rgba(255,255,255,.8)" font-family="Nunito" font-size="11" text-anchor="middle" x="450" y="293">Saans Ki Lifeline</text>
<!-- Pre-oxygenation -->
<rect fill="#fff0f0" height="96" rx="14" stroke="#e63946" stroke-width="2.5" width="200" x="120" y="82"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="220" y="112">ğŸ«§ Pehle Oxygen Do!</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="128">â€¢ BVM + 100% Oâ‚‚ Ã— 3 minute</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="142">â€¢ Patient ko thoda utha ke rakho</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="156">â€¢ HFNO 60 L/min â€” best option!</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="170">â€¢ SpOâ‚‚ â‰¥95% honi chahiye pehle</text>
<!-- RSI Drugs -->
<rect fill="#fff5e6" height="96" rx="14" stroke="#f4a261" stroke-width="2.5" width="200" x="580" y="82"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="680" y="112">ğŸ’‰ RSI Ki Dawaaein</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="128">â€¢ Ketamine 1-2 mg/kg â€” BP safe!</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="142">â€¢ Sux 1.5 mg/kg ya Roc 1.2 mg/kg</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="156">â€¢ Fentanyl 1-2 mcg/kg blunt kare</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="170">â€¢ Sab ek saath dena â€” no delay!</text>
<!-- Difficult Airway -->
<rect fill="#eefaff" height="96" rx="14" stroke="#0096c7" stroke-width="2.5" width="196" x="52" y="254"></rect>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="150" y="284">âš ï¸ Difficult Airway?</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="150" y="300">â€¢ LEMON check karo pehle!</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="150" y="314">â€¢ Video Laryngoscope use karo</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="150" y="328">â€¢ LMA rescue mein kaam aata hai</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="150" y="342">â€¢ Help bulao â€” akele mat lado!</text>
<!-- Post intubation -->
<rect fill="#eafff6" height="96" rx="14" stroke="#06d6a0" stroke-width="2.5" width="196" x="652" y="254"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="750" y="284">âœ… Tube Gaya â€” Ab Kya?</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="750" y="300">â€¢ EtCOâ‚‚ waveform dekho â€” pakka!</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="750" y="314">â€¢ CXR order karo turant</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="750" y="328">â€¢ Cuff pressure 20-30 cmHâ‚‚O</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="750" y="342">â€¢ Sedation aur analgesia shuru</text>
<!-- CICO -->
<rect fill="#fff5e6" height="95" rx="14" stroke="#f9c74f" stroke-width="2.5" width="200" x="120" y="405"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="220" y="435">ğŸ”´ CICO â€” Sabse Bada Darr!</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="451">â€¢ "CICO hai!" â€” Zor se bolo!</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="465">â€¢ Surgical Cricothyrotomy karo</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="479">â€¢ Scalpel-Finger-Bougie method</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="493">â€¢ Haath mat kaanpo â€” jaldi karo!</text>
<!-- Tracheostomy -->
<rect fill="#f0eeff" height="95" rx="14" stroke="#7209b7" stroke-width="2.5" width="200" x="580" y="405"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="680" y="435">ğŸ”© Tracheostomy</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="451">â€¢ 7-10 din baad sochna</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="465">â€¢ PDT (percutaneous) prefer karo</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="479">â€¢ Sedation kam ho jaati hai</text>
<text fill="#555" font-family="Nunito" font-size="10" text-anchor="middle" x="680" y="493">â€¢ Weaning bhi asaan hoti hai</text>
</svg>
</div>
<div class="alert alert-red">
<div class="icon">ğŸš¨</div>
<div><strong>CICO Emergency â€” Sab Se Khatarnak Situation!</strong> Jab na intubate ho raha hai, na oxygen aa rahi â€” yeh CICO hai bhai! Zor se "CICO!" bolke declare karo, sabko call karo, aur bina der ke Surgical Cricothyrotomy karo. Scalpel-Finger-Bougie method fastest hai. Har second mein brain cells mar rahi hain!</div>
</div>
<div class="cards">
<div class="card g-red">
<div class="card-icon">ğŸ«</div>
<h4>LEMON Check â€” Yaad Rakho!</h4>
<p><strong>L</strong>ook externally, <strong>E</strong>valuate 3-3-2, <strong>M</strong>allampati, <strong>O</strong>bstruction, <strong>N</strong>eck mobility. Score â‰¥4 hai toh difficult airway expect karo bhai!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ“¹</div>
<h4>Video Laryngoscope â€” ICU Ka Hero</h4>
<p>ICU mein pehla attempt hamesha VL se karo. Direct laryngoscopy se 40% zyada success rate hai. Ek baar laga lo â€” jyada baar nahi!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ“Š</div>
<h4>EtCOâ‚‚ â€” Pakki Confirmation</h4>
<p>Waveform capnography gold standard hai. Chest rise dekh ke mat kaho "ho gaya" â€” EtCOâ‚‚ dekho, CXR karo. Dono zaroori hain!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ’Š</div>
<h4>BP Girne Se Bachao</h4>
<p>Intubation se pehle agar BP kum hai â€” Noradrenaline lagao. Push-dose Adrenaline 10-20 mcg IV bhi ready rakho. Pehle stabilize, phir intubate!</p>
</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ Dr. Varshney Ka Tip â€” Yaad Rakho Bhai!</div>
    "ICU intubation OT se zyada difficult hoti hai kyunki patient already sick hai â€” hypoxic hai, BP kum hai, full stomach ho sakta hai. Isliye hamesha worst-case plan ready rakho. Plan A fail ho toh Plan B, B fail ho toh Plan C â€” CICO tak plan hona chahiye!"
  </div>

<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#e63946,#c1121f)">
<th>Drug</th><th>Dose</th><th>Kab Use Karein?</th><th>Dhyan Rakho</th>
</tr></thead>
<tbody>
<tr><td><strong>Ketamine</strong></td><td>1â€“2 mg/kg IV</td><td>Hemodynamically unstable patient</td><td>BP protect karta hai, bronchodilator bhi!</td></tr>
<tr><td><strong>Propofol</strong></td><td>1â€“2 mg/kg IV</td><td>Stable patient, ICP nahi raised</td><td>BP gira sakta hai â€” careful!</td></tr>
<tr><td><strong>Etomidate</strong></td><td>0.3 mg/kg IV</td><td>Shock patient, cardiac</td><td>Adrenal suppression â€” ek baar hi use karo</td></tr>
<tr><td><strong>Succinylcholine</strong></td><td>1.5 mg/kg IV</td><td>RSI, full stomach, rapid paralysis</td><td>Hyperkalemia contraindication â€” burns, crush!</td></tr>
<tr><td><strong>Rocuronium</strong></td><td>1.2 mg/kg IV</td><td>Succinylcholine contraindication</td><td>Sugammadex se reverse ho sakta hai!</td></tr>
<tr><td><strong>Fentanyl</strong></td><td>1â€“2 mcg/kg IV</td><td>Blunt haemodynamic response</td><td>Bradycardia ho sakti hai large dose mein</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-red">
<div class="card-icon">ğŸ†˜</div>
<h4>Intubation Failed â€” Plan B!</h4>
<p>Pehla attempt fail? 2nd attempt different technique/blade se karo. 3rd attempt se pehle senior ko bulaao. Bag-mask ventilation maintain karo beech mein. Desaturate nahi hone dena â€” SpOâ‚‚ â‰¥90% hamesha!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ”¬</div>
<h4>RSI vs DSI â€” Konsa Choose Karein?</h4>
<p>RSI = traditional â€” ek saath hypnotic + paralytic. DSI (Delayed Sequence) = pehle ketamine deke patient ko cooperate karwao, phir pre-oxygenate, phir RSI. Agitated patients mein DSI kaafi kaam aata hai!</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ›¡ï¸</div>
<h4>Apnoeic Oxygenation â€” ICU Ka Secret!</h4>
<p>NC 15 L/min lagao laryngoscopy ke dauraan. Apnoeic oxygenation se SpOâ‚‚ maintain hoti hai 3-4 minute extra â€” yeh safe time deta hai difficult intubation mein. Har ICU mein yeh trick use karo!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ“‹</div>
<h4>Post-Intubation Checklist</h4>
<p>EtCOâ‚‚ waveform âœ“ | SpOâ‚‚ improving âœ“ | Bilateral chest rise âœ“ | CXR order âœ“ | Tube depth note karo âœ“ | Cuff pressure 20-30 cmHâ‚‚O âœ“ | Sedation + Analgesia shuru âœ“ | HOB 30Â° âœ“</p>
</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸš¨ HIGH ALERT â€” Peri-Intubation Arrest!</div>
Intubation se pehle aur baad mein arrest ho sakta hai bhai! <strong>4 reasons yaad karo:</strong><br/>
1. <strong>Hypoxia</strong> â€” theek se pre-oxygenate nahi kiya<br/>
2. <strong>Hypotension</strong> â€” sedation ne BP gira diya<br/>
3. <strong>Acidosis</strong> â€” hypoventilation se COâ‚‚ badha, pH gira<br/>
4. <strong>Vagal Response</strong> â€” laryngoscopy se bradycardia<br/>
<strong>Prevention:</strong> Pre-load karo fluid, vasopressor ready rakho, ETCOâ‚‚ monitor karo, aur aggressive post-intubation care karo!
</div>

</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--teal)">Chapter 02</div>
<h2 style="color:var(--teal)">ğŸ”§ Mechanical Ventilation â€” Machine Se Saans!</h2>
<div class="chapter-intro" style="border-color:var(--teal)">
    Bhai, ventilator lagaya matlab kaam khatam nahi hua â€” abhi asli kaam shuru hota hai! Machine se saans dena life-saving hai, lekin galat settings se phaephde aur kharab ho sakte hain. Isliye <strong>lung-protective ventilation</strong> â€” yeh mantra yaad kar lo!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:960px" viewbox="0 0 960 580" width="100%">
<defs>
<radialgradient cx="50%" cy="40%" id="rg2">
<stop offset="0%" stop-color="#00b4d8"></stop>
<stop offset="100%" stop-color="#023e8a"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#0096c7" stroke-width="3" x1="480" x2="230" y1="290" y2="120"></line>
<line opacity=".5" stroke="#0096c7" stroke-width="3" x1="480" x2="730" y1="290" y2="120"></line>
<line opacity=".5" stroke="#0096c7" stroke-width="3" x1="480" x2="120" y1="290" y2="290"></line>
<line opacity=".5" stroke="#0096c7" stroke-width="3" x1="480" x2="840" y1="290" y2="290"></line>
<line opacity=".5" stroke="#0096c7" stroke-width="3" x1="480" x2="230" y1="290" y2="460"></line>
<line opacity=".5" stroke="#0096c7" stroke-width="3" x1="480" x2="730" y1="290" y2="460"></line>
<ellipse cx="480" cy="290" fill="url(#rg2)" rx="120" ry="60"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="480" y="282">VENTILATOR</text>
<text fill="rgba(255,255,255,.8)" font-family="Nunito" font-size="11" text-anchor="middle" x="480" y="302">Machine Wali Saans</text>
<rect fill="#eef8ff" height="104" rx="14" stroke="#0096c7" stroke-width="2" width="230" x="115" y="68"></rect>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="230" y="100">ğŸ“ Shuru Kaisa Karein?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="117">â€¢ TV = 6 ml/kg IBW â€” zyada mat do!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="131">â€¢ RR = 12-18/min rakhna</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="145">â€¢ PEEP = 5-8 cmHâ‚‚O se shuru</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="159">â€¢ FiOâ‚‚ = 100% â†’ titrate karo â‰¤60%</text>
<rect fill="#fff0f0" height="104" rx="14" stroke="#e63946" stroke-width="2" width="230" x="615" y="68"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="730" y="100">ğŸ“ˆ Pressure Kaun Kaun Si?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="117">â€¢ Peak â‰¤35 cmHâ‚‚O â€” nahi toh risk!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="131">â€¢ Plateau â‰¤30 cmHâ‚‚O â€” yaad rakho!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="145">â€¢ Driving â‰¤15 cmHâ‚‚O â€” sabse zaroori</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="159">â€¢ PEEP = recruit karne ke liye</text>
<rect fill="#eafff6" height="104" rx="14" stroke="#06d6a0" stroke-width="2" width="200" x="25" y="238"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="125" y="268">ğŸŒ€ Modes â€” Kaun Sa?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="125" y="285">â€¢ AC/VC â€” volume control</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="125" y="299">â€¢ SIMV + PS â€” transitional</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="125" y="313">â€¢ PSV â€” jab patient ready ho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="125" y="327">â€¢ APRV â€” severe ARDS mein</text>
<rect fill="#fff5e6" height="104" rx="14" stroke="#f9c74f" stroke-width="2" width="200" x="735" y="238"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="835" y="268">ğŸ”“ Weaning â€” Kab Nikaalein?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="835" y="285">â€¢ RSBI &lt;105 = nikaalo bhai!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="835" y="299">â€¢ Roz SAT + SBT karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="835" y="313">â€¢ T-piece ya 5/5 PSV Ã— 30 min</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="835" y="327">â€¢ Tolerate kare toh extubate!</text>
<rect fill="#f0eeff" height="104" rx="14" stroke="#7209b7" stroke-width="2" width="230" x="115" y="408"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="230" y="438">âš ï¸ Complications â€” Dhyan Rakho!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="455">â€¢ VILI â€” volutrauma, barotrauma</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="469">â€¢ VAP â€” HOB 30Â°, oral care karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="483">â€¢ Auto-PEEP â€” I:E ratio theek karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="230" y="497">â€¢ BP gir sakta hai ventilator se!</text>
<rect fill="#fff0fa" height="104" rx="14" stroke="#f72585" stroke-width="2" width="230" x="615" y="408"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="730" y="438">ğŸ©º Rescue Strategies</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="455">â€¢ Prone â€” seedha let jaao! â‰¥16 hr</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="469">â€¢ iNO â€” PH aur refractory hypoxia</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="483">â€¢ VV-ECMO â€” last resort!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="730" y="497">â€¢ Recruitment manoeuvre karo</text>
</svg>
</div>
<div class="alert alert-blue">
<div class="icon">ğŸ’¡</div>
<div><strong>ARDSNet Ka Golden Rule â€” Yaad Raho:</strong> TV sirf 6 ml/kg IBW do â€” zyada mat do chahe number kam lagein. Plateau pressure â‰¤30 rakho. FiOâ‚‚/PEEP ladder se titrate karo SpOâ‚‚ 88-95% ke liye. Iss protocol ne 22% mortality kam ki thi landmark trial mein â€” yeh koi mazaak nahi!</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#0096c7,#023e8a)">
<th>Parameter</th><th>Target Kya Hai?</th><th>Kyun? â€” Reason</th>
</tr></thead>
<tbody>
<tr><td>Tidal Volume (TV)</td><td>6 ml/kg IBW</td><td>Volutrauma se bachao â€” phaephde chhote hain!</td></tr>
<tr><td>Plateau Pressure</td><td>â‰¤ 30 cmHâ‚‚O</td><td>Barotrauma prevent karna hai</td></tr>
<tr><td>Driving Pressure</td><td>â‰¤ 15 cmHâ‚‚O</td><td>Sabse strong mortality predictor hai</td></tr>
<tr><td>SpOâ‚‚</td><td>88â€“95%</td><td>Permissive hypoxaemia â€” chalti hai!</td></tr>
<tr><td>pH</td><td>â‰¥ 7.20</td><td>Permissive hypercapnia acceptable</td></tr>
<tr><td>PEEP</td><td>5â€“20 cmHâ‚‚O</td><td>FiOâ‚‚ ke hisaab se titrate karo</td></tr>
</tbody>
</table>
</div>

<div class="cards" style="margin-top:0">
<div class="card g-teal">
<div class="card-icon">âš™ï¸</div>
<h4>Initial Ventilator Setup â€” Step by Step</h4>
<p>Mode: AC/VC se shuru karo. TV: 6 ml/kg IBW (height se calculate karo â€” actual weight nahi!). FiOâ‚‚: 100% se shuru, 15 min baad titrate. PEEP: 5 se shuru. RR: 14-18. Goal: SpOâ‚‚ 88-95%, pH â‰¥7.20. Phir waveforms dekho!</p>
</div>
<div class="card g-red">
<div class="card-icon">âš ï¸</div>
<h4>Auto-PEEP â€” Chhupa Hua Killer!</h4>
<p>COPD/Asthma mein airflow obstruction hoti hai â€” expiration poori nahi hoti. Trapped air â†’ Auto-PEEP â†’ BP gir jaata hai! Detect: expiratory pause hold karo. Fix: RR kam karo, I:E ratio 1:3-1:4 rakho, bronchodilators do!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ”“</div>
<h4>SAT + SBT â€” Roz Ka Routine!</h4>
<p>SAT (Spontaneous Awakening Trial): Sedation band karo roz subah. SBT (Spontaneous Breathing Trial): CPAP 5/5 ya T-piece pe 30-120 min. Dono pass kare toh extubate! ABCDEF bundle â€” yeh survival improve karta hai proved!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ“ˆ</div>
<h4>RSBI â€” Extubation Ka Judge!</h4>
<p>RSBI = RR Ã· TV (litres). &lt;105 = extubate karo. &gt;105 = nahi ho sakta abhi. Simple bedside test! SBT ke baad RSBI measure karo. Cough strength bhi check karo â€” "Khanso!" bol ke dekho. Swallow bhi assess karo.</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#0096c7,#023e8a)">
<th>Problem</th><th>Cause</th><th>Solution â€” Kya Karein?</th>
</tr></thead>
<tbody>
<tr><td><strong>High Peak Pressure</strong></td><td>Secretions, bronchospasm, bite</td><td>Suction karo, bronchodilator, sedation check</td></tr>
<tr><td><strong>High Plateau Pressure</strong></td><td>Poor compliance (ARDS, edema)</td><td>TV kam karo 4-5 ml/kg, PEEP titrate</td></tr>
<tr><td><strong>Low SpOâ‚‚</strong></td><td>Dislodged tube, pneumothorax, secretions</td><td>Suction, CXR, position check, FiOâ‚‚ badhao</td></tr>
<tr><td><strong>Hypotension after vent</strong></td><td>Auto-PEEP, high PEEP, sedation</td><td>Fluid bolus, RR kam, vasopressor consider</td></tr>
<tr><td><strong>Patient-Vent Dyssynchrony</strong></td><td>Effort nahi match kar raha</td><td>Mode change, trigger sensitivity adjust, sedation</td></tr>
<tr><td><strong>Sudden Deterioration</strong></td><td>DOPE â€” remember karo!</td><td>Disconnect, bag-mask, DOPE: Displaced/Obstructed/Pneumothorax/Equipment</td></tr>
</tbody>
</table>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ DOPE â€” Jab Sab Theek Nahi Lag Raha!</div>
Sudden deterioration on ventilator? <strong>DOPE</strong> yaad karo:<br/>
ğŸ”´ <strong>D</strong> â€” Displaced tube (right main bronchus ya esophagus?)<br/>
ğŸ”´ <strong>O</strong> â€” Obstructed (secretions, kink, bite block?)<br/>
ğŸ”´ <strong>P</strong> â€” Pneumothorax (trachea deviated? Breath sounds ek taraf?)<br/>
ğŸ”´ <strong>E</strong> â€” Equipment failure (vent kaam nahi kar raha?)<br/>
<strong>Action:</strong> Patient ko ventilator se disconnect karo, BVM se bag karo, aur DOPE check karo ek ek karke!
</div>

</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--orange)">Chapter 03</div>
<h2 style="color:var(--orange)">ğŸ’” Shock â€” Jab BP Gir Jaaye!</h2>
<div class="chapter-intro" style="border-color:var(--orange)">
    Shock matlab â€” body ke cells ko oxygen nahi mil rahi, chahe BP kuch bhi ho. MAP &lt;65 + hypoperfusion ke signs = Shock! Pehle type identify karo â€” phir sahi treatment do. Galat type mein galat treatment aur patient window se bahar!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 530" width="100%">
<defs>
<radialgradient cx="50%" cy="40%" id="rg3">
<stop offset="0%" stop-color="#f4a261"></stop>
<stop offset="100%" stop-color="#c1121f"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="200" y1="265" y2="105"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="700" y1="265" y2="105"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="95" y1="265" y2="285"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="805" y1="265" y2="285"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="200" y1="265" y2="430"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="700" y1="265" y2="430"></line>
<ellipse cx="450" cy="265" fill="url(#rg3)" rx="115" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="17" font-weight="800" text-anchor="middle" x="450" y="257">SHOCK</text>
<text fill="rgba(255,255,255,.8)" font-family="Nunito" font-size="11" text-anchor="middle" x="450" y="278">MAP &lt;65 + Cells Taras Rahein!</text>
<rect fill="#fff0f0" height="100" rx="14" stroke="#e63946" stroke-width="2.5" width="210" x="95" y="55"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="88">ğŸ©¸ Hypovolaemic Shock</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="105">â€¢ Khoon gaya, jal gaya, dast lage</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="119">â€¢ Preload kam, CO kam, SVR zyada</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="133">â€¢ Treatment: Fluid do, source rokko!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="147">â€¢ Blood bhi do agar Hb kam hai</text>
<rect fill="#eef8ff" height="100" rx="14" stroke="#0096c7" stroke-width="2.5" width="210" x="595" y="55"></rect>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="88">ğŸ¦  Distributive Shock</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="105">â€¢ Sepsis, Anaphylaxis, Spinal shock</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="119">â€¢ SVR bahut kam, blood misdistribute</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="133">â€¢ Norad pehle, phir fluid</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="147">â€¢ Anaphylaxis = Adrenaline turant!</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2.5" width="190" x="15" y="232"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="110" y="264">â¤ï¸ Cardiogenic Shock</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="110" y="280">â€¢ Heart attack, myocarditis</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="110" y="294">â€¢ CO bahut kam, BP gir gaya</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="110" y="308">â€¢ Norad + Dobutamine dono</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="110" y="322">â€¢ PCI jaldi karo!</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="190" x="695" y="232"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="790" y="264">ğŸ«€ Obstructive Shock</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="790" y="280">â€¢ PE, Cardiac tamponade, PTX</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="790" y="294">â€¢ Koi cheez pump rok rahi hai</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="790" y="308">â€¢ Pehle obstruction hatao!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="790" y="322">â€¢ Fluid se kuch nahi hoga</text>
<rect fill="#f0eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="210" x="95" y="395"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="425">ğŸ“ˆ Vasopressors â€” Konsa?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="442">â€¢ Noradrenaline: 1st line hamesha</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="456">â€¢ Vasopressin: 0.03 U/min add karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="470">â€¢ Adrenaline: jab sab fail ho jaaye</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="484">â€¢ MAP target â‰¥65 mmHg rakho</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="210" x="595" y="395"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="425">ğŸ©º Monitor Kaise Karein?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="442">â€¢ ScvOâ‚‚ &gt;70% = DOâ‚‚ theek hai</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="456">â€¢ Lactate clearance &gt;10%/2hr</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="470">â€¢ POCUS: IVC, LV function dekho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="484">â€¢ Urine output â‰¥0.5 ml/kg/hr</text>
</svg>
</div>
<div class="cards">
<div class="card g-orange">
<div class="card-icon">âš¡</div>
<h4>Shock Index â€” Simple Formula!</h4>
<p>HR Ã· Systolic BP. Normal &lt;0.7. Agar &gt;1.0 hai toh serious hai bhai â€” kuch bada chal raha hai. Bedside pe turant lagao yeh formula!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ©¸</div>
<h4>Fluid â€” Kitna Do?</h4>
<p>Septic shock mein pehle 3 hours mein 30 ml/kg crystalloid. Balanced solution use karo â€” NS nahi! Har bolus ke baad reassess karo â€” bahut zyada bhi nahi dena!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ“Š</div>
<h4>Fluid Responsive Hai Ya Nahi?</h4>
<p>Pulse pressure variation (PPV) &gt;13% = fluid do. Stroke volume variation bhi same kaam karta hai. Mechanical ventilation pe hi chalte hain yeh parameters.</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ”</div>
<h4>Lactate â€” Asli Judge!</h4>
<p>Har 2 ghante mein lactate check karo. 10% se zyada clearance chahiye. Agar high reh raha hai toh tissue ischaemia abhi bhi chal rahi hai â€” kuch toh chhoot raha hai!</p>
</div>
</div>

<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#f4a261,#e63946)">
<th>Shock Type</th><th>CVP/Preload</th><th>CO/Cardiac Output</th><th>SVR</th><th>Treatment</th>
</tr></thead>
<tbody>
<tr><td><strong>Hypovolaemic</strong></td><td>â†“â†“ Kam</td><td>â†“ Kam</td><td>â†‘ Zyada</td><td>Fluid + Blood, source control</td></tr>
<tr><td><strong>Septic / Distributive</strong></td><td>â†“ Kam</td><td>â†‘ Zyada</td><td>â†“â†“ Bahut Kam</td><td>Noradrenaline + Fluid + Abx</td></tr>
<tr><td><strong>Cardiogenic</strong></td><td>â†‘ Zyada</td><td>â†“â†“ Bahut Kam</td><td>â†‘â†‘ Bahut Zyada</td><td>Norad + Dobutamine, PCI/IABP</td></tr>
<tr><td><strong>Obstructive (PE)</strong></td><td>â†‘ Zyada</td><td>â†“ Kam</td><td>â†‘ Zyada</td><td>Lyse/Thrombectomy, anticoagulation</td></tr>
<tr><td><strong>Tamponade</strong></td><td>â†‘ Equalised</td><td>â†“â†“ Bahut Kam</td><td>â†‘ Zyada</td><td>Pericardiocentesis â€” ABHI!</td></tr>
<tr><td><strong>Neurogenic</strong></td><td>â†“ Kam</td><td>â†“/N Normal</td><td>â†“â†“ Bahut Kam</td><td>Norad, fluids, spine care</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-orange">
<div class="card-icon">ğŸ©º</div>
<h4>POCUS â€” Shock Diagnose Karo Bedside!</h4>
<p>Cardiac: LV function, tamponade, RV dilation (PE sign). IVC: flat = hypovolaemic, plethoric = cardiogenic/obstructive. Lung: B-lines = pulmonary edema. FAST: haemoperitoneum. 5 minute mein diagnosis â€” superpower!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ”´</div>
<h4>Noradrenaline â€” ICU Ka First Friend</h4>
<p>0.01-3 mcg/kg/min titrate karo. Central line se do â€” peripheral short term chalti hai emergency mein. MAP target â‰¥65 (TBI mein â‰¥80). Vasopressin add karo 0.03 U/min agar norad &gt;0.25 mcg/kg/min. Yeh steroid-sparing bhi hai!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ’Š</div>
<h4>Fluid Resuscitation â€” Konsa Fluid?</h4>
<p>Balanced crystalloid (Hartmann's / PlasmaLyte) â€” NS se better! NS = hyperchloraemic acidosis ka risk. Albumin 4%: sepsis mein evidence limited. Blood: Hb &lt;7 g/dL (ICU), &lt;8 agar cardiac disease. FFP sirf bleeding ke liye â€” volume ke liye nahi!</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ¯</div>
<h4>End-Points of Resuscitation</h4>
<p>MAP â‰¥65 âœ“ | UO â‰¥0.5 ml/kg/hr âœ“ | Lactate &lt;2 (clearance &gt;10%/2hr) âœ“ | ScvOâ‚‚ â‰¥70% âœ“ | Skin mottling resolve ho raha ho âœ“ | Sensorium improve ho raha ho âœ“. Inse over-resuscitate mat karo â€” fluid bhi harm karta hai!</p>
</div>
</div>
<div class="alert alert-red">
<div class="icon">âš¡</div>
<div><strong>Cardiogenic Shock â€” Difficult Management!</strong> Fluid doge toh aur oedema badhega! IABP (Intra-Aortic Balloon Pump) â€” evidence weak hai lekin use hota hai. Impella â€” newer, better haemodynamic support. VA-ECMO â€” most severe cases mein. PCI ya CABG â€” underlying CAD ke liye. Inotropes: Dobutamine 2.5-20 mcg/kg/min. Levosimendan bhi option hai. Milrinone: vasodilator + inotrope dono!</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ Permissive Hypotension â€” Kab Chalti Hai?</div>
Trauma + uncontrolled bleeding mein aggressive fluid resuscitation haemostasis bigaad deti hai!<br/>
<strong>Target:</strong> Penetrating trauma â€” SBP 80-90 mmHg (jab tak OR nahi milti). Blunt trauma mein TBI + trauma = MAP â‰¥80 rakho. <strong>DCR â€” Damage Control Resuscitation:</strong> 1:1:1 ratio (RBC:FFP:Platelets). Permissive hypotension + Haemostatic resuscitation + Damage control surgery = Triangle of Death avoid karo!
</div>

</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--purple)">Chapter 04</div>
<h2 style="color:var(--purple)">ğŸ¦  Sepsis â€” Infection Ka Toofan!</h2>
<div class="chapter-intro" style="border-color:var(--purple)">
    Sepsis-3 definition yaad karo: <strong>"Life-threatening organ dysfunction caused by dysregulated host response to infection."</strong> SOFA score â‰¥2 acute increase hona chahiye. Septic shock matlab â€” sepsis plus vasopressor plus lactate &gt;2 mmol/L. Yeh trifecta hai maut ka!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:960px" viewbox="0 0 960 570" width="100%">
<defs>
<radialgradient cx="50%" cy="40%" id="rg4">
<stop offset="0%" stop-color="#9b59b6"></stop>
<stop offset="100%" stop-color="#3a0ca3"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="480" x2="200" y1="285" y2="115"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="480" x2="760" y1="285" y2="115"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="480" x2="85" y1="285" y2="285"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="480" x2="875" y1="285" y2="285"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="480" x2="200" y1="285" y2="455"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="480" x2="760" y1="285" y2="455"></line>
<ellipse cx="480" cy="285" fill="url(#rg4)" rx="120" ry="60"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="15" font-weight="800" text-anchor="middle" x="480" y="277">SEPSIS-3</text>
<text fill="rgba(255,255,255,.8)" font-family="Nunito" font-size="11" text-anchor="middle" x="480" y="297">1 Ghante Mein Sab Karo!</text>
<rect fill="#fff0f0" height="104" rx="14" stroke="#e63946" stroke-width="2" width="225" x="88" y="63"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="96">ğŸ”¬ 1-Hour Bundle â€” Run!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="113">â€¢ Lactate measure karo ABHI</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="127">â€¢ Blood cultures Ã— 2 â€” ANTIBIOTIC SE PEHLE!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="141">â€¢ Broad-spectrum Abx 1 ghante mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="155">â€¢ 30 ml/kg fluid, BP ke liye Norad</text>
<rect fill="#eef8ff" height="104" rx="14" stroke="#0096c7" stroke-width="2" width="225" x="648" y="63"></rect>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="760" y="96">ğŸ“Š SOFA Score</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="113">â€¢ Respiratory: P/F ratio kitna hai?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="127">â€¢ Coagulation: Platelets dekho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="141">â€¢ Liver: Bilirubin kitna hai?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="155">â€¢ Cardiovascular + Renal + CNS</text>
<rect fill="#eafff6" height="104" rx="14" stroke="#06d6a0" stroke-width="2" width="205" x="-5" y="233"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="97" y="264">ğŸ’Š Antibiotic â€” Konsa?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="281">â€¢ Community: Pip-Tazo ya Ceftriaxone</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="295">â€¢ Hospital: Meropenem + Vancomycin</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="309">â€¢ De-escalate 48-72 ghante mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="323">â€¢ Procalcitonin guide karta hai</text>
<rect fill="#fff5e6" height="104" rx="14" stroke="#f9c74f" stroke-width="2" width="205" x="762" y="233"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="864" y="264">âš—ï¸ Steroid Kab Dein?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="864" y="281">â€¢ Hydrocortisone 200 mg/day</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="864" y="295">â€¢ Norad &gt;0.25 mcg/kg/min ho toh</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="864" y="309">â€¢ Continuous infusion better hai</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="864" y="323">â€¢ Vasopressor band hone pe taper karo</text>
<rect fill="#f0eeff" height="104" rx="14" stroke="#7209b7" stroke-width="2" width="225" x="88" y="403"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="434">ğŸ©¹ Source Control â€” Zaroor!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="451">â€¢ 6-12 ghante mein source dhundho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="465">â€¢ Abscess drain karo, line hatao</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="479">â€¢ Surgery agar zaroori hai</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="493">â€¢ Kam invasive approach pehle</text>
<rect fill="#fff0fa" height="104" rx="14" stroke="#f72585" stroke-width="2" width="225" x="648" y="403"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="760" y="434">ğŸ¯ Targets â€” Kya Chahiye?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="451">â€¢ MAP â‰¥65 mmHg hona chahiye</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="465">â€¢ Urine â‰¥0.5 ml/kg/hr dekho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="479">â€¢ Lactate &lt;2 within 6 ghante</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="760" y="493">â€¢ ScvOâ‚‚ â‰¥70% maintain karo</text>
</svg>
</div>
<div class="alert alert-yellow">
<div class="icon">â°</div>
<div><strong>Bhai â€” Time Bahut Important Hai Sepsis Mein!</strong> Har ek ghante ki delay mein mortality approximately 7% badhti hai! Antibiotics dene ke liye blood culture se zyada der mat karo â€” 45 minute se zyada nahi. Culture lene mein 5 minute lagte hain â€” phir antibiotic dedo. Yaad rakho: Culture pehle, antibiotic 1 ghante mein!</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ qSOFA â€” Bedside Screening Tool</div>
    Bhai, SOFA calculate karne mein time lagta hai ICU ke bahar. Toh qSOFA use karo:<br/>
    â€¢ Respiratory Rate &gt;22/min â€” <strong>1 point</strong><br/>
    â€¢ Altered consciousness (GCS &lt;15) â€” <strong>1 point</strong><br/>
    â€¢ Systolic BP â‰¤100 mmHg â€” <strong>1 point</strong><br/>
    Score â‰¥2 = Sepsis suspect karo aur ICU bhejo!
  </div>

<div class="cards" style="margin-top:0">
<div class="card g-purple">
<div class="card-icon">ğŸ”¬</div>
<h4>Blood Culture â€” Sahi Tarike Se Lo!</h4>
<p>2 sets (alag alag sites se) â€” antibiotic se PEHLE! Each set = aerobic + anaerobic bottle. Skin sterilize karo properly â€” betadine ya chlorhexidine. Volume: 10 ml per bottle. Antibiotic dene se pehle 45 min se zyada wait mat karo cultures ke liye!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ’Š</div>
<h4>Antibiotic Selection â€” Algorithm</h4>
<p>Community-acquired: Pip-Tazo Â± Vancomycin. Hospital-acquired (&gt;48h): Meropenem + Vancomycin Â± Antifungal. Immunocompromised: Broad spectrum + anti-PCP + antifungal. De-escalate 48-72h mein culture aane par â€” antimicrobial stewardship zaroori!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ’§</div>
<h4>Fluid Therapy â€” Smart Approach</h4>
<p>Pehle 3 hours mein 30 ml/kg crystalloid agar lactate &gt;4 ya hypotensive. Phir fluid-responsiveness assess karo (PPV, SV variation, POCUS). Aggressive de-resuscitation phase: diuresis ya ultrafiltration â€” excess fluid bhi harmful hai (SOAP-II trial)!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ“Š</div>
<h4>Procalcitonin â€” Guide Karo!</h4>
<p>PCT &lt;0.25 ng/mL = antibiotic band karo (agar clinical picture theek hai). PCT &gt;0.5 ng/mL = infection likely. PCT trend bhi important â€” rising = response nahi, falling = good! PCT-guided therapy ne antibiotic days reduce kiye hain without harm â€” stewardship tool!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#7209b7,#3a0ca3)">
<th>Organ System</th><th>SOFA Score</th><th>Assessment Method</th><th>Target</th>
</tr></thead>
<tbody>
<tr><td><strong>Respiratory</strong></td><td>PaOâ‚‚/FiOâ‚‚ ratio</td><td>ABG â€” paOâ‚‚ Ã· FiOâ‚‚</td><td>&gt;400 = 0 points, &lt;100 = 4 points</td></tr>
<tr><td><strong>Coagulation</strong></td><td>Platelet count</td><td>CBC</td><td>&gt;150k = 0, &lt;20k = 4 points</td></tr>
<tr><td><strong>Liver</strong></td><td>Bilirubin</td><td>LFTs</td><td>&lt;1.2 mg/dL = 0, &gt;12 = 4 points</td></tr>
<tr><td><strong>Cardiovascular</strong></td><td>MAP / Vasopressors</td><td>BP monitoring</td><td>No vasopressor = 0, high dose = 4</td></tr>
<tr><td><strong>CNS</strong></td><td>GCS</td><td>Neurological exam</td><td>15 = 0, &lt;6 = 4 points</td></tr>
<tr><td><strong>Renal</strong></td><td>Creatinine / UO</td><td>Serum Cr + Urine output</td><td>&lt;1.2 mg/dL = 0, &gt;5 = 4 points</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-purple">
<div class="icon">ğŸ’‰</div>
<div><strong>Steroids â€” Kab Dein, Kab Nahi?</strong> Hydrocortisone 200 mg/day (50 mg q6h ya 200mg continuous) â€” sirf tab jab Noradrenaline &gt;0.25 mcg/kg/min 6+ hours mein response nahi diya. ADRENAL aur APROCCHSS trials mein steroid ne vasopressor weaning fast ki. Fludrocortisone add karna: controversial â€” ADRENAL trial mein nahi diya, APROCCHSS ne diya. Mortality benefit abhi bhi debated hai.</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ¯ Surviving Sepsis Campaign â€” Latest Bundles</div>
<strong>1-Hour Bundle (2018 update):</strong><br/>
âœ… Lactate measure karo â€” agar &gt;2, re-measure 2h mein<br/>
âœ… Blood cultures Ã— 2 â€” antibiotic SE PEHLE<br/>
âœ… Broad-spectrum antibiotics SHURU karo<br/>
âœ… 30 ml/kg IV crystalloid agar lactate &gt;4 ya hypotensive<br/>
âœ… Vasopressor shuru karo agar fluid ke baad MAP &lt;65<br/>
<strong>Yaad rakho:</strong> Yeh guidelines minimum hain â€” clinical judgment sabse zyada zaroori hai!
</div>

</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--pink)">Chapter 05</div>
<h2 style="color:var(--pink)">ğŸ« ARDS â€” Phaephde Ka Crisis!</h2>
<div class="chapter-intro" style="border-color:var(--pink)">
    ARDS = Acute Respiratory Distress Syndrome. Matlab â€” phaephde mein achanak itna paani aa jaata hai ki oxygen pass nahi ho paati. Bilateral infiltrates, hypoxaemia, non-cardiogenic â€” yeh trifecta hai. Berlin definition se classify karo aur lung-protective ventilation immediately shuru karo!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 510" width="100%">
<defs>
<radialgradient cx="50%" cy="40%" id="rg5">
<stop offset="0%" stop-color="#f72585"></stop>
<stop offset="100%" stop-color="#b5179e"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#f72585" stroke-width="3" x1="450" x2="200" y1="255" y2="105"></line>
<line opacity=".5" stroke="#f72585" stroke-width="3" x1="450" x2="700" y1="255" y2="105"></line>
<line opacity=".5" stroke="#f72585" stroke-width="3" x1="450" x2="100" y1="255" y2="275"></line>
<line opacity=".5" stroke="#f72585" stroke-width="3" x1="450" x2="800" y1="255" y2="275"></line>
<line opacity=".5" stroke="#f72585" stroke-width="3" x1="450" x2="200" y1="255" y2="420"></line>
<line opacity=".5" stroke="#f72585" stroke-width="3" x1="450" x2="700" y1="255" y2="420"></line>
<ellipse cx="450" cy="255" fill="url(#rg5)" rx="115" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="16" font-weight="800" text-anchor="middle" x="450" y="247">ARDS</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="11" text-anchor="middle" x="450" y="267">Berlin Se Classify Karo!</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2" width="220" x="90" y="55"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="88">ğŸ“‹ Berlin Severity</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="105">â€¢ Mild: P/F 200-300 â€” thoda sa</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="119">â€¢ Moderate: P/F 100-200 â€” zyada</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="133">â€¢ Severe: P/F &lt;100 â€” bahut zyada!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="147">â€¢ PEEP â‰¥5 pe measure karo</text>
<rect fill="#eef8ff" height="100" rx="14" stroke="#0096c7" stroke-width="2" width="220" x="590" y="55"></rect>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="88">ğŸŒŠ Prone â€” Seedha Letao!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="105">â€¢ â‰¥16 ghante per day prone rakho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="119">â€¢ 16% mortality reduction milti hai</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="133">â€¢ P/F &lt;150 pe zaroor karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="147">â€¢ Team ka coordination zaroori hai</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2" width="200" x="20" y="223"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="120" y="256">ğŸ›¡ï¸ Ventilation</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="273">â€¢ TV 6 ml/kg IBW â€” bas itna!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="287">â€¢ Driving pressure â‰¤15</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="301">â€¢ SpOâ‚‚ 88-95% chalega</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="315">â€¢ Permissive hypercapnia okay!</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f9c74f" stroke-width="2" width="200" x="680" y="223"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="780" y="256">ğŸ’Š Dawaaein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="273">â€¢ NMBAs 48 ghante â€” severe ARDS</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="287">â€¢ Dexamethasone (DEXA-ARDS trial)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="301">â€¢ Conservative fluid strategy</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="315">â€¢ Avoid fluid overload!</text>
<rect fill="#f0eeff" height="90" rx="14" stroke="#7209b7" stroke-width="2" width="220" x="90" y="385"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="416">âš™ï¸ PEEP Strategy</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="433">â€¢ FiOâ‚‚/PEEP ladder follow karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="447">â€¢ Oesophageal balloon se Pbal</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="461">â€¢ P-SILI se bachana zaroori hai</text>
<rect fill="#fff0f0" height="90" rx="14" stroke="#e63946" stroke-width="2" width="220" x="590" y="385"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="416">ğŸ”´ ECMO Kab Bhejo?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="433">â€¢ P/F &lt;80 on FiOâ‚‚ 100%</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="447">â€¢ pH &lt;7.25 aur COâ‚‚ badh raha</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="461">â€¢ ECMO centre refer karo ASAP</text>
</svg>
</div>

<div class="cards" style="margin-top:0">
<div class="card g-pink">
<div class="card-icon">ğŸ›ï¸</div>
<h4>Prone Position â€” Kaise Karein?</h4>
<p>Team chahiye: 4-5 log minimum. Eyes tape karo, pressure areas pad karo, ETT secure karo pehle. 16 ghante prone, 8 ghante supine. Tube obstruction dekho, suction ready rakho. Hemodynamics better hoti hain prone mein aksar! P/F ratio improve nahi ho rahi? Wapas supine pe aao.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ’‰</div>
<h4>Neuromuscular Blockade â€” Kab Do?</h4>
<p>P/F &lt;150 + deep sedation ke bawajood dyssynchrony â€” NMBA consider karo. Cisatracurium 48 hours ke liye (ACURASYS trial benefit dikha tha, ROSE trial ne nahi â€” controversy hai!). Sedation-analgesia-delirium bundle ke saath use karo. TOF monitoring zaroori.</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ”Š</div>
<h4>Recruitment Manoeuvre â€” Sahi Tarika</h4>
<p>CPAP 40 cmHâ‚‚O Ã— 40 seconds (traditional) ya staircase RM. ART Trial mein aggressive RM ne harm kiya! So: gentle RM, haemodynamics monitor karo saath mein. Pneumothorax risk hai â€” dekho! Best titration: PEEP titrate using FiOâ‚‚/PEEP table (ARDSNet ladder).</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ¥</div>
<h4>VV-ECMO â€” Last Resort!</h4>
<p>P/F &lt;80 despite optimal care â‰¥6h, ya severe hypercapnia â€” ECMO refer karo. CESAR aur EOLIA trials mein benefit dikha ARDS mein. Early referral â€” late referral mein irreversible lung injury hoti hai. ECMO centre mein bhejo â€” wahan expertise hoti hai. Contraindications: unrecoverable lung, coagulopathy severe.</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#f72585,#b5179e)">
<th>P/F Ratio</th><th>ARDS Severity</th><th>PEEP Target</th><th>Key Interventions</th>
</tr></thead>
<tbody>
<tr><td><strong>200â€“300</strong></td><td>Mild ARDS</td><td>5â€“10 cmHâ‚‚O</td><td>LPV, treat cause, fluid balance</td></tr>
<tr><td><strong>100â€“200</strong></td><td>Moderate ARDS</td><td>8â€“14 cmHâ‚‚O</td><td>+ Prone position consider, NMBA</td></tr>
<tr><td><strong>&lt;100</strong></td><td>Severe ARDS</td><td>12â€“18 cmHâ‚‚O</td><td>+ Prone â‰¥16h, NMBA 48h, ECMO referral</td></tr>
</tbody>
</table>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#f72585,#b5179e)">
<th>FiOâ‚‚</th><th>0.3</th><th>0.4</th><th>0.5</th><th>0.6</th><th>0.7</th><th>0.8</th><th>0.9</th><th>1.0</th>
</tr></thead>
<tbody>
<tr><td><strong>PEEP (low)</strong></td><td>5</td><td>5</td><td>8</td><td>10</td><td>10</td><td>10</td><td>14</td><td>18</td></tr>
<tr><td><strong>PEEP (high)</strong></td><td>5</td><td>8</td><td>10</td><td>12</td><td>14</td><td>14</td><td>18</td><td>22</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-red">
<div class="icon">ğŸš¨</div>
<div><strong>ARDS Mein Kya NAHI Karna!</strong> âŒ High TV (>8 ml/kg) â€” volutrauma. âŒ High FiOâ‚‚ for long â€” Oâ‚‚ toxicity. âŒ Aggressive fluid â€” pulmonary edema badhega. âŒ Steroids routinely â€” evidence weak hai (late ARDS mein Dexamethasone trial positive tha). âŒ Tight glucose &lt;6 â€” hypoglycaemia risk. âŒ Delay prone â€” ek baar decide kar liya toh jaldi karo!</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ COVID-19 ARDS â€” Kya Alag Tha?</div>
COVID ARDS mein kuch alag features the: <strong>L-phenotype</strong> (compliant lungs, low recruitability) vs <strong>H-phenotype</strong> (classic ARDS). Initially SpOâ‚‚ bahut kum hone ke bawajood patients comfortable â€” "happy hypoxia". Prone position COVID mein bhi awake patients ko diya gaya (Awake Prone Positioning â€” APP). Dexamethasone 6 mg OD Ã— 10 days = RECOVERY trial ne mortality reduce kiya. IL-6 inhibitors (Tocilizumab) bhi kaam aaye severe cases mein. COVID ARDS lesson: awake prone, anticoagulation, dexamethasone â€” sab zaroori tha!
</div>

</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--green)">Chapter 06</div>
<h2 style="color:var(--green)">ğŸ«˜ AKI â€” Gurde Ka Achanak Dhoka!</h2>
<div class="chapter-intro" style="border-color:var(--green)">
    50-60% ICU patients mein AKI hoti hai bhai! Aur yeh akele mortality badhaata hai â€” 3-5 guna! KDIGO staging se classify karo. Prevention zaroori hai â€” nephrotoxins hatao, renal perfusion maintain karo aur early recognize karo! <strong>AKI sirf creatinine nahi â€” oliguria bhi hai!</strong>
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 520" width="100%">
<defs><radialgradient cx="50%" cy="40%" id="rgAKI"><stop offset="0%" stop-color="#06d6a0"/><stop offset="100%" stop-color="#023e8a"/></radialgradient></defs>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="200" y1="260" y2="100"/><line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="700" y1="260" y2="100"/>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="80" y1="260" y2="270"/><line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="820" y1="260" y2="270"/>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="200" y1="260" y2="420"/><line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="700" y1="260" y2="420"/>
<ellipse cx="450" cy="260" fill="url(#rgAKI)" rx="115" ry="57"/>
<text fill="#fff" font-family="Nunito" font-size="16" font-weight="800" text-anchor="middle" x="450" y="252">AKI</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="272">Gurda Bandh Hone Wala Hai!</text>
<rect fill="#eafff6" height="104" rx="14" stroke="#06d6a0" stroke-width="2.5" width="215" x="92" y="48"/>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="82">ğŸ“Š KDIGO Staging</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="99">â€¢ Stage 1: Cr Ã—1.5 ya UO &lt;0.5ml/kg/hr Ã—6h</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="113">â€¢ Stage 2: Cr Ã—2 ya UO &lt;0.5ml/kg/hr Ã—12h</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="127">â€¢ Stage 3: Cr Ã—3 ya UO &lt;0.3ml Ã—24h ya anuria</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="141">â€¢ Baseline creatinine se compare karo!</text>
<rect fill="#fff0f0" height="104" rx="14" stroke="#e63946" stroke-width="2.5" width="215" x="593" y="48"/>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="82">ğŸ” Pre/Intra/Post Renal</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="99">â€¢ Pre: Dehydration, sepsis, cardiogenic</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="113">â€¢ Intra: ATN (contrast, sepsis, drugs)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="127">â€¢ Post: Bladder outlet, stones, clots</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="141">â€¢ FENa &lt;1% = Pre-renal (oliguric ATN bhi!)</text>
<rect fill="#fff5e6" height="104" rx="14" stroke="#f9c74f" stroke-width="2.5" width="175" x="5" y="215"/>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="247">ğŸš« Nephrotoxins Hatao!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="263">â€¢ NSAIDs â€” HAMESHA band karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="277">â€¢ Aminoglycosides â€” trough monitor</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="291">â€¢ Contrast â€” pre-hydrate karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="305">â€¢ Vancomycin â€” AUC-guided dosing</text>
<rect fill="#f5eeff" height="104" rx="14" stroke="#7209b7" stroke-width="2.5" width="175" x="720" y="215"/>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="808" y="247">ğŸ’§ Haemodynamics Fix!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="263">â€¢ MAP â‰¥65 mmHg maintain karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="277">â€¢ Norad if vasodilated</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="291">â€¢ Volume responsive? Fluid do</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="305">â€¢ Avoid fluid overload â€” harm!</text>
<rect fill="#eef3ff" height="104" rx="14" stroke="#4361ee" stroke-width="2.5" width="215" x="92" y="368"/>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="401">âš¡ Emergency Indications RRT</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="418">â€¢ Kâº &gt;6.5 ya ECG changes</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="432">â€¢ Fluid overload with pulm oedema</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="446">â€¢ Severe acidosis pH &lt;7.15</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="460">â€¢ Uraemic encephalopathy/pericarditis</text>
<rect fill="#fff0fa" height="104" rx="14" stroke="#f72585" stroke-width="2.5" width="215" x="593" y="368"/>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="401">ğŸ”¬ AKI Biomarkers</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="418">â€¢ NGAL: Early injury marker â€” 2-4h</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="432">â€¢ KIM-1: Tubular injury specific</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="446">â€¢ Cystatin C: Better GFR estimate</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="460">â€¢ TIMP-2 Ã— IGFBP7: Cell cycle arrest</text>
</svg>
</div>
<div class="cards">
<div class="card g-green">
<div class="card-icon">ğŸ“Š</div>
<h4>KDIGO Stages â€” Yaad Karo!</h4>
<p><strong>Stage 1:</strong> Creatinine Ã—1.5 ya UO &lt;0.5 ml/kg/hr Ã—6h<br/><strong>Stage 2:</strong> Cr Ã—2 ya UO &lt;0.5 Ã—12h<br/><strong>Stage 3:</strong> Cr Ã—3 ya RRT ki zaroorat</p>
</div>
<div class="card g-red">
<div class="card-icon">âš ï¸</div>
<h4>ICU Mein AKI Kyun Hoti Hai?</h4>
<p>Sabse zyada: Sepsis-AKI. Phir: Contrast diya, aminoglycosides diye, vancomycin trough zyada, hypovolaemia, aur zyada fluid diya â€” dono extremes nuksaan dete hain!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ’‰</div>
<h4>RRT â€” AEIOU Mein Yaad Karo!</h4>
<p><strong>A</strong>cidosis (pH &lt;7.1), <strong>E</strong>lectrolytes (K+ &gt;6.5), <strong>I</strong>ntoxication, <strong>O</strong>verload (fluid), <strong>U</strong>raemia â€” in mein se koi ek bhi absolute indication hai!</p>
</div>
<div class="card g-purple">
<div class="card-icon">âš™ï¸</div>
<h4>Konsa RRT Mode?</h4>
<p><strong>CVVHDF:</strong> Haemodynamically unstable patient ke liye best. <strong>IHD:</strong> Stable patient. <strong>SLED:</strong> Bridge mode. ICU mein CVVHDF zyadatar use hota hai.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ›¡ï¸</div>
<h4>Gurda Bachao â€” Nephroprotection</h4>
<p>NSAIDs band karo, aminoglycosides avoid karo, contrast se pehle hydrate karo. MAP â‰¥65 hamesha. Nephrotoxic drugs ek ek karke check karo!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’§</div>
<h4>Fluid Strategy â€” Balance!</h4>
<p>Hypovolaemia bhi nuksaan karta hai, hypervolaemia bhi. Daily fluid balance check karo. Gurde ke liye MAP maintain karo â€” vasopressors se bhi sahi hai!</p>
</div>
</div>
<div class="alert alert-blue">
<div class="icon">ğŸ’§</div>
<div><strong>Furosemide Se AKI Theek Nahi Hoti â€” Yaad Rakho!</strong> Diuretics AKI treat nahi karte â€” sirf fluid overload manage karte hain. Agar RRT indication aa gayi toh furosemide se time mat waste karo. Volume overload mein RRT se ultrafiltration zyada effective hai. Aur "urine badha diya matlab gurda theek hai" â€” yeh bilkul galat soch hai!</div>
</div>
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#023e8a)">
<th>Parameter</th><th>Pre-Renal</th><th>ATN (Intra-Renal)</th>
</tr></thead>
<tbody>
<tr><td><strong>FENa</strong></td><td>&lt;1%</td><td>&gt;2%</td></tr>
<tr><td><strong>Urine Osmolality</strong></td><td>&gt;500 mOsm/kg</td><td>&lt;350 mOsm/kg</td></tr>
<tr><td><strong>Urine Sodium</strong></td><td>&lt;20 mEq/L</td><td>&gt;40 mEq/L</td></tr>
<tr><td><strong>Urine Cr/Plasma Cr</strong></td><td>&gt;40</td><td>&lt;20</td></tr>
<tr><td><strong>BUN:Creatinine ratio</strong></td><td>&gt;20:1</td><td>10-15:1</td></tr>
<tr><td><strong>Urinary Casts</strong></td><td>Hyaline casts</td><td>Muddy brown granular casts (ATN)</td></tr>
<tr><td><strong>Response to fluids</strong></td><td>UO badhti hai</td><td>UO nahi badhti</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-green">
<div class="card-icon">ğŸ”‘</div>
<h4>Conservative Management â€” Pehle Yeh Karo!</h4>
<p>Nephrotoxins band karo turant. MAP â‰¥65 rakho (MAP â‰¥75 chronic hypertension wale mein). Fluid balance daily monitor karo. Loop diuretics â€” volume overload mein do, AKI prevent nahi karte! Foley catheter se hourly UO track karo. Drug dosing adjust karo â€” renal clearance kam ho gayi hai!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ“‹</div>
<h4>Contrast-Induced AKI â€” Kaise Bachao?</h4>
<p>High-risk patients: CKD (eGFR &lt;60), diabetes, dehydration, NSAIDs. Prevention: IV 0.9% NaCl ya bicarb pre/post procedure. N-acetylcysteine â€” weak evidence but harmless. Iso-osmolar contrast prefer karo. Minimum contrast volume use karo. Nephrology consult if high risk!</p>
</div>
<div class="card g-orange">
<div class="card-icon">âš ï¸</div>
<h4>Hyperkalemia in AKI â€” Emergency!</h4>
<p>Kâº &gt;6.5 ya ECG changes (peaked T, wide QRS, sine wave) = ACT NOW! Calcium gluconate 10ml 10% IV (membrane stabilize). Insulin 10U + Dextrose 50%. Salbutamol nebulization. Sodium bicarb agar acidotic. Kayexalate/patiromer â€” slow onset. RRT agar refractory. ECG monitor karo continuously!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ”</div>
<h4>AKI Recovery â€” Kab Hogi?</h4>
<p>Stage 1-2 AKI: 50-70% full recovery within 7-14 days agar cause hatao. Stage 3: Higher risk of CKD progression. Polyuric phase: huge urine output, electrolyte loss â€” monitor karo! Follow-up creatinine 3 months baad â€” CKD develop to nahi hua? Nephrology outpatient follow essential hai.</p>
</div>
</div>
<div class="alert alert-green">
<div class="icon">ğŸ’¡</div>
<div><strong>Dr. Varshney Ka Tip â€” AKI Mein Dopamine Mat Do!</strong> "Renal dose dopamine" â€” yeh myth hai bhai! Multiple RCTs ne prove kiya hai ki low-dose dopamine AKI nahi rokta, dialysis need nahi karta, aur mortality nahi kam karta. Ulta, tachycardia aur arrhythmias ho sakti hain. Seedha hemodynamics theek karo â€” norad do agar MAP kam ho!</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ§ª AEIOU â€” RRT Indications Yaad Karo!</div>
<strong>A</strong>cidosis â€” metabolic, refractory (pH &lt;7.15)<br/>
<strong>E</strong>lectrolytes â€” Kâº &gt;6.5 ya refractory hypernatremia/hyponatremia<br/>
<strong>I</strong>ntoxication â€” dialyzable toxins (lithium, salicylates, methanol)<br/>
<strong>O</strong>verload â€” fluid overload refractory to diuretics (&gt;10% body weight)<br/>
<strong>U</strong>raemia â€” uraemic encephalopathy, pericarditis, bleeding diathesis<br/><br/>
Yeh indications emergent hain â€” delay mat karo jab ek bhi present ho aur conservative fail ho!
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--blue)">Chapter 07</div>
<h2 style="color:var(--blue)">ğŸ’¤ Dard Aur Neend â€” Sedation, Analgesia, Delirium</h2>
<div class="chapter-intro" style="border-color:var(--blue)">
    ABCDEF bundle ne ICU ka culture badal diya! Pehle zyada sedation dena "safe" lagta tha â€” ab pata chala ki yeh nuksaan karta tha. Analgesia pehle, sedation baad mein, aur roz patient ko jagao! Delirium bhi treat karo â€” yeh bhi ek emergency hai!
  </div>
<div class="divider"></div>
<!-- ABCDEF Full SVG Mind Map -->
<div class="mindmap-wrap">
<svg style="max-width:960px" viewbox="0 0 960 560" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg7">
<stop offset="0%" stop-color="#4361ee"></stop>
<stop offset="100%" stop-color="#3a0ca3"></stop>
</radialgradient>
</defs>
<!-- Lines from center to nodes -->
<line opacity=".5" stroke="#4361ee" stroke-width="2.5" x1="480" x2="210" y1="280" y2="100"></line>
<line opacity=".5" stroke="#e63946" stroke-width="2.5" x1="480" x2="750" y1="280" y2="100"></line>
<line opacity=".5" stroke="#06d6a0" stroke-width="2.5" x1="480" x2="80" y1="280" y2="280"></line>
<line opacity=".5" stroke="#f9c74f" stroke-width="2.5" x1="480" x2="880" y1="280" y2="280"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="2.5" x1="480" x2="210" y1="280" y2="460"></line>
<line opacity=".5" stroke="#f72585" stroke-width="2.5" x1="480" x2="750" y1="280" y2="460"></line>
<!-- Center ellipse -->
<ellipse cx="480" cy="280" fill="url(#rg7)" filter="drop-shadow(0 4px 10px rgba(67,97,238,.4))" rx="120" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="17" font-weight="900" text-anchor="middle" x="480" y="270">ABCDEF</text>
<text fill="rgba(255,255,255,.8)" font-family="Nunito" font-size="10" text-anchor="middle" x="480" y="290">ICU Liberation Bundle</text>
<!-- A â€” Analgesia First -->
<rect fill="#eef3ff" height="120" rx="14" stroke="#4361ee" stroke-width="2.5" width="240" x="90" y="30"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="13" font-weight="900" x="107" y="56">ğŸ… Assess &amp; Manage Pain</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="76">â€¢ Analgesia PEHLE â€” sedation BAAD mein</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="91">â€¢ NRS/BPS/CPOT se score karo roz</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="106">â€¢ Fentanyl 25â€“100 mcg/hr IV infusion</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="121">â€¢ Paracetamol IV + Ketamine adjunct</text>
<text fill="#555" font-family="Nunito" font-size="9" font-style="italic" x="107" y="136">Target: NRS â‰¤3, BPS â‰¤5</text>
<!-- B â€” Both SAT & SBT -->
<rect fill="#fff0f0" height="120" rx="14" stroke="#e63946" stroke-width="2.5" width="240" x="630" y="30"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="13" font-weight="900" x="647" y="56">ğŸ…‘ Both SAT &amp; SBT Daily</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="76">â€¢ SAT: Roz sedation band karo subah</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="91">â€¢ SBT: SAT ke baad T-piece ya PS 5/5</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="106">â€¢ Paired SAT+SBT = 3 din vent kam!</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="121">â€¢ Fail criteria: SpOâ‚‚&lt;88, RR&gt;35, agitation</text>
<text fill="#555" font-family="Nunito" font-size="9" font-style="italic" x="647" y="136">Agar pass karo â†’ extubation consider karo!</text>
<!-- C â€” Choice of Sedation -->
<rect fill="#eafff6" height="130" rx="14" stroke="#06d6a0" stroke-width="2.5" width="220" x="10" y="210"></rect>
<text fill="#004d30" font-family="Nunito" font-size="13" font-weight="900" x="27" y="236">ğŸ…’ Choice of Sedation</text>
<text fill="#333" font-family="Nunito" font-size="10" x="27" y="256">â€¢ RASS target âˆ’1 to 0 (light sedation)</text>
<text fill="#333" font-family="Nunito" font-size="10" x="27" y="271">â€¢ Propofol: titrate, fast offset</text>
<text fill="#333" font-family="Nunito" font-size="10" x="27" y="286">â€¢ Dexmedetomidine: delirium kam karta</text>
<text fill="#333" font-family="Nunito" font-size="10" x="27" y="301">â€¢ Midazolam AVOID â€” delirium risk!</text>
<text fill="#333" font-family="Nunito" font-size="10" x="27" y="316">â€¢ Deep sedation = worse outcomes</text>
<text fill="#555" font-family="Nunito" font-size="9" font-style="italic" x="27" y="333">RASS/SAS se monitor karo hamesha</text>
<!-- D â€” Delirium -->
<rect fill="#fff5e6" height="130" rx="14" stroke="#f9c74f" stroke-width="2.5" width="220" x="730" y="210"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="13" font-weight="900" x="747" y="236">ğŸ…“ Delirium â€” Pagalpan!</text>
<text fill="#333" font-family="Nunito" font-size="10" x="747" y="256">â€¢ CAM-ICU se roz screen karo</text>
<text fill="#333" font-family="Nunito" font-size="10" x="747" y="271">â€¢ Non-pharm FIRST: light, clock, family</text>
<text fill="#333" font-family="Nunito" font-size="10" x="747" y="286">â€¢ Day/night cycle maintain karo</text>
<text fill="#333" font-family="Nunito" font-size="10" x="747" y="301">â€¢ Dexmedetomidine best pharma option</text>
<text fill="#333" font-family="Nunito" font-size="10" x="747" y="316">â€¢ Haloperidol/Quetiapine â€” hyperactive</text>
<text fill="#555" font-family="Nunito" font-size="9" font-style="italic" x="747" y="333">Types: Hyperactive / Hypoactive / Mixed</text>
<!-- E â€” Early Mobility -->
<rect fill="#f0eeff" height="120" rx="14" stroke="#7209b7" stroke-width="2.5" width="240" x="90" y="395"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="13" font-weight="900" x="107" y="421">ğŸ…” Early Mobility &amp; Exercise</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="441">â€¢ Vent pe bhi mobilise kar sakte hain!</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="456">â€¢ Step 1: Passive ROM exercises</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="471">â€¢ Step 2: Active exercises (bed mein)</text>
<text fill="#333" font-family="Nunito" font-size="10" x="107" y="486">â€¢ Step 3: Dangling â†’ standing â†’ walk</text>
<text fill="#555" font-family="Nunito" font-size="9" font-style="italic" x="107" y="501">ICU-acquired weakness rokta hai!</text>
<!-- F â€” Family Engagement -->
<rect fill="#fff0fa" height="120" rx="14" stroke="#f72585" stroke-width="2.5" width="240" x="630" y="395"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="13" font-weight="900" x="647" y="421">ğŸ…• Family Engagement</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="441">â€¢ Open visiting hours encourage karo</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="456">â€¢ Family ko rounds mein shamil karo</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="471">â€¢ ICU diary â€” patient ke liye likho</text>
<text fill="#333" font-family="Nunito" font-size="10" x="647" y="486">â€¢ PTSD aur delirium dono kam hote hain</text>
<text fill="#555" font-family="Nunito" font-size="9" font-style="italic" x="647" y="501">Family = best non-pharm intervention!</text>
</svg>
</div>
<!-- ABCDEF Detail Cards -->
<div style="margin-top:30px;">
<h3 style="font-size:1.15rem;font-weight:900;color:var(--blue);margin-bottom:20px;text-align:center;">ğŸ“Œ ABCDEF â€” Har Step Detail Mein</h3>
<div class="cards">
<div class="card g-blue">
<div class="card-icon">ğŸ…</div>
<h4>Assess, Prevent &amp; Manage Pain</h4>
<p>Pain assessment tools: <strong>NRS</strong> (0â€“10, communicable patients), <strong>BPS</strong> (non-communicable), <strong>CPOT</strong> (intubated). Multimodal analgesia best hai â€” opioid + non-opioid (Paracetamol, Ketorolac, low-dose Ketamine). Opioid dose titrate karo, bolus se infusion pe shift karo. <strong>Analgesia first, sedation second!</strong></p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ…‘</div>
<h4>Both SAT &amp; SBT â€” Roz Karo!</h4>
<p><strong>SAT (Spontaneous Awakening Trial):</strong> Roz subah sedation band karo agar safe ho. Fail criteria: agitation, SpOâ‚‚&lt;88%, respiratory distress. <strong>SBT (Spontaneous Breathing Trial):</strong> SAT pass karne ke baad pressure support 5/5 ya T-piece. 30â€“120 min trial. Dono milake ventilator days 3 din tak kam hote hain!</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ…’</div>
<h4>Choice of Analgesia &amp; Sedation</h4>
<p>Light sedation target: <strong>RASS âˆ’1 to 0</strong>. Propofol: titrate karna aasaan, fast onset-offset. Dexmedetomidine: alpha-2 agonist, delirium aur agitation dono kam karta hai, extubation ke qaabil bhi rakhta hai. <strong>Benzodiazepines (Midazolam) avoid karo</strong> â€” delirium, prolonged vent, aur mortality badhata hai!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ…“</div>
<h4>Delirium â€” Assess, Prevent, Manage</h4>
<p><strong>CAM-ICU</strong> se roz screen karo. Non-pharmacological measures FIRST: light in daytime, orientation cues (clock, calendar), family presence, mobility, avoid sleep disruption. Pharmacological: Dexmedetomidine (evidence best), Haloperidol/Quetiapine hyperactive delirium mein. Antipsychotics routine use evidence-based nahi hain â€” targeted use karo.</p>
</div>
<div class="card" style="background:linear-gradient(135deg,#7209b7,#560bad)">
<div class="card-icon">ğŸ…”</div>
<h4>Early Mobility &amp; Exercise</h4>
<p>ICU-acquired weakness (ICU-AW) 25â€“50% long-stay patients mein hoti hai â€” muscular atrophy, neuropathy, aur sarcopenia. Vent pe bhi passive ROM shuru karo day 1 se. Progression: passive ROM â†’ active ROM â†’ bed exercises â†’ sitting edge of bed â†’ standing â†’ ambulation. Physiotherapist ko ICU team ka part banao!</p>
</div>
<div class="card" style="background:linear-gradient(135deg,#f72585,#b5179e)">
<div class="card-icon">ğŸ…•</div>
<h4>Family Engagement &amp; Empowerment</h4>
<p>ICU mein family ka role evidence-based hai. Open visiting hours se delirium kam hoti hai, PTSD (post-ICU) bhi kam hota hai. Family ko daily rounds mein bulao, decision-making mein include karo. <strong>ICU diary</strong> rakho â€” recovery ke baad patient padhe, psychological healing hoti hai. Family = most powerful non-pharmacological tool!</p>
</div>
</div>
</div>
<!-- Scoring Tools Table -->
<div class="tbl-wrap" style="margin-top:30px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#4361ee,#3a0ca3)">
<th>Tool</th><th>Kya Measure Karta Hai?</th><th>Kab Use Karo?</th><th>Score / Target</th>
</tr></thead>
<tbody>
<tr><td><strong>NRS</strong> (Numeric Rating Scale)</td><td>Pain â€” 0 se 10</td><td>Awake &amp; communicable patient</td><td>Target â‰¤3</td></tr>
<tr><td><strong>BPS</strong> (Behavioural Pain Scale)</td><td>Pain â€” face, arms, vent compliance</td><td>Non-communicable, intubated</td><td>Target â‰¤5 (max 12)</td></tr>
<tr><td><strong>CPOT</strong> (Critical-Care Pain Obs Tool)</td><td>Pain â€” 4 domains</td><td>Non-communicable (alternative to BPS)</td><td>Target â‰¤2</td></tr>
<tr><td><strong>RASS</strong> (Richmond Agitation-Sedation Scale)</td><td>Sedation / Agitation level (âˆ’5 to +4)</td><td>Roz assess karo â€” sedation titrate karne ko</td><td>Target âˆ’1 to 0 (light sedation)</td></tr>
<tr><td><strong>CAM-ICU</strong></td><td>Delirium â€” 4 features</td><td>Roz delirium screen karo</td><td>Positive = Delirium present</td></tr>
<tr><td><strong>ICDSC</strong> (ICU Delirium Screening Checklist)</td><td>Delirium â€” 8 item scale</td><td>Shift-based assessment</td><td>Score â‰¥4 = Delirium</td></tr>
</tbody>
</table>
</div>
<!-- Drug Summary Table -->
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#e63946,#c1121f)">
<th>Drug</th><th>Role</th><th>Dose (Typical)</th><th>Watch Out!</th>
</tr></thead>
<tbody>
<tr><td><strong>Fentanyl</strong></td><td>Analgesia (1st choice)</td><td>25â€“100 mcg/hr infusion</td><td>Accumulation in renal failure</td></tr>
<tr><td><strong>Morphine</strong></td><td>Analgesia (alternative)</td><td>2â€“5 mg/hr infusion</td><td>Histamine release, renal caution</td></tr>
<tr><td><strong>Paracetamol IV</strong></td><td>Non-opioid adjunct</td><td>1g q6h IV</td><td>Safe â€” hepatic dose adjust karo</td></tr>
<tr><td><strong>Ketamine</strong></td><td>Opioid-sparing adjunct</td><td>0.1â€“0.5 mg/kg/hr</td><td>Emergence phenomena â€” kam dose pe safe</td></tr>
<tr><td><strong>Propofol</strong></td><td>Sedation (short-term)</td><td>5â€“50 mcg/kg/min</td><td>PRIS (&gt;4 mg/kg/hr &gt;48 hr) â€” TG, lactic acidosis</td></tr>
<tr><td><strong>Dexmedetomidine</strong></td><td>Sedation + Delirium</td><td>0.2â€“1.5 mcg/kg/hr</td><td>Bradycardia, hypotension</td></tr>
<tr><td><strong>Midazolam</strong></td><td>Avoid routine use!</td><td>â€”</td><td>Delirium â†‘, prolonged vent â†‘, mortality â†‘</td></tr>
<tr><td><strong>Haloperidol</strong></td><td>Hyperactive delirium</td><td>0.5â€“2 mg IV q6â€“8h</td><td>QTc prolong karo monitor</td></tr>
<tr><td><strong>Quetiapine</strong></td><td>Delirium (oral)</td><td>25â€“50 mg BD</td><td>Sedation, QTc</td></tr>
</tbody>
</table>
</div>
<!-- Tip Box -->
<div class="tip-box" style="margin-top:28px;">
<div class="t-head">ğŸ’¡ ABCDEF Bundle Ki Khasiyat â€” Ek Nazar Mein!</div>
<p><strong>A</strong> â€” Analgesia first. Dard ka ilaj karo, sedation se mask mat karo.<br/>
<strong>B</strong> â€” Both SAT + SBT roz â€” ventilator se nikalna zaroori hai jaldi.<br/>
<strong>C</strong> â€” Choose wisely: Propofol &gt; Dex &gt;&gt;&gt; Midazolam.<br/>
<strong>D</strong> â€” Delirium screen karo, non-pharm se shuru karo, pharm last resort.<br/>
<strong>E</strong> â€” Exercise â€” day 1 se start karo passive ROM bhi sahi hai.<br/>
<strong>F</strong> â€” Family â€” ICU mein unhe bulao, diary likho, empower karo.<br/><br/>
<strong>eCASH Mantra:</strong> <em>Early Comfort using Analgesia, minimal Sedatives, and maximal Humane care.</em> â€” Yeh line yaad kar lo bhai!</p>
</div>
<div class="alert alert-green" style="margin-top:20px;">
<div class="icon">ğŸš¨</div>
<div><strong>Propofol Infusion Syndrome (PRIS) â€” Yaad Rakho!</strong> High-dose propofol (&gt;4 mg/kg/hr) &gt;48 ghante mein PRIS ho sakta hai. Signs: metabolic acidosis, rhabdomyolysis, cardiac arrhythmia, renal failure. TG levels monitor karo. Agar suspicious ho â€” propofol band karo turant aur Dexmedetomidine ya Midazolam (short-term) switch karo!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--red)">Chapter 08</div>
<h2 style="color:var(--red)">â¤ï¸ Dil Ki Emergency â€” Cardiac Emergencies in ICU</h2>
<div class="chapter-intro" style="border-color:var(--red)">
    ICU mein heart bhi dhoka deta hai â€” arrhythmias, AMI, aur cardiogenic shock â€” sab common hain. POCUS se 5 minute mein LV function dekho, haemodynamic state samjho, aur sahi treatment do. <strong>"Feeling se" kaam nahi chalega â€” data chahiye! ECG + POCUS + biomarkers = Triangle of Truth!</strong>
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:960px" viewbox="0 0 960 540" width="100%">
<defs><radialgradient cx="50%" cy="40%" id="rgCard"><stop offset="0%" stop-color="#ff6b6b"/><stop offset="100%" stop-color="#9d0208"/></radialgradient></defs>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="480" x2="220" y1="270" y2="110"/><line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="480" x2="740" y1="270" y2="110"/>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="480" x2="80" y1="270" y2="280"/><line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="480" x2="880" y1="270" y2="280"/>
<line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="480" x2="220" y1="270" y2="440"/><line opacity=".6" stroke="#e63946" stroke-dasharray="6,3" stroke-width="3" x1="480" x2="740" y1="270" y2="440"/>
<ellipse cx="480" cy="270" fill="url(#rgCard)" rx="120" ry="60"/>
<text fill="#fff" font-family="Nunito" font-size="15" font-weight="800" text-anchor="middle" x="480" y="262">CARDIAC EMERGENCY</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="480" y="283">Dil Ka Darr â€” Sambhalo Turant!</text>
<rect fill="#fff0f0" height="108" rx="14" stroke="#e63946" stroke-width="2.5" width="220" x="110" y="56"/>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="220" y="88">âš¡ VF/VT â€” Shock Do Abhi!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="104">â€¢ 200J biphasic â€” IMMEDIATELY!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="118">â€¢ CPR 30:2 â€” quality matters!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="132">â€¢ Adrenaline 1mg q3-5min IV</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="146">â€¢ Amiodarone 300mg bolus (shockable)</text>
<rect fill="#eefaff" height="108" rx="14" stroke="#0096c7" stroke-width="2.5" width="220" x="630" y="56"/>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="740" y="88">ğŸ’” Cardiogenic Shock</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="104">â€¢ Norad + Dobutamine combo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="118">â€¢ IABP / Impella escalate karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="132">â€¢ AMI hai? PCI turant â€” door nahi jaana!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="146">â€¢ VA-ECMO agar refractory shock</text>
<rect fill="#eafff6" height="108" rx="14" stroke="#06d6a0" stroke-width="2.5" width="185" x="0" y="225"/>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="258">ğŸ«€ AF â€” Rate Control!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="274">â€¢ Metoprolol IV 5mg slow</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="288">â€¢ Diltiazem agar contraindicated</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="302">â€¢ Digoxin â€” low EF mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="316">â€¢ Amiodarone â€” rhythm control</text>
<rect fill="#f5eeff" height="108" rx="14" stroke="#7209b7" stroke-width="2.5" width="185" x="775" y="225"/>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="868" y="258">ğŸ“Š POCUS â€” 5 Min!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="868" y="274">â€¢ LVEF: &lt;30% = severe dysfunction</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="868" y="288">â€¢ Pericardial effusion â€” tamponade?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="868" y="302">â€¢ RV dilatation â€” PE ya PHTN?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="868" y="316">â€¢ IVC â€” fluid responsive?</text>
<rect fill="#fffbea" height="105" rx="14" stroke="#f9c74f" stroke-width="2.5" width="220" x="110" y="383"/>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="220" y="416">ğŸ©º SVT â€” Adenosine Se!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="432">â€¢ Vagal first â€” carotid sinus, Valsalva</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="446">â€¢ Adenosine 6mg rapid IV + flush</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="460">â€¢ 12mg x2 agar nahi kaam kiya</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="220" y="474">â€¢ Wide complex? Adenosine mat do!</text>
<rect fill="#fff0fa" height="105" rx="14" stroke="#f72585" stroke-width="2.5" width="220" x="630" y="383"/>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="740" y="416">ğŸ”Œ Heart Block â€” Pacing!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="432">â€¢ 3rd degree: Transcutaneous pace karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="446">â€¢ Atropine 0.5-1mg bridge ke liye</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="460">â€¢ Transvenous pacing: permanent fix</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="740" y="474">â€¢ Inferior MI + CHB: usually transient</text>
</svg>
</div>
<div class="divider"></div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#e63946,#c1121f)">
<th>Arrhythmia</th><th>Pehle Kya Karo?</th><th>Dawaai</th>
</tr></thead>
<tbody>
<tr><td><strong>VF / Pulseless VT</strong></td><td>200J se defibrillate karo ABHI + CPR shuru!</td><td>Adrenaline 1mg q3-5min + Amiodarone 300mg</td></tr>
<tr><td><strong>VT with Pulse</strong></td><td>Unstable hai? Cardiovert karo synchronised!</td><td>Amiodarone 150 mg IV over 10 min slowly</td></tr>
<tr><td><strong>AF with RVR</strong></td><td>Rate control pehle agar stable hai</td><td>Metoprolol IV ya Diltiazem ya Digoxin</td></tr>
<tr><td><strong>SVT</strong></td><td>Vagal manoeuvre try karo, phir Adenosine</td><td>Adenosine 6 mg rapid IV â€” fast dena!</td></tr>
<tr><td><strong>Complete Heart Block</strong></td><td>Transcutaneous pacing turant lagao!</td><td>Atropine 0.5 mg temporary bridge ke liye</td></tr>
<tr><td><strong>Torsades</strong></td><td>Defibrillate + QTc prolong karne wali cheez hataao</td><td>MgSOâ‚„ 2g IV over 15 min â€” magic drug!</td></tr>
</tbody>
</table>
</div>
<div class="cards">
<div class="card g-red">
<div class="card-icon">ğŸ’”</div>
<h4>Cardiogenic Shock â€” Dono Lagao!</h4>
<p>Noradrenaline pehle (MAP ke liye) + Dobutamine 5-20 mcg/kg/min (pump ke liye). Refractory hai? IABP ya Impella lagao. AMI hai? PCI â€” jitna jaldi utna acha!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ«€</div>
<h4>POCUS â€” 5 Minute Ka Jadoo!</h4>
<p>LVEF kitna hai? Pericardial effusion? IVC collapsible? RV dilated? (PE ka sign) Wall motion abnormality? (STEMI ka sign) â€” Yeh sab 5 minute mein pata chalte hain!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ©º</div>
<h4>Mechanical Support â€” Kab?</h4>
<p>IABP: Diastolic pressure badhata hai. Impella 2.5/CP: 4 L/min tak support. VA-ECMO: Refractory shock â€” bridge to recovery ya transplant. Escalation step by step!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ“Š</div>
<h4>Type 1 vs Type 2 MI</h4>
<p>Type 1: Plaque rupture = PCI karo. Type 2: Demand mismatch (sepsis, AF, hypoxia se) = underlying cause theek karo. Dono mein alag treatment! Cardiology consult zaroor karo!</p>
</div>
</div>
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#e63946,#c1121f)">
<th>Arrhythmia</th><th>Immediate Action</th><th>Drug of Choice</th><th>Energy (if cardiovert)</th>
</tr></thead>
<tbody>
<tr><td><strong>VF / Pulseless VT</strong></td><td>Defibrillate NOW + CPR</td><td>Adrenaline 1mg + Amiodarone 300mg</td><td>200J biphasic (unsynchronised)</td></tr>
<tr><td><strong>VT with Pulse (Unstable)</strong></td><td>Synchronised cardioversion</td><td>Amiodarone 150mg over 10 min</td><td>100-200J synchronised</td></tr>
<tr><td><strong>AF with RVR (Stable)</strong></td><td>Rate control first</td><td>Metoprolol IV / Diltiazem / Digoxin</td><td>120-200J agar cardiovert karo</td></tr>
<tr><td><strong>SVT</strong></td><td>Vagal manoeuvre â†’ Adenosine</td><td>Adenosine 6mg â†’ 12mg IV rapid</td><td>50-100J synchronised</td></tr>
<tr><td><strong>Complete Heart Block</strong></td><td>Transcutaneous pacing immediately</td><td>Atropine 0.5mg bridge</td><td>N/A â€” pacing lagao</td></tr>
<tr><td><strong>Torsades de Pointes</strong></td><td>Defibrillate + QTc drugs hatao</td><td>MgSOâ‚„ 2g IV over 10-15 min</td><td>200J agar haemodynamically unstable</td></tr>
<tr><td><strong>Bradycardia (Symptomatic)</strong></td><td>Atropine 0.5mg IV</td><td>Dopamine 5-20 mcg/kg/min infusion</td><td>Transcutaneous pacing if drug fail</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-red">
<div class="card-icon">ğŸ“Š</div>
<h4>Troponin in ICU â€” Kab Significant Hai?</h4>
<p>Type 1 MI: plaque rupture â€” immediate PCI. Type 2 MI: demand mismatch (tachycardia, sepsis, hypoxia se) â€” underlying cause treat karo. ICU mein troponin uthna common hai â€” critically ill mein hamesha Type 2 rule out karo. Serial troponins dekho: rise-fall pattern = ACS. Cardiology consult karo!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’Š</div>
<h4>Antiarrhythmic Drugs â€” Class Yaad Karo!</h4>
<p>Class I: Lignocaine (VT). Class II: Beta-blockers (AF rate control, SVT). Class III: Amiodarone (most versatile â€” VF, VT, AF). Class IV: Calcium channel blockers (AF, SVT). Amiodarone sabse useful ICU mein â€” broad spectrum antiarrhythmic. Thyroid, pulmonary, hepatic toxicity long term mein monitor karo!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ”</div>
<h4>Pericardial Tamponade â€” Beck's Triad!</h4>
<p>Beck's Triad: Hypotension + JVD + Muffled heart sounds. POCUS mein: diastolic RV collapse + IVC plethora + swinging heart. Treatment: pericardiocentesis immediately â€” needle parasternal ya subcostal approach. Reversal dramatic hota hai! Echocardiography guide karo procedure.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ“ˆ</div>
<h4>Troponin Elevation Causes in ICU</h4>
<p>ACS, myocarditis, PE (massive), heart failure, sepsis-induced cardiomyopathy, Takotsubo, renal failure. Yeh sab troponin uthate hain! Context se decide karo: ECG changes? Regional WMA on POCUS? Agar doubt ho â€” cardiology consult karo, PCI lab ready karo. "When in doubt, call the cardiologist!"</p>
</div>
</div>
<div class="alert alert-red">
<div class="icon">ğŸš¨</div>
<div><strong>STEMI in ICU â€” Door to Balloon &lt;90 minutes!</strong> STEMI identify karo: ST elevation â‰¥1mm contiguous leads, new LBBB. Aspirin 325mg + P2Y12 (Ticagrelor 180mg) dena bypass karo. Heparin 60U/kg IV bolus. PCI lab activate karo IMMEDIATELY. If PCI &gt;120 min door-to-balloon â€” thrombolysis consider karo (no contraindication ho toh). Cardiogenic shock mein PCI even more urgent hai!</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ Amiodarone â€” ICU Ka Swiss Army Knife!</div>
Loading dose: 150mg IV over 10 min (acute arrhythmia) ya 5mg/kg over 30-60 min. Maintenance: 1mg/min Ã— 6h, phir 0.5mg/min Ã— 18h. Oral: 200mg TDS Ã— 1 week, BD Ã— 1 week, phir OD maintenance.<br/><br/>
Side effects: Hypotension (IV se â€” slow infuse), phlebitis (central line se do), thyroid dysfunction, pulmonary toxicity, hepatotoxicity. Long-term: LFT, TFT, CXR annually check karo!
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--yellow)">Chapter 09</div>
<h2 style="color:#c8860a">ğŸ§  Dimag Ki Emergency â€” Neurological Emergencies!</h2>
<div class="chapter-intro" style="border-color:var(--yellow)">
    Status epilepticus, TBI, SAH, stroke â€” yeh sab neuro-critical care ke major topics hain. Primary injury ko reverse nahi kar sakte aksar, lekin <strong>secondary injury zaroor rok sakte hain!</strong> Normothermia, normoglycaemia, avoid hypoxia â€” yeh teeno sabse important hain. 
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 510" width="100%">
<defs>
<radialgradient cx="50%" cy="40%" id="rg9">
<stop offset="0%" stop-color="#f9c74f"></stop>
<stop offset="100%" stop-color="#f8961e"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#f9c74f" stroke-width="3" x1="450" x2="200" y1="255" y2="105"></line>
<line opacity=".6" stroke="#f9c74f" stroke-width="3" x1="450" x2="700" y1="255" y2="105"></line>
<line opacity=".6" stroke="#f9c74f" stroke-width="3" x1="450" x2="100" y1="255" y2="275"></line>
<line opacity=".6" stroke="#f9c74f" stroke-width="3" x1="450" x2="800" y1="255" y2="275"></line>
<line opacity=".6" stroke="#f9c74f" stroke-width="3" x1="450" x2="200" y1="255" y2="415"></line>
<line opacity=".6" stroke="#f9c74f" stroke-width="3" x1="450" x2="700" y1="255" y2="415"></line>
<ellipse cx="450" cy="255" fill="url(#rg9)" rx="115" ry="57"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="450" y="247">NEURO</text>
<text fill="rgba(255,255,255,.9)" font-family="Nunito" font-size="11" text-anchor="middle" x="450" y="267">Secondary Injury Rokna Zaroori!</text>
<rect fill="#fffbea" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="220" x="90" y="55"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="87">âš¡ Status Epilepticus</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="104">â€¢ Lorazepam 0.1 mg/kg IV â€” pehli</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="118">â€¢ Levetiracetam ya Valproate</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="132">â€¢ RSE: Propofol ya Thiopentone</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="146">â€¢ EEG monitor karo coma mein</text>
<rect fill="#eef8ff" height="100" rx="14" stroke="#0096c7" stroke-width="2.5" width="220" x="590" y="55"></rect>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="87">ğŸ§  TBI Management</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="104">â€¢ ICP &lt;20 mmHg rakhna target</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="118">â€¢ CPP 60-70 mmHg maintain karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="132">â€¢ HOB 30Â°, Mannitol ya HTS</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="146">â€¢ Avoid hypotension bilkul!</text>
<rect fill="#fff0f0" height="100" rx="14" stroke="#e63946" stroke-width="2.5" width="200" x="20" y="222"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="120" y="254">ğŸ©¸ SAH â€” Brain Mein Khoon!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="271">â€¢ Nimodipine 60 mg q4h â€” zaroor!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="285">â€¢ SBP &lt;160 pre-clipping rakho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="299">â€¢ DCI: TCD ya CTA se monitor</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="120" y="313">â€¢ Vasospasm se bachao!</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2.5" width="200" x="680" y="222"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="780" y="254">ğŸ§¬ Stroke â€” Jaldi Karo!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="271">â€¢ tPA 4.5 ghante ke andar!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="285">â€¢ Thrombectomy â‰¤24 ghante</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="299">â€¢ Lysis ke liye BP &lt;185/110</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="780" y="313">â€¢ Time = Brain cells! â€” Bhago!</text>
<rect fill="#f0eeff" height="90" rx="14" stroke="#7209b7" stroke-width="2.5" width="220" x="90" y="385"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="414">ğŸ“¡ ICP Monitor</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="431">â€¢ EVD = gold standard + CSF drain</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="445">â€¢ ONSD &gt;5mm = raised ICP on USS</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="459">â€¢ Pupil changes bhi dekho!</text>
<rect fill="#fff5e6" height="90" rx="14" stroke="#f9c74f" stroke-width="2.5" width="220" x="590" y="385"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="414">ğŸ›¡ï¸ Secondary Injury Rokko!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="431">â€¢ Fever nahi â€” Normothermia!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="445">â€¢ Sugar 6-10 mmol/L rakho</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="459">â€¢ Hypoxia bilkul nahi honi chahiye!</text>
</svg>
</div>
<div class="alert alert-yellow">
<div class="icon">â°</div>
<div><strong>"Time is Brain" â€” Yeh Koi Slogan Nahi, Sach Hai!</strong> Stroke mein har minute mein 19 lakh brain cells marti hain. tPA window 4.5 ghante ki hai â€” door ka hospital bhi consider karo. Thrombectomy abhi 24 ghante tak ho sakti hai selected patients mein. Door stroke centre mein bhejo â€” wahan thoda aur door hai lekin treatment milegi!</div>
</div>

<div class="cards" style="margin-top:0">
<div class="card g-yellow">
<div class="card-icon">âš¡</div>
<h4>Status Epilepticus â€” Step Protocol</h4>
<p><strong>0-5 min:</strong> ABCs, IV access, BGL check, Oâ‚‚ do. <strong>5-20 min:</strong> Benzodiazepine (Lorazepam 0.1 mg/kg IV ya Midazolam 0.2 mg/kg IM). <strong>20-40 min:</strong> 2nd line: Levetiracetam 60 mg/kg IV ya Valproate 40 mg/kg. <strong>&gt;40 min:</strong> RSE â€” Thiopentone/Propofol infusion, EEG monitor, ICU admit!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ§ </div>
<h4>TBI â€” Munroe-Kellie Doctrine</h4>
<p>Cranial vault mein 3 compartments: Brain (80%), CSF (10%), Blood (10%). Ek badha toh doosra compress hoga. ICP &gt;20 mmHg = treat karo! CPP = MAP â€“ ICP. CPP target: 60-70 mmHg. Cushing's triad: HTN + bradycardia + irregular breathing = uncal herniation! Emergency!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’Š</div>
<h4>ICP Lowering â€” Stepwise</h4>
<p>Step 1: HOB 30Â°, head midline. Step 2: Adequate sedation + analgesia. Step 3: Mannitol 0.5-1 g/kg ya HTS 3% (NaCl). Step 4: Hyperventilation BRIEFLY (PCOâ‚‚ 30-35, short term!). Step 5: CSF drainage via EVD. Step 6: Barbiturate coma. Step 7: Decompressive craniectomy!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ”</div>
<h4>SAH â€” Nimodipine Kyun Zaroori?</h4>
<p>Nimodipine = calcium channel blocker. Vasospasm prevent karta hai â€” NOT prevent karta hai, par FUNCTIONAL outcome better karta hai. 60 mg q4h Ã— 21 days. Oral route prefer karo â€” IV nimodipine se BP zyada girti hai. Discontinue agar SBP &lt;90. DCI watch karo â€” TCD se daily monitor!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#f9c74f,#f8961e)">
<th>Condition</th><th>Immediate Action</th><th>Investigations</th><th>ICU Target</th>
</tr></thead>
<tbody>
<tr><td><strong>Status Epilepticus</strong></td><td>Benzos â†’ 2nd line â†’ Coma</td><td>EEG, metabolic panel, AED levels</td><td>EEG burst suppression in RSE</td></tr>
<tr><td><strong>TBI (Severe)</strong></td><td>Intubate, ICP monitor</td><td>CT head (non-contrast), coag</td><td>ICP &lt;20, CPP 60-70 mmHg</td></tr>
<tr><td><strong>SAH</strong></td><td>CT â†’ LP â†’ CTA/DSA</td><td>CT angio, echocardiogram</td><td>SBP &lt;160, Nimodipine, DCI watch</td></tr>
<tr><td><strong>Ischaemic Stroke</strong></td><td>NIHSS, CT, thrombolysis?</td><td>CT perfusion, MRI DWI</td><td>BP &lt;185/110 (lysis), &lt;220 others</td></tr>
<tr><td><strong>HACE / Herniation</strong></td><td>Mannitol, Hyperventilate</td><td>CT head STAT, Neurosurg call</td><td>Emergency craniectomy consider</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-yellow">
<div class="icon">ğŸ§ </div>
<div><strong>Neuro-ICU Ka Golden Rule â€” Secondary Injury Rokko!</strong> Primary injury toh ho chuki â€” TBI, stroke, SAH â€” isko reverse nahi kar sakte hum. Lekin secondary injury â€” hypoxia, hypotension, hyperthermia, hyperglycaemia, seizures â€” yeh sab rokke hum bahut saari deaths aur disability prevent kar sakte hain! Normothermia (36-37Â°C), Normoglycaemia (6-10), Normoxia (SpOâ‚‚ 94-98%), Normotension (CPP target maintain karo) â€” yeh "4 Norm" yaad kar lo!</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ GCS â€” Jaldi Calculate Karo!</div>
<strong>E</strong>yes (1-4): 1=None, 2=Pain, 3=Voice, 4=Spontaneous<br/>
<strong>V</strong>erbal (1-5): 1=None, 2=Sounds, 3=Words, 4=Confused, 5=Oriented<br/>
<strong>M</strong>otor (1-6): 1=None, 2=Extension(decerebrate), 3=Flexion(decorticate), 4=Withdrawal, 5=Localising, 6=Obeys<br/>
<strong>GCS â‰¤8 = Intubation consider karo!</strong> Remember: GCS 8 se kam matlab airway protect nahi kar sakta patient khud. "Eyes closed at 8 â€” intubate" â€” yeh rule yaad kar lo!
</div>

</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--green)">Chapter 10</div>
<h2 style="color:var(--green)">ğŸ¥— ICU Mein Khaana Peena â€” Nutrition!</h2>
<div class="chapter-intro" style="border-color:var(--green)">
    Bhai, ICU patients ko lagta hai inhe sirf saline chahiye â€” nahi! Yeh bande bahut fast mein khaana tod dete hain. Malnutrition = infections zyada, wound heal nahi hote, ventilator par jyada dino tak rehna padta hai. <strong>Early enteral nutrition</strong> = 24-48 ghante mein shuru karo!
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-green">
<div class="card-icon">â±ï¸</div>
<h4>Kab Shuru Karein?</h4>
<p>24-48 ghante mein EN shuru karo ICU admission ke baad. Vasopressors par bhi â€” low dose par chalti hai feed. Wait mat karo!Gut kaam kar raha hai toh use karo!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ“Š</div>
<h4>Kitna Dena Hai?</h4>
<p>Energy: 25-30 kcal/kg/day. Protein: 1.2-2 g/kg/day. Burns/trauma mein 2.5 g/kg tak. Indirect calorimetry se measure karo agar ho sake â€” predictive equations bhi chalte hain.</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸš«</div>
<h4>Feed Kab Band Karein?</h4>
<p>Uncontrolled shock (norad &gt;0.5 mcg/kg/min), bowel ischaemia, obstruction â€” tab band karo. Haemodynamically stable hone pe turant restart karo. Band karna bhi ek decision hai!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’‰</div>
<h4>TPN â€” Kab?</h4>
<p>EN nahi chal rahi ya contraindicated hai â‰¥7 days (well-nourished) ya â‰¥3-5 days (malnourished) â€” tab TPN shuru karo. Early EN+TPN combine mat karo â€” EPaNIC trial ne yeh prove kiya!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ§ª</div>
<h4>Refeeding Syndrome â€” Dangerous!</h4>
<p>Bhookha raha patient, alcoholic, anorexic â€” inhe refeeding ka risk hai. Phosphate, K+, Mg2+ monitor karo closely. 50% rate se shuru karo, 3-4 din mein target pe aao. Thiamine dena mat bhoolo!</p>
</div>
<div class="card g-pink">
<div class="card-icon">ğŸ©º</div>
<h4>Monitor Kaise Karein?</h4>
<p>Gastric residual &gt;500 ml = band karo, sochna. Blood glucose q4-6h (target 6-10 mmol/L). Weekly nutritional screening. Motility agents consider karo agar GRV zyada hai.</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#0096c7)">
<th>Condition</th><th>Special Dhyan â€” Kya Karna Hai?</th>
</tr></thead>
<tbody>
<tr><td><strong>AKI on RRT</strong></td><td>Protein zyada â€” 2.5 g/kg tak do. Fluid restriction mat karo unnecessarily.</td></tr>
<tr><td><strong>ARDS / Ventilator</strong></td><td>Overfeeding mat karo. Prone pe bhi EN chalti hai nasogastric se!</td></tr>
<tr><td><strong>Sepsis / Septic Shock</strong></td><td>Pehle 2 din trophic EN (10-20 kcal/hr), phir full dose pe aao.</td></tr>
<tr><td><strong>Liver Failure</strong></td><td>Protein restrict mat karo â€” hepatic encephalopathy mein bhi! BCAA + Zinc do.</td></tr>
<tr><td><strong>TBI</strong></td><td>High protein 2-2.5 g/kg/day. Early EN zaroori â€” brain ko energy chahiye!</td></tr>
<tr><td><strong>Burns &gt;20% BSA</strong></td><td>Curreri formula use karo. Protein 2-3 g/kg. Vitamin C, Zinc, Selenium add karo.</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-green">
<div class="icon">ğŸŒŸ</div>
<div><strong>Golden Rule â€” "Agar Aant Kaam Kar Rahi Hai, Usse Use Karo!"</strong> Enteral nutrition gut mucosal integrity maintain karta hai, bacterial translocation rokta hai, microbiome maintain karta hai, aur TPN se bahut sasta bhi hai! Gastric trial pehle karo â€” post-pyloric ya TPN sirf tabhi jab EN possible nahi ho.</div>
</div>
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#0096c7)">
<th>Condition</th><th>Protein Target</th><th>Calorie Target</th><th>Special Notes</th>
</tr></thead>
<tbody>
<tr><td><strong>Sepsis / Critical Illness</strong></td><td>1.5-2 g/kg IBW/day</td><td>15-20 kcal/kg (acute phase)</td><td>Trophic 48h, phir advance</td></tr>
<tr><td><strong>AKI (no RRT)</strong></td><td>0.8-1.2 g/kg/day</td><td>25-30 kcal/kg</td><td>Protein restrict karo â€” BUN nahi badhna chahiye</td></tr>
<tr><td><strong>AKI (on CRRT)</strong></td><td>1.5-2.5 g/kg/day</td><td>25-30 kcal/kg</td><td>CRRT amino acids clear karta hai â€” zyada do!</td></tr>
<tr><td><strong>ARDS</strong></td><td>1.5-2 g/kg/day</td><td>20-25 kcal/kg</td><td>Avoid overfeeding â€” COâ‚‚ production badhti hai!</td></tr>
<tr><td><strong>Liver Failure</strong></td><td>1.2-1.5 g/kg/day (BCAA prefer)</td><td>30-35 kcal/kg</td><td>Old myth: protein restrict karna â€” WRONG!</td></tr>
<tr><td><strong>Burns (&gt;20% TBSA)</strong></td><td>2-2.5 g/kg/day</td><td>35-40 kcal/kg</td><td>Hypermetabolic â€” aggressive nutrition zaroori!</td></tr>
<tr><td><strong>Obese ICU Patient</strong></td><td>2-2.5 g/kg IBW/day</td><td>65-70% calorie needs</td><td>Hypocaloric, high-protein â€” better outcomes</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-green">
<div class="card-icon">âš¡</div>
<h4>Refeeding Syndrome â€” Pehchano!</h4>
<p>High-risk: BMI &lt;18, 5+ days khaana nahi, significant weight loss. Signs: hypophosphatemia (&lt;0.5 mmol/L), hypokalemia, hypomagnesemia. Prevention: NICE guidelines â€” 10 kcal/kg/day se shuru, phosphate supplement, thiamine 200mg IV OD (Wernicke's prevent karo!). Slow aur steady!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ“</div>
<h4>Nutrition Assessment â€” NRS-2002!</h4>
<p>NRS-2002 score â‰¥3 = at nutritional risk â€” aggressive nutrition support chahiye. NUTRIC score: ICU mein nutrition benefit predict karta hai â€” score â‰¥5 high risk. BMI &lt;18 ya &gt;40 both require special attention. MUST score community setting ke liye. Dietician referral â‰¥3 score pe always karo!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’‰</div>
<h4>Supplemental PN â€” Kab Add Karo?</h4>
<p>Early PN: first 7 days EN se targets achieve nahi ho rahe ho toh PN add karo (SPN). EPANIC trial: early PN harm karta hai. CALORIES trial: PN vs EN â€” similar outcomes. Recommendation: 7 days tak wait karo EN try karke. Agar absolute contraindication â€” PN day 1. Glutamine supplement: burns + trauma mein benefit.</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ”</div>
<h4>Glucose Control â€” Target 7.8-10!</h4>
<p>Tight control (4.4-6.1): NICE-SUGAR trial mein MORE mortality! So target 7.8-10 mmol/L. Insulin infusion protocol use karo. Hypoglycemia (&lt;4 mmol/L) bahut dangerous hai ICU mein â€” neuroglycopenia, arrhythmias. Check BG q1-2h jab insulin infusion ho. Enteral nutrition ke saath BG control asaan ho jaata hai!</p>
</div>
</div>
<div class="alert alert-green">
<div class="icon">ğŸ½ï¸</div>
<div><strong>Enteral vs Parenteral â€” Gut Ka Faisla!</strong> "If the gut works, use it!" â€” yeh ICU ka golden rule hai. EN = gut barrier maintain karta hai, bacterial translocation rokta hai, GVHD prevent karta hai, CLABSI risk nahi, aur PN se 3-4x sasta. PN sirf jab EN impossible ya unsafe ho â€” 7 din ke liye wait karo agar stable critically ill patient hai. Short bowel, high-output fistula = PN indicate hota hai.</div>
</div>

<div class="cards" style="margin-top:0">
<div class="card g-green">
<div class="card-icon">ğŸ§¬</div>
<h4>Micronutrients â€” Bhool Gaye Toh?</h4>
<p>Vitamin C: 1-3 g/day (antioxidant, wound healing). Vitamin D: deficiency common in ICU â€” supplement karo agar &lt;50 nmol/L. Zinc: 25-40 mg/day (burns, wound). Selenium: 60-100 mcg/day (antioxidant). Thiamine: ZAROOR do alcoholics, refeeding risk mein. Iron: anaemia correct karo carefully.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ”§</div>
<h4>Feeding Route â€” Konsa Choose Karein?</h4>
<p><strong>NGT (Nasogastric):</strong> Pehli choice â€” easy, safe. <strong>NJT (Nasojejunal):</strong> Gastroparesis, high aspiration risk. <strong>PEG:</strong> Long-term (&gt;4 weeks). <strong>TPN:</strong> Absolute gut contraindication. Post-pyloric feeding aspiration risk kam karti hai â€” high-risk patients mein prefer. Confirm placement â€” pH &lt;5.5 ya CXR.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ“‰</div>
<h4>Underfeeding vs Overfeeding</h4>
<p>Underfeeding: muscle wasting, poor wound healing, infections, ventilator dependence. Overfeeding: hyperglycaemia, COâ‚‚ production badhti hai (ventilator weaning hard), fatty liver, hypertriglyceridaemia. Target: 80-100% of calculated needs (not 120%!). ICU mein "less is more" often applies!</p>
</div>
<div class="card g-red">
<div class="card-icon">âš ï¸</div>
<h4>Aspiration Risk â€” Manage Karo!</h4>
<p>HOB 30-45Â° hamesha. Oral care q4h chlorhexidine se. Gastric residual volume (GRV) check â€” &gt;500 ml toh band karo, metoclopramide ya erythromycin try karo. High-risk: post-pyloric feeding. Continuous vs bolus: continuous se GRV better control. SBT ke time feed band karo 2h pehle!</p>
</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ½ï¸ Dr. Varshney Ka Nutrition Memory Aid</div>
<strong>"STOP STARVING ICU PATIENTS!"</strong><br/><br/>
<strong>S</strong> â€” Start within 24-48 hours (early EN!)<br/>
<strong>T</strong> â€” Target: 25-30 kcal/kg, 1.5-2 g protein/kg<br/>
<strong>O</strong> â€” Oral/Enteral first â€” gut use karo!<br/>
<strong>P</strong> â€” Parenteral sirf jab EN impossible â‰¥7 days<br/><br/>
<strong>S</strong> â€” Special conditions = special targets (AKI, burns, liver)<br/>
<strong>T</strong> â€” Thiamine dena mat bhoolo refeeding risk mein!<br/>
<strong>A</strong> â€” Assess daily â€” GRV, BG, electrolytes<br/>
<strong>R</strong> â€” Refeeding syndrome = slow and steady approach<br/>
<strong>V</strong> â€” Vitamins and micronutrients supplement karo<br/>
<strong>I</strong> â€” Insulin: BG 7.8-10 mmol/L target (NICE-SUGAR remember!)<br/>
<strong>N</strong> â€” NRS-2002 â‰¥3 = dietician consult mandatory<br/>
<strong>G</strong> â€” Glucose monitoring q4-6h jab on nutrition
</div>

</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--red)">Chapter 11</div>
<h2 style="color:var(--red)">ğŸ©¸ GI Bleeding â€” ICU Mein Manage Karo!</h2>
<div class="chapter-intro" style="border-color:var(--red)">
    Bhai, upper GI bleed aata hai toh haematemesis, melena â€” aur patient shock mein bhi aa sakta hai. Lower GI bleed mein fresh blood rectum se. ICU mein Priority: <strong>Resuscitate â†’ Stabilize â†’ Investigate â†’ Treat!</strong> Endoscopy sabse important hai â€” delay mat karo!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 520" width="100%">
<defs>
<radialgradient cx="50%" cy="40%" id="rg11">
<stop offset="0%" stop-color="#e63946"></stop>
<stop offset="100%" stop-color="#7a0000"></stop>
</radialgradient>
</defs>
<!-- Lines -->
<line opacity=".5" stroke="#e63946" stroke-width="3" x1="450" x2="200" y1="260" y2="100"></line>
<line opacity=".5" stroke="#e63946" stroke-width="3" x1="450" x2="700" y1="260" y2="100"></line>
<line opacity=".5" stroke="#e63946" stroke-width="3" x1="450" x2="95" y1="260" y2="280"></line>
<line opacity=".5" stroke="#e63946" stroke-width="3" x1="450" x2="805" y1="260" y2="280"></line>
<line opacity=".5" stroke="#e63946" stroke-width="3" x1="450" x2="200" y1="260" y2="420"></line>
<line opacity=".5" stroke="#e63946" stroke-width="3" x1="450" x2="700" y1="260" y2="420"></line>
<ellipse cx="450" cy="260" fill="url(#rg11)" rx="120" ry="60"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="16" font-weight="800" text-anchor="middle" x="450" y="252">GI BLEED</text>
<text fill="rgba(255,255,255,.8)" font-family="Nunito" font-size="11" text-anchor="middle" x="450" y="272">ICU Ka Khatrnak Mehman!</text>
<rect fill="#fff0f0" height="105" rx="14" stroke="#e63946" stroke-width="2.5" width="230" x="80" y="45"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="195" y="78">ğŸš¨ Upper GI Bleed â€” Causes</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="95">â€¢ Peptic ulcer (most common)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="109">â€¢ Oesophageal varices (cirrhosis)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="123">â€¢ Mallory Weiss tear, erosions</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="137">â€¢ Dieulafoy lesion â€” rare but nasty!</text>
<rect fill="#eef3ff" height="105" rx="14" stroke="#4361ee" stroke-width="2.5" width="230" x="590" y="45"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="705" y="78">ğŸ©º Resuscitation â€” Pehle Karo!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="95">â€¢ 2 large-bore IV access, CrossMatch</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="109">â€¢ Hb &lt;7 = transfuse; varices &lt;8</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="123">â€¢ PPI infusion: omeprazole 80mg bolus</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="137">â€¢ Octreotide varices mein zaroori!</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2.5" width="175" x="10" y="228"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="97" y="258">ğŸ“Š Scoring Tools</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="274">â€¢ Rockall Score (pre+post)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="288">â€¢ Glasgow-Blatchford Score</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="302">â€¢ GBS â‰¥1 = admit karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="97" y="316">â€¢ High score = ICU/HD direct!</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="175" x="715" y="228"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="802" y="258">ğŸ”­ Endoscopy â€” Kab?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="802" y="274">â€¢ Unstable = 12 hr mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="802" y="288">â€¢ Stable = 24 hr mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="802" y="302">â€¢ Varices = band ligation</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="802" y="316">â€¢ Ulcer = clip/adrenaline inj</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="230" x="80" y="385"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="195" y="415">ğŸ«€ Variceal Bleed Protocol</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="431">â€¢ Terlipressin 2mg IV q4h</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="445">â€¢ Prophylactic antibiotics (ceftriaxone)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="459">â€¢ TIPS if refractory bleeding</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="195" y="473">â€¢ Sengstaken tube = last resort!</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="230" x="590" y="385"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="705" y="415">âš ï¸ Re-bleeding Rokko!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="431">â€¢ PPI 72 hr infusion baad mein OD</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="445">â€¢ H.pylori treat karo agar +ve</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="459">â€¢ NSAIDs band karo bilkul!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="705" y="473">â€¢ Beta-blocker varices secondary prophylaxis</text>
</svg>
</div>
<div class="cards">
<div class="card g-red">
<div class="card-icon">ğŸš¨</div>
<h4>Massive GI Bleed â€” ABC!</h4>
<p>Airway protect karo â€” haematemesis mein aspiration ka risk hai. Intubate early agar GCS gir raha ho ya endoscopy karna hai unstable patient mein. Massive transfusion protocol activate karo.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ’Š</div>
<h4>Drugs â€” Kya Dena, Kya Nahi?</h4>
<p>PPI mandatory upper GI mein. Octreotide/terlipressin varices mein. Tranexamic acid â€” HALT-IT trial mein GI bleed mein koi benefit nahi thi, avoid karo! Antibiotics cirrhosis mein SBP rokne ke liye.</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ”´</div>
<h4>Lower GI Bleed</h4>
<p>Diverticular disease, angiodysplasia, ischaemic colitis. CT angiography useful hai agar bleeding active ho. Colonoscopy definitive. 80% apne aap ruk jaati hai! Surgery last option.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ“ˆ</div>
<h4>ICU Stress Ulcer Prophylaxis</h4>
<p>Ventilated patients (&gt;48h) ya coagulopathy walo mein PPI ya H2RA do. VAP risk zyada hai PPI se â€” H2RA better ho sakta hai. Har patient mein zaroorat nahi!</p>
</div>
</div>
<div class="alert alert-red">
<div class="icon">ğŸ”¥</div>
<div><strong>Variceal Bleed Mein Golden Rule:</strong> Fluid overload mat karo â€” portal pressure badhega aur rebleeding hogi! Restrictive transfusion strategy use karo (Hb target 7-8). Antibiotics dene se 30-day survival improve hoti hai â€” bhoolna nahi!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--orange)">Chapter 12</div>
<h2 style="color:var(--orange)">ğŸ”´ DIC â€” Disseminated Intravascular Coagulation!</h2>
<div class="chapter-intro" style="border-color:var(--orange)">
    DIC ek ajeeb situation hai â€” ek saath khoon bhi ban raha hai aur chutt bhi raha hai! Coagulation system pagal ho jaata hai. Underlying cause treat karna SABSE ZAROORI hai â€” baki sab secondary hai. Yeh diagnosis hai, not a disease â€” cause dhundho!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 480" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg12">
<stop offset="0%" stop-color="#f4a261"></stop>
<stop offset="100%" stop-color="#c1121f"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#f4a261" stroke-width="3" x1="450" x2="180" y1="240" y2="90"></line>
<line opacity=".5" stroke="#f4a261" stroke-width="3" x1="450" x2="720" y1="240" y2="90"></line>
<line opacity=".5" stroke="#f4a261" stroke-width="3" x1="450" x2="80" y1="240" y2="260"></line>
<line opacity=".5" stroke="#f4a261" stroke-width="3" x1="450" x2="820" y1="240" y2="260"></line>
<line opacity=".5" stroke="#f4a261" stroke-width="3" x1="450" x2="180" y1="240" y2="390"></line>
<line opacity=".5" stroke="#f4a261" stroke-width="3" x1="450" x2="720" y1="240" y2="390"></line>
<ellipse cx="450" cy="240" fill="url(#rg12)" rx="120" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="16" font-weight="800" text-anchor="middle" x="450" y="232">D.I.C.</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="252">Clot bhi, Bleed bhi â€” Pagal system!</text>
<rect fill="#fff0f0" height="110" rx="14" stroke="#e63946" stroke-width="2" width="235" x="60" y="35"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="178" y="68">ğŸ” Causes â€” Trigger Kya?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="84">â€¢ Sepsis (most common) â€” gram -ve</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="98">â€¢ Obstetric: abruption, APH, AFE</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="112">â€¢ Trauma, Burns, Malignancy</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="126">â€¢ ABO mismatch transfusion</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2" width="235" x="605" y="35"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="722" y="68">ğŸ”¬ Diagnosis â€” Labs!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="84">â€¢ Platelets â†“â†“ (thrombo-cytopenia)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="98">â€¢ PT/APTT â†‘, Fibrinogen â†“</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="112">â€¢ D-Dimer â†‘â†‘â†‘ (very high)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="126">â€¢ ISTH Score â‰¥5 = overt DIC</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2" width="165" x="10" y="208"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="238">ğŸ’‰ Treat Kaise?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="254">â€¢ Cause treat karo FIRST!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="268">â€¢ FFP: PT/APTT â†‘ + bleeding</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="282">â€¢ Cryoprecipitate: fibrinogen &lt;1</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="296">â€¢ Platelets &lt;50 bleeding mein</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f9c74f" stroke-width="2" width="165" x="725" y="208"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="807" y="238">âš ï¸ Heparin â€” Kab?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="254">â€¢ Thrombosis dominant DIC</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="268">â€¢ Purpura fulminans</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="282">â€¢ Bleeding dominant mein AVOID</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="296">â€¢ Controversial â€” consult senior!</text>
<rect fill="#f5eeff" height="95" rx="14" stroke="#7209b7" stroke-width="2" width="235" x="60" y="355"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="178" y="384">ğŸŒ¡ï¸ Clinical Features</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="400">â€¢ Oozing from all sites: IV lines, gums</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="414">â€¢ Petechiae, purpura, ecchymosis</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="428">â€¢ Organ failure: MODS develop hoti hai</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="178" y="442">â€¢ Cyanosis, gangrene of digits bhi!</text>
<rect fill="#fff0fa" height="95" rx="14" stroke="#f72585" stroke-width="2" width="235" x="605" y="355"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="722" y="384">ğŸ“Š ISTH Scoring</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="400">â€¢ Platelets &lt;50 = 2 pts, 50-100 = 1pt</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="414">â€¢ D-Dimer &gt;strong = 3 pts</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="428">â€¢ PT prolonged &gt;6s = 2pts</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="722" y="442">â€¢ Fibrinogen &lt;1 = 1pt; Score â‰¥5 = DIC</text>
</svg>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#f4a261,#e63946)">
<th>Component</th><th>DIC Mein Kya Hota Hai?</th><th>Kya Dena Hai?</th>
</tr></thead>
<tbody>
<tr><td><strong>Platelets</strong></td><td>Consumed â€” rapidly girti hain</td><td>Transfuse agar &lt;50k + active bleeding</td></tr>
<tr><td><strong>Fibrinogen</strong></td><td>Consumed â€” critical &lt;1 g/L</td><td>Cryoprecipitate (10 units), ya Fibrinogen concentrate</td></tr>
<tr><td><strong>PT/APTT</strong></td><td>Prolonged â€” factors consumed</td><td>FFP 15 ml/kg agar bleeding hai</td></tr>
<tr><td><strong>D-Dimer</strong></td><td>Very high â€” fibrin degradation</td><td>Sirf diagnosis ke liye â€” treat nahi</td></tr>
<tr><td><strong>Cause</strong></td><td>Trigger hai DIC ka</td><td>PEHLE CAUSE TREAT KARO â€” baaki sab secondary</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-yellow">
<div class="icon">ğŸ’¡</div>
<div><strong>DIC ka sabse bada lesson:</strong> Yeh ek syndrome hai, disease nahi. Lab values treat karne se zyada zaroori hai underlying cause dhundhna aur treat karna. Sepsis mein antibiotics, obstetric emergency mein uterus khali karo â€” DIC apne aap behtar hogi!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--green)">Chapter 13</div>
<h2 style="color:var(--green)">ğŸ’‰ ICU Infections &amp; Antibiotics â€” Antimicrobial Stewardship!</h2>
<div class="chapter-intro" style="border-color:var(--green)">
    ICU mein infections aam hain aur janlewa bhi. HAI (Hospital Acquired Infections) â€” VAP, CLABSI, CAUTI, CDI â€” yeh sab preventable hain! <strong>Antibiotic stewardship</strong> matlab: sahi antibiotic, sahi dose, sahi duration â€” na zyada, na kam!
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-green">
<div class="card-icon">ğŸ«</div>
<h4>VAP â€” Ventilator Associated Pneumonia</h4>
<p>48h post intubation naya fever + infiltrate + purulent secretions. Prevention: HOB 30-45Â°, oral care chlorhexidine, subglottic suctioning, SDD. Treatment: anti-pseudomonal beta-lactam + aminoglycoside/ciprofloxacin.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ©¸</div>
<h4>CLABSI â€” Central Line Infection</h4>
<p>CVC se bacteraemia. Prevention: full barrier precautions insertion mein, daily review for removal, chlorhexidine dressing. Treatment: line remove karo + empirical vancomycin. Culture aane pe de-escalate karo.</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’§</div>
<h4>CAUTI â€” Catheter UTI</h4>
<p>Urinary catheter se UTI. Sabse common HAI. Prevention: catheter early remove karo, closed drainage, aseptic insertion. Symptomatic hone par hi treat karo â€” bacteriuria alone nahi!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ¦ </div>
<h4>C. Difficile (CDI)</h4>
<p>Antibiotics ke baad watery diarrhoea. Toxin test karo. Oral fidaxomicin ya vancomycin (NOT metronidazole severe mein). Loperamide bilkul nahi â€” toxic megacolon ka risk! Contact precautions lagao.</p>
</div>
<div class="card g-pink">
<div class="card-icon">ğŸ§«</div>
<h4>MRSA &amp; MDR Organisms</h4>
<p>Vancomycin for MRSA (trough 15-20). ESBL walon mein carbapenems. CRE â€” colistin ya ceftazidime-avibactam. De-escalate culture milne pe hamesha. Isolation zaroori MDR mein!</p>
</div>
<div class="card g-orange">
<div class="card-icon">â±ï¸</div>
<h4>Antibiotic Duration â€” Kam Rakho!</h4>
<p>VAP: 7-8 days kaafi (15 nahi). BSI: 7-14 days. Uncomplicated UTI: 5-7 days. Procalcitonin-guided therapy se duration kam hoti hai. Broad-spectrum hamesha narrow karo culture pe!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#0096c7)">
<th>Infection</th><th>First Line Antibiotic</th><th>Duration</th>
</tr></thead>
<tbody>
<tr><td><strong>CAP â€” ICU</strong></td><td>Piperacillin-tazobactam + Azithromycin ya Levofloxacin</td><td>5-7 days (PCT guide karo)</td></tr>
<tr><td><strong>VAP</strong></td><td>Pip-tazo/cefepime + amikacin (MRSA risk = +Vancomycin)</td><td>7-8 days</td></tr>
<tr><td><strong>Abdominal Sepsis</strong></td><td>Pip-tazo / Meropenem (severe) + Metronidazole</td><td>4-7 days post source control</td></tr>
<tr><td><strong>Meningitis</strong></td><td>Ceftriaxone 2g BD + Ampicillin (Listeria risk) + Dex</td><td>10-14 days (bacterial)</td></tr>
<tr><td><strong>Candidaemia</strong></td><td>Echinocandin (caspofungin) first line; fluconazole ONLY sensitive</td><td>14 days post last +ve culture</td></tr>
<tr><td><strong>Febrile Neutropenia</strong></td><td>Pip-tazo / Meropenem monotherapy</td><td>Till ANC &gt;500 + afebrile 48h</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-green">
<div class="icon">ğŸŒŸ</div>
<div><strong>Stewardship ke 4 Golden Rules:</strong> (1) Blood culture PEHLE, antibiotic BAAD. (2) 72 hour review hamesha â€” de-escalate ya stop. (3) IV se oral switch early karo. (4) Procalcitonin use karo duration guide karne ke liye. Resistant bacteria paida karna hamara kaam nahi!</div>
</div>
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#023e8a)">
<th>HAI Type</th><th>Common Pathogens</th><th>Prevention Bundle</th><th>Empiric Treatment</th>
</tr></thead>
<tbody>
<tr><td><strong>VAP</strong></td><td>Pseudomonas, MRSA, Acinetobacter</td><td>HOB 30Â°, oral CHX, daily SBT, subglottic suction</td><td>Pip-Tazo + Vancomycin / Meropenem</td></tr>
<tr><td><strong>CLABSI</strong></td><td>CoNS, MRSA, Candida</td><td>Maximal barrier, CHX prep, remove ASAP</td><td>Vancomycin Â± Echinocandin</td></tr>
<tr><td><strong>CAUTI</strong></td><td>E. coli, Klebsiella, Candida</td><td>Foley remove ASAP, closed system</td><td>Ceftriaxone / Nitrofurantoin</td></tr>
<tr><td><strong>C. difficile</strong></td><td>C. difficile toxin A/B</td><td>Contact precautions, soap+water, restrict antibiotics</td><td>Vancomycin 125mg QID oral / Fidaxomicin</td></tr>
<tr><td><strong>Candida BSI</strong></td><td>C. albicans, C. glabrata</td><td>Remove CVC, minimize broad-spectrum antibiotics</td><td>Echinocandin (Caspofungin 70mg load)</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-green">
<div class="card-icon">ğŸ¯</div>
<h4>De-escalation Strategy â€” Kab Narrow Karo?</h4>
<p>48-72h mein cultures aane pe: sahi antibiotic identify karo, unnecessary coverage hatao. MRSA negative? Vancomycin band karo. Culture-negative? Clinical improvement hai? Antibiotics stop karo. Procalcitonin &lt;0.25 ya 80% drop = stop karo. Short courses (5-7 days) most infections ke liye safe aur effective hain!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ¦ </div>
<h4>MRSA Coverage â€” Kab Chahiye?</h4>
<p>MRSA ka risk: prior MRSA colonization, skin/soft tissue infection, hemodialysis, recent hospitalization, healthcare worker. Vancomycin: AUC-guided dosing (AUC/MIC 400-600). Alternative: Linezolid (pneumonia mein better lung penetration), Daptomycin (BSI mein good). Teicoplanin OD dosing â€” convenient. Ceftaroline bhi option hai cSSTI mein.</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ”¬</div>
<h4>MDR Gram-negatives â€” Carbapenem-resistant!</h4>
<p>CRE (Carbapenem-resistant Enterobacteriaceae): Ceftazidime-avibactam + Aztreonam combination. CRPA (Carbapenem-resistant Pseudomonas): Ceftolozane-tazobactam, Imipenem-cilastatin-relebactam. CRAB (Carbapenem-resistant Acinetobacter): Colistin + Ampicillin-sulbactam high dose. ID consult mandatory â€” yeh cases difficult hain!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ“Š</div>
<h4>Procalcitonin â€” Antibiotic Stop Karo!</h4>
<p>PCT nahin hai sirf diagnosis ke liye â€” duration guide karne ke liye bhi! PCT &lt;0.25 mcg/L ya â‰¥80% reduction from peak = antibiotics stop karo. PRORATA trial: PCT-guided group mein 2.5 days kam antibiotics, same outcomes. ICU mein daily PCT cheque karo agar on antibiotics. Cost-effective: PCT test =  â‚¹800, vs 1 antibiotic day = â‚¹â‚¹â‚¹.</p>
</div>
</div>
<div class="alert alert-yellow">
<div class="icon">ğŸ§«</div>
<div><strong>Blood Cultures â€” Theek Se Lena Bhai!</strong> Minimum 2 sets â€” different sites se. Aerobic + anaerobic. Yeh antibiotics dene se PEHLE lena hai â€” within 45 minutes of recognizing sepsis. Volume matters: 10ml per bottle = agar kam doge toh yield kum hogi. Central line cultures bhi â€” CLABSI diagnose karne ke liye (differential time to positivity). False positive: contamination common hai skin organisms se â€” aseptic technique use karo!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--yellow)">Chapter 14</div>
<h2 style="color:var(--yellow)">ğŸ«€ Acute Liver Failure â€” Khatarnak Hai!</h2>
<div class="chapter-intro" style="border-color:var(--yellow)">
    ALF matlab: jaundice + coagulopathy (INR â‰¥1.5) + hepatic encephalopathy â€” bina pehle liver disease ke â€” 26 hafton mein! Transplant centre mein refer karo turant. Commonest cause India mein: Hepatitis E, B, drugs (paracetamol overdose West mein). ICU mein multi-organ failure manage karo.
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 500" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg14">
<stop offset="0%" stop-color="#f9c74f"></stop>
<stop offset="100%" stop-color="#e76f51"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#f9c74f" stroke-width="3" x1="450" x2="190" y1="250" y2="90"></line>
<line opacity=".5" stroke="#f9c74f" stroke-width="3" x1="450" x2="710" y1="250" y2="90"></line>
<line opacity=".5" stroke="#f9c74f" stroke-width="3" x1="450" x2="75" y1="250" y2="270"></line>
<line opacity=".5" stroke="#f9c74f" stroke-width="3" x1="450" x2="825" y1="250" y2="270"></line>
<line opacity=".5" stroke="#f9c74f" stroke-width="3" x1="450" x2="190" y1="250" y2="410"></line>
<line opacity=".5" stroke="#f9c74f" stroke-width="3" x1="450" x2="710" y1="250" y2="410"></line>
<ellipse cx="450" cy="250" fill="url(#rg14)" rx="120" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="15" font-weight="800" text-anchor="middle" x="450" y="242">ACUTE LIVER FAILURE</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="262">ICU Ka Critical Emergency!</text>
<rect fill="#fffbea" height="110" rx="14" stroke="#f9c74f" stroke-width="2.5" width="245" x="65" y="35"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="188" y="68">ğŸ” Causes â€” India vs West</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="84">â€¢ India: Hep E, B, DILI, Wilson's</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="98">â€¢ West: Paracetamol OD #1 cause!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="112">â€¢ Autoimmune hepatitis, Budd-Chiari</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="126">â€¢ Mushroom poisoning (Amanita)</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="245" x="590" y="35"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="712" y="68">ğŸ§  Encephalopathy Grades</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="84">â€¢ Gr I: Confused, mood change</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="98">â€¢ Gr II: Drowsy, inappropriate</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="112">â€¢ Gr III: Stuporose, gibberish</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="126">â€¢ Gr IV: Coma â€” Intubate KARO!</text>
<rect fill="#eafff6" height="110" rx="14" stroke="#06d6a0" stroke-width="2.5" width="165" x="5" y="218"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="88" y="248">ğŸ›¡ï¸ ICP Management</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="264">â€¢ Cerebral oedema common!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="278">â€¢ Head end 30Â° raise karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="292">â€¢ Mannitol / 3% saline bolus</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="306">â€¢ Normo-natraemia Na 145-150</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="320">â€¢ Avoid fever &amp; seizures!</text>
<rect fill="#fff5e6" height="110" rx="14" stroke="#f9c74f" stroke-width="2.5" width="165" x="730" y="218"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="812" y="248">ğŸ’‰ N-Acetylcysteine</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="264">â€¢ Paracetamol OD mein standard</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="278">â€¢ Non-paracetamol ALF mein bhi!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="292">â€¢ 150mg/kg over 15 min bolus</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="306">â€¢ Phir infusion 21 hours</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="320">â€¢ Improves transplant-free survival!</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="245" x="65" y="370"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="188" y="400">ğŸ“‹ King's College Criteria</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="416">â€¢ Paracetamol: pH &lt;7.3 OR (INR&gt;6.5</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="430">  + Creatinine&gt;300 + Gr III/IV encep)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="444">â€¢ Non-para: INR&gt;6.5 alone OR 3/5 criteria</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="188" y="458">â€¢ = Transplant listing karo!</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="245" x="590" y="370"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="712" y="400">âš¡ ICU Complications Manage</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="416">â€¢ Hypoglycaemia: 10% Dex infusion</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="430">â€¢ Coagulopathy: FFP only if bleeding</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="444">â€¢ AKI: CRRT preferred</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="712" y="458">â€¢ Infection: antibiotics early, koi steroids!</text>
</svg>
</div>
<div class="alert alert-yellow">
<div class="icon">ğŸš</div>
<div><strong>ALF ka sabse zaruri kaam:</strong> TURANT transplant centre refer karo! King's College Criteria check karo. Paracetamol OD mein NAC dena mat bhoolo â€” chahe late bhi aaya ho. Lactulose hepatic encephalopathy mein dena â€” but ammonia ko over-estimate mat karo.</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--teal)">Chapter 15</div>
<h2 style="color:var(--teal)">ğŸ« Pulmonary Embolism â€” Massive PE Bachao!</h2>
<div class="chapter-intro" style="border-color:var(--teal)">
    PE â€” khoon ka tukda phaephhon mein phas gaya! Massive PE: hypotension + shock = EMERGENCY. Submassive PE: echo mein RV strain + stable BP. Low risk PE: PESI score low. Risk stratify karo â€” treatment alag hai sabka!
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-teal">
<div class="card-icon">ğŸš¨</div>
<h4>Massive PE â€” Karo Immediately!</h4>
<p>Haemodynamic collapse hai toh thrombolysis karo â€” alteplase 100mg over 2hr. Absolute contraindication mein surgical embolectomy ya catheter-directed. CPR mein bhi thrombolysis diya ja sakta hai!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ¥</div>
<h4>Submassive PE â€” Decision</h4>
<p>Stable BP but RV dysfunction + troponin rise = submassive. Anticoagulation start karo. PEITHO trial: thrombolysis se bleeding risk zyada hai â€” heparinize karo pehle. Deterioration par thrombolysis ready rakho.</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ’Š</div>
<h4>Anticoagulation â€” Options</h4>
<p>LMWH standard (enoxaparin 1mg/kg BD). UFH IV agar thrombolysis consider karna ho ya renal failure. DOAC (rivaroxaban/apixaban) discharge pe. VKA monitoring complicated â€” DOAC prefer karo.</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ“Š</div>
<h4>Wells Score + PERC Rule</h4>
<p>Wells &lt;2 + PERC rule negative = PE unlikely, D-dimer bhi mat karo! Wells â‰¥5 = high probability, CTPA direct. D-dimer age-adjusted use karo â€” &gt;50 years mein age Ã— 10 mcg/L threshold.</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ«€</div>
<h4>RV Support in Massive PE</h4>
<p>Fluid bolus careful â€” 500ml maximum. Noradrenaline for BP. Dobutamine agar RV failure severe. Vasopressin add karo. ECMO consider karo refractory cases mein. Avoid excessive fluid â€” worsens RV failure!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ”</div>
<h4>ECHO in PE â€” Signs!</h4>
<p>RV dilatation (RV:LV ratio &gt;0.9), septal D-shape, McConnell sign (RV apex sparing), TR, TAPSE kam. POCUS bedside pe karke turant decision liya ja sakta hai ICU mein!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#0096c7,#4361ee)">
<th>PE Type</th><th>Definition</th><th>Treatment</th>
</tr></thead>
<tbody>
<tr><td><strong>Massive PE</strong></td><td>SBP &lt;90 mmHg ya &gt;40 mmHg drop ya cardiac arrest</td><td>Alteplase 100mg/2hr + UFH baad mein</td></tr>
<tr><td><strong>Submassive PE</strong></td><td>Stable BP but RV dysfunction ya troponin rise</td><td>Anticoagulate, monitor closely, rescue thrombolysis ready</td></tr>
<tr><td><strong>Low Risk PE</strong></td><td>PESI class I-II, no RV strain, haemodynamically stable</td><td>DOAC, early discharge consider karo</td></tr>
<tr><td><strong>Incidental PE</strong></td><td>No symptoms, CT pe mili</td><td>Anticoagulate â‰¥3 months (subsegmental â€” discuss)</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-blue">
<div class="icon">âš¡</div>
<div><strong>Massive PE mein Thrombolysis Decision:</strong> BP &lt;90 ya cardiac arrest = thrombolysis bina deri ke! Agar cardiac arrest mein ho toh CPR ke saath alteplase 50mg IV bolus, 90 min CPR continue karo. Ye ek life-saving decision hai â€” hesitate mat karo!
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#0096c7,#023e8a)">
<th>PE Type</th><th>Haemodynamics</th><th>RV Strain?</th><th>Biomarkers</th><th>Treatment</th>
</tr></thead>
<tbody>
<tr><td><strong>Massive</strong></td><td>SBP &lt;90 ya â‰¥40 mmHg drop</td><td>Yes</td><td>Elevated trop/BNP</td><td>Thrombolysis IMMEDIATELY (Alteplase 100mg/2h)</td></tr>
<tr><td><strong>Submassive</strong></td><td>Stable BP</td><td>Yes (echo ya CTPA)</td><td>Elevated trop/BNP</td><td>Anticoagulate; CDT / systemic thrombolysis consider</td></tr>
<tr><td><strong>Low Risk</strong></td><td>Stable</td><td>No</td><td>Normal</td><td>Anticoagulate; early discharge PESI â‰¤1</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-teal">
<div class="card-icon">ğŸ”¬</div>
<h4>Wells Score â€” Pre-test Probability</h4>
<p>DVT symptoms: +3. PE most likely diagnosis: +3. Heart rate &gt;100: +1.5. Immobilization â‰¥3 days / surgery Ã—4 weeks: +1.5. Prior DVT/PE: +1.5. Haemoptysis: +1. Malignancy: +1. Score &gt;4 = high probability â†’ CT-PA. Score â‰¤4 + D-dimer negative = PE rule out! PERC rule: 8 criteria sab negative = no need for D-dimer even!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’‰</div>
<h4>Anticoagulation â€” Kaun Sa?</h4>
<p>UFH infusion: haemodynamically unstable ya thrombolysis candidate. LMWH (enoxaparin 1mg/kg BD): stable patients. DOAC (Rivaroxaban, Apixaban): outpatient low-risk PE. Warfarin: renal failure, mechanical valves. Duration: provoked PE = 3 months; unprovoked = 6 months minimum; recurrent ya cancer = indefinite (DOAC preferred over Warfarin agar cancer).</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ¥</div>
<h4>Catheter-Directed Thrombolysis (CDT)</h4>
<p>Submassive PE mein systemic thrombolysis ke baad bleeding risk kam karna ho toh CDT. Low dose tPA directly into clot (20mg over 15h). ULTIMA trial: CDT vs UFH â€” RV/LV ratio CDT mein zyada improve hua. SEATTLE II: safe aur effective. Indication: submassive PE + haemodynamic deterioration ya severe hypoxia not responding. Expertise required â€” interventional radiology!</p>
</div>
<div class="card g-purple">
<div class="card-icon">âš¡</div>
<h4>ECMO for Massive PE</h4>
<p>Massive PE + cardiac arrest ya refractory shock: VA-ECMO consider karo. Bridge to thrombolysis, surgical embolectomy, ya catheter-based intervention. E-CPR (ECMO during CPR): femoral cannulation during cardiac arrest. Survival possible agar no contraindications. Centre with surgical backup zaroori hai PE + ECMO ke liye!</p>
</div>
</div>
<div class="alert alert-blue">
<div class="icon">ğŸ’Š</div>
<div><strong>Thrombolysis Contraindications â€” Yaad Karo Bhai!</strong> Absolute: Haemorrhagic stroke kabhi bhi, ischemic stroke Ã—3 months, head trauma Ã—3 months, active internal bleed, intracranial neoplasm, intracranial surgery. Relative: Major surgery Ã—10 days, non-compressible puncture, severe uncontrolled HTN (&gt;180/110), CPR &gt;10 min. Cardiac arrest mein â€” relative contraindications ignore kar sakte ho agar PE confirmed. Jaan bachana priority hai!</div>
</div>
</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--purple)">Chapter 16</div>
<h2 style="color:var(--purple)">â˜ ï¸ Toxicology &amp; Poisoning â€” ICU Mein!</h2>
<div class="chapter-intro" style="border-color:var(--purple)">
    Poisoning common hai India mein â€” pesticides (OP compounds), medications, snakebite, alcohol. ICU mein framework: <strong>Resuscitate â†’ Reduce absorption â†’ Antidote â†’ Supportive care â†’ Psychiatric assessment!</strong> Toxicology helpline se baat karo jab shak ho.
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 500" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg16">
<stop offset="0%" stop-color="#7209b7"></stop>
<stop offset="100%" stop-color="#3a0ca3"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="190" y1="250" y2="90"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="710" y1="250" y2="90"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="70" y1="250" y2="265"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="830" y1="250" y2="265"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="190" y1="250" y2="410"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="710" y1="250" y2="410"></line>
<ellipse cx="450" cy="250" fill="url(#rg16)" rx="120" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="15" font-weight="800" text-anchor="middle" x="450" y="242">TOXICOLOGY ICU</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="262">Zehr Ka Ilaj â€” Systematic!</text>
<rect fill="#f5eeff" height="110" rx="14" stroke="#7209b7" stroke-width="2" width="240" x="65" y="35"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="68">ğŸŒ¾ OP Compounds â€” India Top!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="84">â€¢ Pesticide, excess secretions (SLUDGE)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="98">â€¢ Miosis, bradycardia, bronchospasm</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="112">â€¢ Atropine load karo till dry secretions</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="126">â€¢ Pralidoxime (PAM) 24-48h mein!</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2" width="240" x="595" y="35"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="68">ğŸ’Š Paracetamol OD</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="84">â€¢ Rumack-Matthew nomogram</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="98">â€¢ NAC dono â€” IV ya oral</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="112">â€¢ 8h mein diya toh almost 100% protect</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="126">â€¢ Late presentation mein bhi do â€” help karta!</text>
<rect fill="#fff0f0" height="105" rx="14" stroke="#e63946" stroke-width="2" width="170" x="5" y="218"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="90" y="248">ğŸ Snakebite ICU</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="264">â€¢ Polyvalent ASV 10 vials</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="278">â€¢ Neurotoxic: neostigmine</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="292">â€¢ 20-min clotting test</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="306">â€¢ Ventilate if resp. failure</text>
<rect fill="#fffbea" height="105" rx="14" stroke="#f9c74f" stroke-width="2" width="170" x="725" y="218"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="810" y="248">ğŸº Alcohol Toxicity</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="264">â€¢ Ethanol OD: supportive</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="278">â€¢ Methanol: fomepizole/ethanol</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="292">â€¢ Withdrawal: CIWA scale</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="306">â€¢ Benzodiazepines for delirium</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2" width="240" x="65" y="370"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="400">ğŸ”´ Key Antidotes â€” Yaad Raho!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="416">â€¢ Opioid â†’ Naloxone 0.4-2mg IV</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="430">â€¢ Benzo â†’ Flumazenil (caution!)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="444">â€¢ TCA OD â†’ NaHCOâ‚ƒ (QRS wide)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="458">â€¢ Digoxin â†’ Digibind (Fab)</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2" width="240" x="595" y="370"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="400">ğŸ§¹ Gut Decontamination</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="416">â€¢ Activated charcoal: 1hr mein most toxic</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="430">â€¢ Gastric lavage: only intubated + 1hr</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="444">â€¢ WBI: iron, lithium, SR tablets</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="458">â€¢ Urinary alkalinisation: salicylates</text>
</svg>
</div>
<div class="alert alert-purple">
<div class="icon">â˜£ï¸</div>
<div><strong>OP Poisoning Mein Atropine Ka Use:</strong> Dose toh tab tak badhao jab tak secretions dry ho jaayein â€” miosis ya tachycardia dekhkar mat rokna! 1.8mg se shuru karo, double karte jao. Glycopyrrolate better hai ICU mein â€” nahi cross karta blood-brain barrier. PAM sirf 24-48h ke andar effective hai!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--red)">Chapter 17</div>
<h2 style="color:var(--red)">ğŸš‘ Trauma ICU â€” Maut Se Ladte Hain!</h2>
<div class="chapter-intro" style="border-color:var(--red)">
    Trauma ICU mein triumphs aur tragedies dono hain. Lethal Triad â€” <strong>Hypothermia + Acidosis + Coagulopathy</strong> = death. Damage Control Resuscitation (DCR) aur Damage Control Surgery (DCS) ek saath chalte hain. Primary survey mein ABCDE, secondary survey head to toe!
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-red">
<div class="card-icon">â„ï¸ğŸ”´ğŸ©¸</div>
<h4>Lethal Triad â€” Todna Hai!</h4>
<p>Hypothermia (Temp &lt;35Â°C): warm karo â€” warm fluids, bear hugger. Acidosis (pH &lt;7.2): correct karo. Coagulopathy: 1:1:1 ratio (PRBC:FFP:Platelets) â€” massive transfusion protocol! Yeh triad ek dusre ko bhadhaata hai â€” sab ek saath treat karo.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ©»</div>
<h4>TBI Management in Trauma</h4>
<p>ICP monitor agar GCS â‰¤8 + CT abnormal. CPP 60-70 maintain karo. Mannitol / hypertonic saline. Seizure prophylaxis 7 days (levetiracetam). Avoid hypoxia (SpOâ‚‚ &gt;95%) aur hypotension (SBP &gt;100). Decompressive craniotomy agar refractory ICP!</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ«€</div>
<h4>Haemorrhagic Shock â€” DCR</h4>
<p>Permissive hypotension: SBP 80-90 till bleeding control. TXA (tranexamic acid) 1g IV bolus first hour â€” CRASH-2 trial! Massive transfusion 1:1:1 ratio. Fibrinogen concentrate ya cryo. Calcium dena mat bhoolo (ionised Ca falls!).</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ¥</div>
<h4>Abdominal Compartment Syndrome</h4>
<p>Bladder pressure &gt;20 mmHg + new organ failure = ACS. Risk factors: massive transfusion, bowel oedema, intra-abdominal haemorrhage. Treatment: decompressive laparotomy. Suspect karo agar oliguric + high pressures.</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ¦´</div>
<h4>Long Bone Fractures ICU Issues</h4>
<p>Fat embolism syndrome: petechiae + respiratory failure + confusion 24-72h post fracture. VTE prophylaxis LMWH â€” timing discuss surgeon se. Rhabdomyolysis: IV fluids aggressively, target UO 2-3 ml/kg/hr.</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸŒ¡ï¸</div>
<h4>Damage Control Surgery</h4>
<p>Stop bleeding + contamination = step 1. Pack, close temporarily. ICU mein stabilize â€” 48-72 hours. Phir definitive surgery. Open abdomen management â€” negative pressure wound therapy. Lethal triad correct karke hi theatre wapas leke jao!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#e63946,#c1121f)">
<th>Parameter</th><th>Trauma ICU Target</th><th>Comment</th>
</tr></thead>
<tbody>
<tr><td><strong>BP</strong></td><td>SBP 80-90 (pre-haemostasis) â†’ 100-110 (TBI)</td><td>Permissive hypotension jab tak control nahi</td></tr>
<tr><td><strong>Temperature</strong></td><td>&gt;36Â°C rakho</td><td>Warm everything â€” fluids, patient, theatre!</td></tr>
<tr><td><strong>pH</strong></td><td>&gt;7.35</td><td>Bicarb se nahi â€” bicarb se ventilate/resuscitate karo</td></tr>
<tr><td><strong>CaÂ²âº (ionised)</strong></td><td>&gt;1.1 mmol/L</td><td>Massive transfusion mein regularly dena zaroori</td></tr>
<tr><td><strong>Haemoglobin</strong></td><td>7-9 g/dL (haemo-stable)</td><td>TBI mein Hb &gt;9 consider karo</td></tr>
<tr><td><strong>Fibrinogen</strong></td><td>&gt;2 g/L in trauma</td><td>Viscoelastic testing (TEG/ROTEM) guide karo</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-red">
<div class="icon">â±ï¸</div>
<div><strong>Golden Hour in Trauma:</strong> Pehla kaam bleeding rokna aur airways secure karna. TXA 3 hours ke andar dena â€” uske baad harmful! Massive transfusion activate karo early. Permissive hypotension tab tak maintain karo jab tak surgical haemostasis achieve nahi hota.
<div class="mindmap-wrap" style="margin-top:24px;">
<svg style="max-width:900px" viewbox="0 0 900 490" width="100%">
<defs><radialgradient cx="50%" cy="40%" id="rgTR"><stop offset="0%" stop-color="#e63946"/><stop offset="100%" stop-color="#9d0208"/></radialgradient></defs>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="200" y1="245" y2="90"/><line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="700" y1="245" y2="90"/>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="80" y1="245" y2="255"/><line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="820" y1="245" y2="255"/>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="200" y1="245" y2="400"/><line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="700" y1="245" y2="400"/>
<ellipse cx="450" cy="245" fill="url(#rgTR)" rx="115" ry="57"/>
<text fill="#fff" font-family="Nunito" font-size="15" font-weight="800" text-anchor="middle" x="450" y="237">TRAUMA ICU</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="257">Lethal Triad Rokna Hai!</text>
<rect fill="#fff0f0" height="100" rx="14" stroke="#e63946" stroke-width="2.5" width="215" x="92" y="42"/>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="74">â„ï¸ Hypothermia Fix</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="91">â€¢ Warm IV fluids (42Â°C se)  </text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="105">â€¢ Bear hugger blankets</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="119">â€¢ Warm theatre, warm patient</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="133">â€¢ Target temp &gt;36Â°C</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="215" x="593" y="42"/>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="74">ğŸ©¸ Haemorrhage Control</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="91">â€¢ Direct pressure â€” pehla kaam</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="105">â€¢ Tourniquet limb injury mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="119">â€¢ TXA: 1g IV within 3 hours!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="133">â€¢ MTP activate: 1:1:1 ratio</text>
<rect fill="#eef3ff" height="100" rx="14" stroke="#4361ee" stroke-width="2.5" width="175" x="5" y="208"/>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="240">ğŸ§  TBI Goals</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="256">â€¢ ICP &lt;20-22 mmHg</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="270">â€¢ CPP 60-70 mmHg</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="284">â€¢ SpOâ‚‚ &gt;95% â€” hypoxia killer!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="298">â€¢ SBP &gt;100 hamesha</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="175" x="720" y="208"/>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="808" y="240">ğŸ“Š DCR Strategy</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="256">â€¢ Permissive hypotension</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="270">â€¢ Limit crystalloids</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="284">â€¢ Damage control surgery</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="298">â€¢ ICU resuscitate phir re-operate</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2.5" width="215" x="92" y="368"/>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="200" y="400">ğŸ”¬ Abdominal Compartment</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="416">â€¢ Bladder pressure &gt;20 + organ failure</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="430">â€¢ Decompressive laparotomy</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="200" y="444">â€¢ NPWT open abdomen</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="215" x="593" y="368"/>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="700" y="400">ğŸ’‰ Rhabdomyolysis</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="416">â€¢ CK &gt;5000 = significant</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="430">â€¢ IV fluids aggressively</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="700" y="444">â€¢ Target UO 3 ml/kg/hr</text>
</svg>
</div>
<div class="cards" style="margin-top:24px">
<div class="card g-orange">
<div class="card-icon">ğŸ¦´</div>
<h4>Fat Embolism Syndrome</h4>
<p>Long bone fractures ke 24-72h baad. Classic triad: petechiae (axillae, conjunctiva) + respiratory failure + confusion. Treatment: supportive â€” Oâ‚‚ + lung-protective ventilation agar ARDS. Early fracture stabilisation prevent karta hai FES. Usually self-limiting agar survive karo acute phase. Petechiae â‰  DIC â€” yeh fat emboli se hoti hai!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ«€</div>
<h4>Chest Trauma â€” 6 Killers!</h4>
<p>Tension PTX: needle decompression NOW â€” 2nd ICS MCL. Haemothorax: chest tube + blood replace. Cardiac tamponade: POCUS â†’ pericardiocentesis. Open PTX: three-sided dressing. Massive haemothorax: chest tube + thoracotomy agar &gt;1500ml instant. Flail chest: lung-protective ventilation + epidural analgesia for ribs. In-and-out â€” identify quickly!</p>
</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ CRASH-2 Trial â€” TXA Ki Story!</div>
20,000+ trauma patients randomized. TXA within 1 hour: Mortality RR = 0.68 (32% relative reduction!). 1-3 hours: RR = 0.79 (still benefit). After 3 hours: RR = 1.44 â€” HARMFUL!<br/><br/>
TXA mechanism: Antifibrinolytic â€” plasminogen activation rokta hai â†’ fibrin clot preserve karta hai. WHO Essential Medicine hai, cheap hai (â‚¹100 per vial). Every trauma patient mein pehle 3 ghante mein dena chahiye agar significant haemorrhage ho!
</div>
</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--blue)">Chapter 18</div>
<h2 style="color:var(--blue)">ğŸŒ¬ï¸ Ventilator Weaning â€” Kab Nikaalo?</h2>
<div class="chapter-intro" style="border-color:var(--blue)">
    Ventilator lagana mushkil nahi â€” nikalna zyada mushkil hai! Har din puchho: <strong>Kya patient ventilator se nikal sakta hai?</strong> Daily spontaneous breathing trial (SBT) karo. Prolonged ventilation = ICU-acquired weakness, VAP, ICU delirium â€” sab badhta hai!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 490" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg18">
<stop offset="0%" stop-color="#4361ee"></stop>
<stop offset="100%" stop-color="#023e8a"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#4361ee" stroke-width="3" x1="450" x2="190" y1="245" y2="90"></line>
<line opacity=".5" stroke="#4361ee" stroke-width="3" x1="450" x2="710" y1="245" y2="90"></line>
<line opacity=".5" stroke="#4361ee" stroke-width="3" x1="450" x2="60" y1="245" y2="260"></line>
<line opacity=".5" stroke="#4361ee" stroke-width="3" x1="450" x2="840" y1="245" y2="260"></line>
<line opacity=".5" stroke="#4361ee" stroke-width="3" x1="450" x2="190" y1="245" y2="400"></line>
<line opacity=".5" stroke="#4361ee" stroke-width="3" x1="450" x2="710" y1="245" y2="400"></line>
<ellipse cx="450" cy="245" fill="url(#rg18)" rx="120" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="450" y="237">VENTILATOR WEANING</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="258">Har Din Puchho â€” Kab Nikaalen?</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="240" x="65" y="35"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="68">âœ… Weaning Readiness â€” Check!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="84">â€¢ Cause of respiratory failure improve hui?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="98">â€¢ FiOâ‚‚ â‰¤0.4, PEEP â‰¤5-8 cmHâ‚‚O</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="112">â€¢ Haemodynamically stable, vasopressors kam</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="126">â€¢ Patient conscious, follows commands</text>
<rect fill="#eafff6" height="110" rx="14" stroke="#06d6a0" stroke-width="2.5" width="240" x="595" y="35"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="68">ğŸ§ª SBT â€” Spontaneous Breathing Trial</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="84">â€¢ T-piece ya low PS (5-8 cmHâ‚‚O)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="98">â€¢ 30 minutes se 2 ghante</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="112">â€¢ RSBI = RR/TV &lt; 105 = pass</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="126">â€¢ SBT pass = extubate karo!</text>
<rect fill="#fff5e6" height="110" rx="14" stroke="#f9c74f" stroke-width="2.5" width="175" x="5" y="210"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="240">âŒ SBT Fail Signs</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="256">â€¢ RR &gt;35 ya agitation</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="270">â€¢ SpOâ‚‚ &lt;90% on FiOâ‚‚ 0.4</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="284">â€¢ BP changes &gt;20%</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="298">â€¢ Diaphoresis, panic</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="312">â€¢ Accessory muscle use</text>
<rect fill="#fff0fa" height="110" rx="14" stroke="#f72585" stroke-width="2.5" width="175" x="720" y="210"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="807" y="240">ğŸ”„ SAT + SBT Pair!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="256">â€¢ SAT = Spontaneous Awaken Trial</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="270">â€¢ Sedation band karo pehle</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="284">â€¢ Phir SBT karo = ABCDE bundle</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="298">â€¢ SAT+SBT paired = ICU days kam</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="807" y="312">â€¢ Girard trial proved this!</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="240" x="65" y="365"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="394">ğŸ—£ï¸ Extubation â€” Kab Karo?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="410">â€¢ SBT pass + cough strong + GCS â‰¥8</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="424">â€¢ Secretions manage kar sake</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="438">â€¢ Cuff leak test large airway oedema ke liye</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="452">â€¢ NIV backup ready rakho!</text>
<rect fill="#fff0f0" height="100" rx="14" stroke="#e63946" stroke-width="2.5" width="240" x="595" y="365"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="394">ğŸ” Tracheostomy â€” Kab?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="410">â€¢ Expected prolonged ventilation &gt;14 days</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="424">â€¢ Early (7-10 days) vs late â€” similar</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="438">â€¢ PDT bedside ho sakti hai ICU mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="452">â€¢ Sedation kam, oral feeding possible, comfort</text>
</svg>
</div>
<div class="alert alert-blue">
<div class="icon">ğŸ¯</div>
<div><strong>ABCDE Bundle â€” ICU Liberation ka Formula!</strong> A = Awaken (SAT), B = Breathing (SBT), C = Choice of sedation (light), D = Delirium assess (CAM-ICU), E = Early mobility + Exercise. Yeh bundle follow karo toh ventilator days aur ICU LOS dono kam hote hain! Daily rounds mein hamesha yeh puchho.</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--pink)">Chapter 19</div>
<h2 style="color:var(--pink)">âš™ï¸ ECMO â€” Jab Sab Fail Ho Jaaye!</h2>
<div class="chapter-intro" style="border-color:var(--pink)">
    ECMO = Extracorporeal Membrane Oxygenation â€” body ke bahar khoon oxygenate karna. VV-ECMO = phaephhon ke liye (ARDS), VA-ECMO = dil aur phaephhon dono ke liye (cardiogenic shock). Yeh last resort hai â€” sahi patient mein, sahi centre mein, sahi time pe!
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-pink">
<div class="card-icon">ğŸŒ€</div>
<h4>VV-ECMO â€” Lung Rest</h4>
<p>Severe ARDS jab conventional ventilation fail ho (P:F &lt;80, plateau &gt;30, ARDS net fail). Jugular + femoral vein cannulation. Gas exchange sustain karta hai jab lungs recover hoti hain. Mortality benefit severe ARDS mein!</p>
</div>
<div class="card g-red">
<div class="card-icon">â¤ï¸â€ğŸ”¥</div>
<h4>VA-ECMO â€” Heart + Lung Support</h4>
<p>Refractory cardiogenic shock, massive PE, refractory cardiac arrest (E-CPR). Femoral artery + vein (peripheral) ya central (post-cardiac surgery). Unloads LV â€” but Impella add karo agar LV distension. Bridge to recovery/transplant!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ“‹</div>
<h4>ECMO Criteria â€” Patient Select Karo!</h4>
<p>Reversible condition honi chahiye ya transplant candidate hona chahiye. Contraindications: unrecoverable brain damage, severe multi-organ failure, advanced malignancy. ELSO guidelines follow karo. Early ECMO centre referral karo!</p>
</div>
<div class="card g-teal">
<div class="card-icon">âš ï¸</div>
<h4>ECMO Complications â€” Kya Dekho?</h4>
<p>Bleeding (anticoagulation chahiye toh). Limb ischaemia (distal perfusion cannula), haemolysis, circuit clot. Harlequin syndrome VA-ECMO mein â€” à¤Šà¤ªà¤° ECMO blood, neeche patient ka blood. Sepsis, neurological events.</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ’‰</div>
<h4>ECMO Anticoagulation</h4>
<p>UFH infusion â€” aPTT 45-80 sec target. Anti-Xa monitoring preferred. Heparin-induced thrombocytopenia (HIT) â€” argatroban use karo. ACT monitoring circuit side se karo. Bleeding vs clotting balance â€” daily decision!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ”„</div>
<h4>Weaning from ECMO</h4>
<p>VV-ECMO: sweep gas gradually kam karo â€” agar lungs recover kar rahi hain FiOâ‚‚ 0.21 pe. VA-ECMO: flow kam karo, cardiac function assess karo echo se. Trial off karo clamp lagakar. Recovery signs = wean karo!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#f72585,#7209b7)">
<th>Feature</th><th>VV-ECMO</th><th>VA-ECMO</th>
</tr></thead>
<tbody>
<tr><td><strong>Indication</strong></td><td>Respiratory failure (ARDS)</td><td>Cardiac failure / shock / arrest</td></tr>
<tr><td><strong>Cannulation</strong></td><td>Femoral vein â†’ jugular vein (drain â†’ return)</td><td>Femoral vein (drain) â†’ femoral artery (return)</td></tr>
<tr><td><strong>What it supports</strong></td><td>Gas exchange â€” Oâ‚‚ deta hai, COâ‚‚ nikalta hai</td><td>Cardiac output + gas exchange dono</td></tr>
<tr><td><strong>Heart function</strong></td><td>Unchanged (native heart beats normally)</td><td>Unloads heart â€” reduces workload</td></tr>
<tr><td><strong>Pulse</strong></td><td>Pulse present (native)</td><td>May be pulseless or low pulse</td></tr>
<tr><td><strong>ABG from right radial</strong></td><td>Best assessment of native lung</td><td>Upper body oxygenation check karo!</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-purple">
<div class="icon">ğŸ¥</div>
<div><strong>ECMO = Team Sport!</strong> Intensivist, cardiac surgeon, perfusionist, nurses â€” sab ek team mein kaam karte hain. Yeh expensive, resource-intensive, aur complication-prone hai. Sahi patient mein sahi time pe lagao â€” nahi toh nuksaan zyada. ELSO registry guidelines follow karo hamesha!
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#f72585,#b5179e)">
<th>Parameter</th><th>VV-ECMO</th><th>VA-ECMO</th>
</tr></thead>
<tbody>
<tr><td><strong>Primary Indication</strong></td><td>Severe ARDS (P/F &lt;80, refractory hypoxia)</td><td>Refractory cardiogenic shock, massive PE, E-CPR</td></tr>
<tr><td><strong>Cannula Sites</strong></td><td>Femoral vein â†’ Jugular vein</td><td>Femoral artery + femoral vein (peripheral)</td></tr>
<tr><td><strong>COâ‚‚ Control</strong></td><td>Sweep gas flow badho = COâ‚‚ kam (like RR)</td><td>Sweep gas flow badho = COâ‚‚ kam</td></tr>
<tr><td><strong>Oâ‚‚ Delivery</strong></td><td>Lungs bypass â€” oxygenated blood RA mein returns</td><td>Oxygenated blood aorta mein returns (bypasses heart)</td></tr>
<tr><td><strong>LV Unloading</strong></td><td>Not required</td><td>LV distension ho sakti â€” Impella add karo ("ECMELLA")</td></tr>
<tr><td><strong>Harlequin Syndrome</strong></td><td>N/A</td><td>Upper body from patient's heart (hypoxic), lower from ECMO. Right arm SpOâ‚‚ check karo!</td></tr>
<tr><td><strong>Anticoagulation</strong></td><td>UFH â€” ACT 160-200s / aPTT 60-80s</td><td>UFH â€” ACT 180-220s / aPTT 60-80s</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-pink">
<div class="card-icon">ğŸ“‹</div>
<h4>ECMO Patient Selection â€” ELSO Criteria</h4>
<p>VV-ECMO: Murray score â‰¥3 OR P/F &lt;80 despite optimal vent settings (6ml/kg, PEEP â‰¥10, prone). Contraindications: unrecoverable neurological injury, advanced malignancy with short prognosis, irreversible multiorgan failure, prolonged mechanical ventilation &gt;7-14 days (relative). VA-ECMO: CI &lt;2.2 + 2+ vasopressors. Always: reversible condition honi chahiye!</p>
</div>
<div class="card g-red">
<div class="card-icon">âš ï¸</div>
<h4>ECMO Complications â€” Roz Dekho!</h4>
<p>Bleeding: most common (anticoagulation se). Limb ischaemia VA-ECMO: distal perfusion cannula 6Fr lagao right away! Haemolysis: plasma-free Hb &gt;500 = oxygenator change. Circuit thrombosis: ACT monitor karo. ECMO-BSI: long lines = infection risk. Neurological events: seizures, stroke. Daily ECHO: circuit, heart function, cannula position. Every component check karo daily!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ”¬</div>
<h4>ECMO Monitoring â€” Daily KPIs</h4>
<p>Flow (L/min), RPM, sweep gas flow (COâ‚‚ control), FiOâ‚‚ECMO. Pre/post-membrane pOâ‚‚ â€” oxygenator efficiency dekho. Hemolysis: LDH, haptoglobin, plasma-free Hb. ACT q4h ya aPTT. ECHO daily: cardiac recovery? Cannula malposition? Daily CXR. TEG/ROTEM guided anticoagulation agar bleeding concern. Temperature: hypothermia prevent karo!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸƒ</div>
<h4>Awake ECMO â€” Future Is Here!</h4>
<p>Intubation-free VV-ECMO possible in some patients. Benefits: no VAP, no ICU-AW, patient can eat/walk, better outcomes. Requirements: cooperative patient, experienced team, no high respiratory drive. Ambulatory ECMO bridge to transplant cases mein â€” patient walks on ECMO. Minimal sedation, NIV backup, physiotherapy daily. Mortality benefit controversial â€” but quality of life better!</p>
</div>
</div>
<div class="alert alert-purple">
<div class="icon">ğŸ¥</div>
<div><strong>ECMO Centre Requirements!</strong> ECMO program ka success: volume &gt;50 cases/year (low-volume = poor outcomes). 24/7 perfusionist + ECMO specialist. Cardiac surgery backup. ECMO database + quality improvement. Transfer to ECMO centre early â€” "scoop and run" better than managing at non-ECMO centre. ELSO registry participate karo â€” outcome tracking essential! Simulators pe training karo before real cases.</div>
</div>
</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--dark)">Chapter 20</div>
<h2 style="color:#2d3748">ğŸ™ End of Life Care in ICU â€” Izzat Se Jaana!</h2>
<div class="chapter-intro" style="border-color:#2d3748">
    Bhai, ICU ka kaam sirf zindagi bachana nahi hai â€” kabhara kabhi zindagi ki quality bhi dekhni hoti hai. <strong>Death is not a failure</strong> â€” futile treatment is! Family se baat karo, goals of care discuss karo, aur patient ki dignity maintain karo. Yeh bhi critical care ka hissa hai.
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-dark">
<div class="card-icon">ğŸ’¬</div>
<h4>Family Meeting â€” Kaise Karo?</h4>
<p>Private jagah pe milao. Multidisciplinary team ho. SPIKES framework: Setting, Perception, Invitation, Knowledge, Emotion, Summary. Suno zyada, bolo kam. Translation ya interpreter arrange karo agar zaroorat ho. Document karo sab.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ“‹</div>
<h4>Goals of Care Discussion</h4>
<p>Kya patient theek ho sakta hai? Full recovery, partial, ya nahi â€” honestly discuss karo. "Sab karo" ka matlab samjhao. Patient ki wishes pehle (advance directive). Surrogate decision maker identify karo. Realistic expectations set karo.</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸš«</div>
<h4>Withholding &amp; Withdrawing</h4>
<p>Ethically equivalent hain dono â€” yeh samjho aur samjhao. Futile treatment continue karna ethical nahi. Comfort-focused care (palliative approach) shuru karo. DNAR orders â€” family se discuss, document, aur follow karo.</p>
</div>
<div class="card g-pink">
<div class="card-icon">ğŸ’Š</div>
<h4>Symptom Control â€” Dignity</h4>
<p>Dard: opioids freely dena chahiye. Breathlessness: opioids + benzodiazepines. Death rattle: hyoscine. Agitation: midazolam. "Double effect" principle â€” comfort ke liye high doses ethical hain even if death hastened. Palliative care consult karo.</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ‘¨â€ğŸ‘©â€ğŸ‘§</div>
<h4>Family Support</h4>
<p>Family ko bedside aane do â€” visiting restrictions loosen karo. Spiritual care, social worker, counsellor. Bereavement support baad mein bhi do. Nurses ki role critical hai â€” woh sabse zyada family ke saath rehti hain. ICU diary bhi helpful hai.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ§ </div>
<h4>Staff Wellbeing â€” Moral Distress</h4>
<p>Futile care dene se ICU staff ko moral distress hota hai. Debriefing sessions, psychological support. Team ko bhi grief hota hai. Burnout aur compassion fatigue common hain. Support culture banao ICU mein â€” yeh zaroori hai!</p>
</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ•Šï¸ ICU Ka Ek Aur Sachcha Lesson</div>
<p>Har din hum life aur death ke beech ke darwaze pe khade hote hain. Technology bahut powerful hai â€” lekin wisdom batata hai ki kab lagani hai aur kab nahi. Patient ko izzat se jeena aur izzat se jaana â€” yeh dono hamari zimmedari hai. <strong>"Cure sometimes, relieve often, comfort always."</strong></p>
</div>
<div class="alert alert-green">
<div class="icon">ğŸŒŸ</div>
<div><strong>ICU Liberation â€” Patient-Centred Care:</strong> ABCDE bundle + Family engagement + Early mobility + Psychological support = ICU ka poora care model. PTSD, cognitive impairment, physical weakness â€” yeh Post Intensive Care Syndrome (PICS) hai. Family bhi affected hoti hai (PICS-F). ICU survival ke baad ka journey bhi hamara kaam hai!
<div class="cards" style="margin-top:24px;">
<div class="card g-blue">
<div class="card-icon">ğŸ’¬</div>
<h4>SPIKES Framework â€” Breaking Bad News</h4>
<p><strong>S</strong>etting: Private room, tissue box ready, all key family members. <strong>P</strong>erception: "Aap ko kya pata hai abhi ki situation ke baare mein?" <strong>I</strong>nvitation: Pehle poochho kitna detail chahiye. <strong>K</strong>nowledge: Simple words â€” "main aapko kuch mushkil khabar batane wala hun." <strong>E</strong>motion: Rona, anger â€” allow karo. <strong>S</strong>ummary: Next steps clear karo. Don't rush. Silence is OK.</p>
</div>
<div class="card" style="background:linear-gradient(135deg,#4a4a6a,#1a1a2e)">
<div class="card-icon">âš–ï¸</div>
<h4>Ethical Framework â€” 4 Principles</h4>
<p><strong>Autonomy</strong>: Patient ka right apna decisions lene ka â€” advance directives respect karo. <strong>Beneficence</strong>: Patient ka overall bhala karo. <strong>Non-maleficence</strong>: Futile treatment harm karta hai. <strong>Justice</strong>: Resources ka fair use. Jab principles conflict karte hain â€” ethics committee consult karo. Family aur team mein conflict ho toh: mediator ya ethics committee zaroor involve karo!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸŒ¿</div>
<h4>Terminal Extubation â€” Dignified Process</h4>
<p>Family prepare karo: kya expect karo, kitna time lag sakta hai. Morphine infusion shuru karo (dyspnoea relieve karo). Glycopyrrolate 0.2mg IV q4h â€” death rattle kam karo. Alarms off, curtains close. Family bedside raho â€” important hai. Post-extubation patient comfortable look kare â€” hamesha. Staff ko bhi affect karta hai â€” debriefing karo. Document everything carefully!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ”</div>
<h4>PICS â€” ICU Ke Baad Ka Safar</h4>
<p>50-70% ICU survivors mein PICS hoti hai. Physical: muscle weakness, fatigue. Cognitive: memory, attention, executive function. Psychological: PTSD (22%), depression (30%), anxiety. PICS-F: family members bhi PTSD develop karte hain! ICU follow-up clinic: 3 months, 6 months, 1 year. ICU diary likho â€” patient read kare recovery mein = PTSD kam hota hai!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#4a4a6a,#1a1a2e)">
<th>Comfort Care Drug</th><th>Indication</th><th>Dose</th><th>Route</th>
</tr></thead>
<tbody>
<tr><td><strong>Morphine</strong></td><td>Pain + dyspnoea</td><td>2-5mg q4h ya 1-5mg/hr infusion</td><td>IV / SC</td></tr>
<tr><td><strong>Midazolam</strong></td><td>Agitation, anxiety, seizures</td><td>1-5mg q4h ya 1-10mg/hr infusion</td><td>IV / SC</td></tr>
<tr><td><strong>Glycopyrrolate</strong></td><td>Death rattle (secretions)</td><td>0.2-0.4mg q4h</td><td>IV / SC (cross nahi karta BBB)</td></tr>
<tr><td><strong>Haloperidol</strong></td><td>Delirium, agitation</td><td>0.5-2mg q6-8h</td><td>IV / SC / PO</td></tr>
<tr><td><strong>Dexamethasone</strong></td><td>Cerebral oedema, nausea</td><td>4mg BD</td><td>IV / SC</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-blue">
<div class="icon">ğŸ™</div>
<div><strong>ICU Mein "Do Everything" Ka Matlab!</strong> Family aksar kehti hai â€” "Doctor, sab karo!" Lekin CPR agar survival impossible hai toh sirf suffering badhata hai. Hamara kaam honest conversation karna hai. "Hum sab kuch kar rahe hain patient ko comfortable rakhne ke liye â€” yeh bhi 'sab karna' hai." Futile treatment withdraw karna ethical hai. Medical team aur family milke decide karein â€” akela mat karo yeh decision.</div>
</div>
</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--orange)">Chapter 21</div>
<h2 style="color:var(--orange)">ğŸ©º Endocrine Emergencies â€” Hormones Pagal Ho Gaye!</h2>
<div class="chapter-intro" style="border-color:var(--orange)">
    ICU mein endocrine emergencies bahut miss ho jaati hain â€” dheere se aati hain, bahut nuksaan karti hain. DKA, HHS, Thyroid Storm, Adrenal Crisis â€” yeh sab janlewa hain. <strong>Recognize â†’ Resuscitate â†’ Replace</strong> â€” yahi formula hai! Glucose monitor karo, hormones sochte raho!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 520" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg21">
<stop offset="0%" stop-color="#f4a261"></stop>
<stop offset="100%" stop-color="#e76f51"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="185" y1="260" y2="90"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="715" y1="260" y2="90"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="70" y1="260" y2="270"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="830" y1="260" y2="270"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="185" y1="260" y2="435"></line>
<line opacity=".6" stroke="#f4a261" stroke-width="3" x1="450" x2="715" y1="260" y2="435"></line>
<ellipse cx="450" cy="260" fill="url(#rg21)" rx="125" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="16" font-weight="800" text-anchor="middle" x="450" y="252">ENDOCRINE ICU</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="273">Hormones Bigad Gaye â€” Sochna Padega!</text>
<rect fill="#fff4ec" height="110" rx="14" stroke="#f4a261" stroke-width="2.5" width="240" x="65" y="35"></rect>
<text fill="#7a3000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="68">ğŸ¬ DKA â€” Diabetic Ketoacidosis</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="84">â€¢ Glucose &gt;11, pH &lt;7.3, bicarb &lt;15</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="98">â€¢ IV fluids pehle â€” 1L NS/hr Ã— 2hr</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="112">â€¢ Insulin drip 0.1 U/kg/hr</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="126">â€¢ K+ MUST replace before insulin!</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="240" x="595" y="35"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="68">ğŸ’§ HHS â€” Hyperosmolar State</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="84">â€¢ Glucose &gt;33, Osm &gt;320, no ketones</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="98">â€¢ Slow rehydration â€” 12-48 hours</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="112">â€¢ 0.45% NaCl after initial NS bolus</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="126">â€¢ DVT prophylaxis zaroori!</text>
<rect fill="#fff0fa" height="110" rx="14" stroke="#f72585" stroke-width="2.5" width="165" x="5" y="215"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="88" y="248">ğŸŒ¡ï¸ Thyroid Storm</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="264">â€¢ Burch-Wartofsky score</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="278">â€¢ PTU + Lugol's iodine</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="292">â€¢ Beta-blocker (propranolol)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="88" y="306">â€¢ Hydrocortisone 300mg/day</text>
<rect fill="#eafff6" height="110" rx="14" stroke="#06d6a0" stroke-width="2.5" width="165" x="730" y="215"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="812" y="248">âš ï¸ Adrenal Crisis</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="264">â€¢ Hypotension + hyponatraemia</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="278">â€¢ Hydrocortisone 100mg IV STAT</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="292">â€¢ Phir 50mg q6h ya infusion</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="812" y="306">â€¢ IV fluids + dextrose</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="240" x="65" y="385"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="415">ğŸ§Š Myxoedema Coma</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="431">â€¢ Hypothermia + bradycardia + coma</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="445">â€¢ T4 200-500mcg IV bolus</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="459">â€¢ Hydrocortisone before T4!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="473">â€¢ Warm slowly, ventilate</text>
<rect fill="#fffbea" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="240" x="595" y="385"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="415">ğŸ“Š Glucose Targets ICU</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="431">â€¢ Target: 6â€“10 mmol/L (108â€“180 mg/dL)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="445">â€¢ Avoid hypoglycaemia (&lt;4 mmol/L)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="459">â€¢ Insulin infusion protocol follow karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="473">â€¢ Check q1-2h when insulin running</text>
</svg>
</div>
<div class="cards">
<div class="card g-orange">
<div class="card-icon">ğŸ¬</div>
<h4>DKA â€” Key Points!</h4>
<p>Potassium PEHLE check karo â€” agar K+ &lt;3.5 hai toh insulin mat shuru karo! Pehle K+ replace karo. Cerebral oedema ka risk hai â€” especially paediatrics mein. Sodium paradox â€” glucose girega toh Na+ badhega (pseudohyponatraemia correct hoga).</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸŒ¡ï¸</div>
<h4>Thyroid Storm â€” Recognize!</h4>
<p>Fever &gt;38.5Â°C + tachycardia + altered mentation + precipitant (infection, surgery, trauma). Burch-Wartofsky score &gt;45 = thyroid storm. PTU pehle do â€” synthesis AND conversion rokta hai. Lugol's iodine sirf PTU ke 1 hour baad do!</p>
</div>
<div class="card g-green">
<div class="card-icon">âš ï¸</div>
<h4>Adrenal Crisis â€” Miss Mat Karo!</h4>
<p>Refractory shock mein hamesha sochna chahiye. Steroids se pehle ACTH stimulation test lo â€” agar possible ho. Agar nahi toh pehle treat karo, phir test karna. Fludrocortisone add karo chronic replacement mein â€” mineralocorticoid activity ke liye.</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ’§</div>
<h4>HHS vs DKA â€” Fark Kya Hai?</h4>
<p>HHS: older T2DM, insidious onset, markedly high glucose, no significant ketones, serum Osmolarity &gt;320. DKA: younger, T1DM, fast onset, ketones +, anion gap metabolic acidosis. HHS mein fluids zyada important hain, insulin later.</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ§Š</div>
<h4>Sick Euthyroid Syndrome</h4>
<p>ICU mein T3 kam hona normal hai â€” yeh thyroid disease nahi hai! Low T3 = adaptive response. Supplement mat karo unless proven hypothyroidism. TFTs interpret karo clinical context mein. Reverse T3 high hoti hai ICU mein â€” normal hai.</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ©º</div>
<h4>Relative Adrenal Insufficiency</h4>
<p>Septic shock mein â€” corticosteroids kab dein? Norad &gt;0.25 mcg/kg/min + hemodynamically unstable = hydrocortisone 200mg/day infusion. ADRENAL trial: steroids se faster shock reversal, lekin 90-day mortality same. Decision individualize karo!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#f4a261,#e76f51)">
<th>Condition</th><th>Key Features</th><th>Immediate Treatment</th>
</tr></thead>
<tbody>
<tr><td><strong>DKA</strong></td><td>Glucose &gt;11, pH &lt;7.3, Ketones 2+, Anion gap â†‘</td><td>IV NS 1L/hr â†’ Insulin 0.1 U/kg/hr (K+ &gt;3.5 hone ke baad)</td></tr>
<tr><td><strong>HHS</strong></td><td>Glucose &gt;33, Osm &gt;320, Minimal ketones</td><td>0.9% NaCl slow rehydration 12-48h, Insulin later</td></tr>
<tr><td><strong>Thyroid Storm</strong></td><td>Fever + tachycardia + AMS + precipitant</td><td>PTU 600mg load â†’ Lugol's iodine â†’ Propranolol â†’ Hydrocortisone</td></tr>
<tr><td><strong>Adrenal Crisis</strong></td><td>Hypotension + hypoNa + eosinophilia (sometimes)</td><td>Hydrocortisone 100mg IV STAT â†’ 50mg q6h + IV fluids</td></tr>
<tr><td><strong>Myxoedema Coma</strong></td><td>Hypothermia, bradycardia, hypoventilation, coma</td><td>Hydrocortisone pehle, phir T4 200-500 mcg IV bolus</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-orange">
<div class="icon">ğŸ’¡</div>
<div><strong>DKA Resolution Criteria â€” Yaad Rakhna!</strong> Glucose &lt;11 mmol/L AND Bicarbonate â‰¥15 mEq/L AND pH &gt;7.3 = DKA resolve hui! Insulin band karne se pehle subcut insulin shuru karo aur 2-4 ghante overlap karo. Anion gap normalize hone ka wait karo â€” agar gap high hai toh DKA abhi bhi hai!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--red)">Chapter 22</div>
<h2 style="color:var(--red)">ğŸ”¥ Burns ICU â€” Aag Ka Ilaj!</h2>
<div class="chapter-intro" style="border-color:var(--red)">
    Burns ek multi-system injury hai â€” sirf skin nahi jalta, pura body burn ho jaata hai andar se! Fluid resuscitation, inhalation injury management, nutrition, infection control, wound care â€” sab ek saath dekhna padta hai. <strong>Rule of 9s â†’ Parkland Formula â†’ Early Excision &amp; Grafting</strong> â€” yeh hai burns ka ABC!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 510" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg22">
<stop offset="0%" stop-color="#e63946"></stop>
<stop offset="100%" stop-color="#c1121f"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="185" y1="255" y2="85"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="715" y1="255" y2="85"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="65" y1="255" y2="265"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="835" y1="255" y2="265"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="185" y1="255" y2="430"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="715" y1="255" y2="430"></line>
<ellipse cx="450" cy="255" fill="url(#rg22)" rx="120" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="16" font-weight="800" text-anchor="middle" x="450" y="247">BURNS ICU</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="268">Rule of 9s â†’ Parkland â†’ Wound Care!</text>
<rect fill="#fff0f0" height="110" rx="14" stroke="#e63946" stroke-width="2.5" width="235" x="65" y="30"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="63">ğŸ“ Rule of 9s â€” TBSA Calculate</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="79">â€¢ Head &amp; Neck: 9%</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="93">â€¢ Each arm: 9%; Chest: 18%</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="107">â€¢ Abdomen: 9%; Back: 9%</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="121">â€¢ Each leg: 18%; Perineum: 1%</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="235" x="600" y="30"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="63">ğŸ’§ Parkland Formula</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="79">â€¢ 4 ml Ã— Weight (kg) Ã— %TBSA</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="93">â€¢ 50% pehle 8h, 50% agle 16h</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="107">â€¢ Ringer's Lactate use karo â€” NS nahi!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="121">â€¢ Time from BURN, not admission!</text>
<rect fill="#eafff6" height="110" rx="14" stroke="#06d6a0" stroke-width="2.5" width="175" x="5" y="210"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="242">ğŸ« Inhalation Injury</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="258">â€¢ Singed nasal hair, soot</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="272">â€¢ Hoarse voice = intubate ASAP!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="286">â€¢ 100% Oâ‚‚ for CO poisoning</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="300">â€¢ Nebulized heparin + NAC</text>
<rect fill="#fff5e6" height="110" rx="14" stroke="#f9c74f" stroke-width="2.5" width="175" x="720" y="210"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="808" y="242">ğŸ¥— Burns Nutrition</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="258">â€¢ Curreri formula: 25 kcal/kg</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="272">  + 40 kcal Ã— %TBSA</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="286">â€¢ Protein 2-3 g/kg/day</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="300">â€¢ Vit C, Zinc, Selenium dena!</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="235" x="65" y="375"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="405">ğŸ©¹ Wound Care â€” Early!
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="421">â€¢ Early excision + grafting (48-72h)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="435">â€¢ Silver sulfadiazine ya mafenide acetate</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="449">â€¢ Escharotomy agar circumferential</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="463">â€¢ Fasciotomy agar compartment syndrome</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="235" x="600" y="375"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="405">ğŸ¦  Infection in Burns</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="421">â€¢ Pseudomonas, MRSA, Candida common</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="435">â€¢ Prophylactic antibiotics NAHI dena</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="449">â€¢ Fever burns mein normal hai!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="463">â€¢ Culture-guided treatment only</text>
</text></svg>
</div>
<div class="cards">
<div class="card g-red">
<div class="card-icon">ğŸš¨</div>
<h4>Burn Referral Criteria â€” Kab Refer?</h4>
<p>&gt;10% TBSA (adults), &gt;5% (children). Full thickness burns koi bhi. Face, hands, feet, genitalia, perineum, major joints. Inhalation injury. Chemical or electrical burns. Burns with major trauma. Burns at extremes of age â€” ye sab specialist burns unit mein jaane chahiye!</p>
</div>
<div class="card g-blue">
<div class="card-icon">âš¡</div>
<h4>Electrical Burns â€” Special!</h4>
<p>Entry aur exit wounds dekho â€” andar kahin bhi damage ho sakta hai. Rhabdomyolysis: aggressively IV fluids, urine output 2-3 ml/kg/hr target. ECG karo â€” arrhythmia ka risk. Cardiac monitoring 24h minimum. Compartment syndrome common hai electrical burns mein!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ”¬</div>
<h4>CO Poisoning â€” Invisible Killer!</h4>
<text>SpOâ‚‚ normal dikhega â€” CO HbOâ‚‚ ki tarah read hoti hai pulse ox pe! CO-oximeter use karo. COHb &gt;25% = hyperbaric Oâ‚‚ consider karo. Symptoms: headache, nausea, confusion, seizures. 100% Oâ‚‚ se half-life 5h se 90 min ho jaati hai!</text>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ’§</div>
<h4>Fluid Resuscitation â€” Monitor Karenge!</h4>
<p>Urine output target: 0.5-1 ml/kg/hr (adults), 1 ml/kg/hr (children). Zyada fluid = pulmonary oedema + compartment syndrome. Kam fluid = renal failure. Colloid add karo agar fluid creeping zyada ho â€” Baxter formula sirf starting estimate hai!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ©º</div>
<h4>Depth of Burns â€” Classification</h4>
<p>Superficial (1Â°): erythema only, no blisters â€” jaise sunburn. Partial thickness (2Â°): blisters, painful. Full thickness (3Â°): leather-like, painless. 4Â°: bone/tendon involved. Full thickness + 4Â° needs grafting â€” apne aap heal nahi hoti!</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ§ </div>
<h4>Burn Encephalopathy</h4>
<p>Early: CO poisoning, hypoxia, electrolyte imbalance, hypovolemia. Late: sepsis, drug toxicity, hepatic failure. Seizures: benzodiazepines first line. Burns patients ka psych support bhi zaroori hai â€” disfigurement aur pain ka mental impact bada hota hai!</p>
</div>
</div>
<div class="alert alert-red">
<div class="icon">ğŸ”¥</div>
<div><strong>Burns ICU Golden Rule â€” "Fluid, Feed, Wound!"</strong> Pehle 24h mein fluid aggressive do â€” Parkland formula se. 24-48h mein enteral nutrition shuru karo â€” metabolism bahut high hota hai burns mein! Early surgical debridement se infection kam hoti hai aur survival improve hoti hai. Escharotomy delay mat karo â€” compartment syndrome life-threatening hai!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--pink)">Chapter 23</div>
<h2 style="color:var(--pink)">ğŸ¤° Obstetric Critical Care â€” Do Zindagiyaan Bachao!</h2>
<div class="chapter-intro" style="border-color:var(--pink)">
    Pregnant woman ICU mein = har decision mein do logon ki sochna hai â€” maa aur bachcha! Physiological changes pregnancy mein sab kuch alter kar dete hain â€” BP, HR, blood tests, oxygen consumption. <strong>Pre-eclampsia, Eclampsia, PPH, HELLP, AFE</strong> â€” yeh sab janlewa hain aur inka management special hai!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 520" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg23">
<stop offset="0%" stop-color="#f72585"></stop>
<stop offset="100%" stop-color="#b5179e"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#f72585" stroke-width="3" x1="450" x2="185" y1="260" y2="90"></line>
<line opacity=".6" stroke="#f72585" stroke-width="3" x1="450" x2="715" y1="260" y2="90"></line>
<line opacity=".6" stroke="#f72585" stroke-width="3" x1="450" x2="70" y1="260" y2="270"></line>
<line opacity=".6" stroke="#f72585" stroke-width="3" x1="450" x2="830" y1="260" y2="270"></line>
<line opacity=".6" stroke="#f72585" stroke-width="3" x1="450" x2="185" y1="260" y2="435"></line>
<line opacity=".6" stroke="#f72585" stroke-width="3" x1="450" x2="715" y1="260" y2="435"></line>
<ellipse cx="450" cy="260" fill="url(#rg23)" rx="125" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="15" font-weight="800" text-anchor="middle" x="450" y="252">OBSTETRIC ICU</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="273">Maa Aur Bachcha â€” Dono Bachane Hain!</text>
<rect fill="#fff0fa" height="110" rx="14" stroke="#f72585" stroke-width="2.5" width="240" x="65" y="35"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="68">ğŸ©º Pre-eclampsia/Eclampsia</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="84">â€¢ BP â‰¥140/90 after 20 wks + proteinuria</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="98">â€¢ Severe: SBP â‰¥160, DBP â‰¥110</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="112">â€¢ MgSOâ‚„ 4g IV bolus â†’ 2g/hr infusion</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="126">â€¢ Labetalol ya hydralazine IV</text>
<rect fill="#fff0f0" height="110" rx="14" stroke="#e63946" stroke-width="2.5" width="240" x="595" y="35"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="68">ğŸ©¸ PPH â€” Postpartum Haemorrhage</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="84">â€¢ &gt;500 ml vaginal / &gt;1000 ml C-section</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="98">â€¢ 4 T's: Tone, Tissue, Trauma, Thrombin</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="112">â€¢ Oxytocin â†’ Ergometrine â†’ TXA</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="126">â€¢ Balloon tamponade ya surgery!</text>
<rect fill="#fffbea" height="110" rx="14" stroke="#f9c74f" stroke-width="2.5" width="170" x="5" y="215"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="90" y="245">âš¡ HELLP Syndrome</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="261">â€¢ Haemolysis, ELTs, Low Platelets</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="275">â€¢ Plt &lt;100k + LDH &gt;600 + AST &gt;70</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="289">â€¢ Delivery = definitive treatment</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="303">â€¢ Steroids for fetal lung maturity</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="170" x="725" y="215"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="810" y="245">ğŸ’¨ AFE â€” Nightmare!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="261">â€¢ Amniotic Fluid Embolism</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="275">â€¢ Collapse + coagulopathy</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="289">â€¢ Resuscitate aggressively!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="303">â€¢ ECMO consider karo!</text>
<rect fill="#eafff6" height="105" rx="14" stroke="#06d6a0" stroke-width="2.5" width="240" x="65" y="380"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="185" y="410">ğŸ«€ Peripartum Cardiomyopathy</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="426">â€¢ Last month pregnancy to 5 months post</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="440">â€¢ EF &lt;45%, no prior cardiac disease</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="454">â€¢ Bromocriptine + HF treatment</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="185" y="468">â€¢ ACEI/ARB post-delivery only</text>
<rect fill="#f5eeff" height="105" rx="14" stroke="#7209b7" stroke-width="2.5" width="240" x="595" y="380"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="715" y="410">ğŸ§  Eclampsia Seizures</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="426">â€¢ MgSOâ‚„ = drug of choice (NOT phenytoin)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="440">â€¢ Toxicity: Loss of reflexes â†’ Resp arrest</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="454">â€¢ Antidote: Calcium gluconate 10ml 10%</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="715" y="468">â€¢ Recurrent: top-up 2g IV bolus</text>
</svg>
</div>
<div class="cards">
<div class="card g-pink">
<div class="card-icon">ğŸ¤°</div>
<h4>Pregnancy Physiology â€” Sab Badal Jaata Hai!</h4>
<p>BP naturally 10-15 mmHg low hoti hai trimester 2 mein. HR 15-20 bpm badh jaati hai. Blood volume 40-50% increase. SpOâ‚‚ thoda high norm. Hb dilution se low dikhta hai. Normal creatinine 0.4-0.5 (lower!). Normal COâ‚‚ kum hoti hai â€” respiratory alkalosis. Yeh sab normal hai pregnant mein!</p>
</div>
<div class="card g-red">
<div class="card-icon">âš¡</div>
<h4>Eclampsia â€” Emergency Protocol</h4>
<p>MgSOâ‚„ 4g IV over 15-20 min loading dose â€” tez mat do (cardiac arrest risk!). Then 2g/hr infusion. Reflexes check karo q1h â€” absent = toxicity. Urine output &gt;25 ml/hr chahiye. Delivery plan karo â€” only cure hai pre-eclampsia ka. BP control: labetalol, nifedipine, hydralazine.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ©¸</div>
<h4>Massive PPH â€” Act Fast!</h4>
<p>HAEMOSTASIS protocol: H-Help, A-Assess (ABC), E-Establish IV access, M-Massage uterus, O-Oxytocin, S-Shift to theatre, T-Tissue (retained products), A-Apply balloon tamponade, S-Surgical haemostasis, I-ICU. Hysterectomy delay mat karo agar uterus contract nahi kar raha!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ’Š</div>
<h4>Safe Drugs in Pregnancy ICU</h4>
<p>Antibiotics: beta-lactams, metronidazole (2nd/3rd tri), clindamycin â€” SAFE. Avoid: tetracyclines, aminoglycosides (ototoxicity), fluoroquinolones. Analgesics: paracetamol safe. NSAIDs avoid (fetal renal, premature closure DA). Vasopressors: norad OK. Steroids: safe (fetal maturity bhi!).</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ«€</div>
<h4>Maternal Cardiac Arrest</h4>
<p>Left lateral displacement of uterus during CPR (tilt ya manual displacement). Standard ACLS protocol follow karo. Perimortem C-section â‰¥20 weeks â€” 4 minutes ke andar agar ROSC nahi aaya. Yeh maa ko bhi bachata hai â€” aorto-caval decompression se CPR better hota hai!</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ§ª</div>
<h4>HELLP â€” Rapid Management</h4>
<p>Dexamethasone 10mg q12h platelet count badha sakta hai (controversial). Plt &lt;50k ya active bleeding = transfuse. Antihypertensives. Seizure prophylaxis MgSOâ‚„. Delivery ASAP â‰¥34 weeks; &lt;34 weeks stabilize then deliver. ICU admission mandatory for severe HELLP!</p>
</div>
</div>
<div class="alert alert-pink" style="background:#fff0fa;border-left:5px solid var(--pink);color:#8a003a;">
<div class="icon">ğŸ¤°</div>
<div><strong>Obstetric ICU Ka Sabse Bada Lesson:</strong> Delivery = treatment for most obstetric emergencies! Pre-eclampsia, HELLP, eclampsia â€” sab mein delivery se hi permanently resolve hogi. Maa ko stabilize karo, deliver karo. Fetal monitoring important hai lekin maa ki jaan pehle aati hai. NEVER delay delivery in haemodynamically unstable mother!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--red)">Chapter 24</div>
<h2 style="color:var(--red)">â¤ï¸ Cardiac Arrest &amp; Post-Resuscitation Care â€” ROSC Ke Baad!</h2>
<div class="chapter-intro" style="border-color:var(--red)">
    ROSC milna sirf shuruwat hai â€” asli kaam uske baad shuru hota hai! Post-Cardiac Arrest Syndrome (PCAS) = brain injury + myocardial dysfunction + systemic ischaemia-reperfusion. <strong>TTM (Targeted Temperature Management), early angiography, organ support</strong> â€” yeh sab ek saath sochna padta hai. IHCA vs OHCA â€” outcomes alag hain!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 510" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg24">
<stop offset="0%" stop-color="#e63946"></stop>
<stop offset="100%" stop-color="#9d0208"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="185" y1="255" y2="85"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="715" y1="255" y2="85"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="65" y1="255" y2="260"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="835" y1="255" y2="260"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="185" y1="255" y2="425"></line>
<line opacity=".6" stroke="#e63946" stroke-width="3" x1="450" x2="715" y1="255" y2="425"></line>
<ellipse cx="450" cy="255" fill="url(#rg24)" rx="120" ry="58"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="450" y="247">POST-CARDIAC ARREST</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="268">ROSC Ke Baad â€” Kaam Shuru!</text>
<rect fill="#fff0f0" height="110" rx="14" stroke="#e63946" stroke-width="2.5" width="235" x="65" y="30"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="63">ğŸ§Š TTM â€” Temperature Target!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="79">â€¢ 32â€“36Â°C for 24h post-ROSC</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="93">â€¢ Avoid hyperthermia (&gt;37.5Â°) strictly!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="107">â€¢ Cool rapidly, rewarm slowly (0.25Â°/hr)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="121">â€¢ TTM2 trial: 33Â°C = 36Â°C similar outcome</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="235" x="600" y="30"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="63">ğŸ«€ Coronary Angiography</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="79">â€¢ STEMI post-OHCA: immediate cath!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="93">â€¢ No STEMI: COACT trial â€” delay OK</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="107">â€¢ Clinical judgement use karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="121">â€¢ Cardiogenic shock = early PCI helps</text>
<rect fill="#eafff6" font-weight="2.5" height="105" rx="14" stroke="#06d6a0" width="170" x="5" y="208"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="90" y="238">ğŸ§  Neuroprognostication</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="254">â€¢ Wait 72h before prognosticating</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="268">â€¢ Pupillary reflex, GCS, SSEPs</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="282">â€¢ CT/MRI brain help karta hai</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="296">â€¢ EEG: burst suppression = bad</text>
<rect fill="#fff5e6" height="105" rx="14" stroke="#f9c74f" stroke-width="2.5" width="170" x="725" y="208"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="810" y="238">ğŸ“Š Haemodynamics</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="254">â€¢ MAP â‰¥65-70 mmHg target</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="268">â€¢ Norad Â± dobutamine</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="282">â€¢ IABP ya Impella if severe</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="296">â€¢ ECHO karo cardiac function dekhne!</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="235" x="65" y="370"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="400">ğŸ« Ventilation Post-ROSC</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="416">â€¢ SpOâ‚‚ 94-98% â€” hypoxia AND hyperoxia avoid</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="430">â€¢ PaCOâ‚‚ 35-45 mmHg target (normocapnia)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="444">â€¢ Lung protective settings</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="458">â€¢ Seizure prophylaxis? (controversial)</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="235" x="600" y="370"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="400">ğŸ”¬ Reversible Causes â€” 4H 4T</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="416">â€¢ Hypoxia, Hypovolemia, Hypo/hyperK, Hypothermia</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="430">â€¢ Tension PTX, Tamponade, Toxins, Thrombosis</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="444">â€¢ During CPR hamesha search karo</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="458">â€¢ POCUS use karo rapidly!</text>
</svg>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#e63946,#c1121f)">
<th>Parameter</th><th>Target Post-ROSC</th><th>Reason</th>
</tr></thead>
<tbody>
<tr><td><strong>Temperature</strong></td><td>32â€“36Â°C for 24h, then normothermia</td><td>Neuroprotection â€” brain metabolism slow karo</td></tr>
<tr><td><strong>SpOâ‚‚</strong></td><td>94â€“98%</td><td>Hyperoxia bhi harmful hai post-ROSC!</td></tr>
<tr><td><strong>PaCOâ‚‚</strong></td><td>35â€“45 mmHg</td><td>Normocapnia â€” avoid cerebral vasoconstriction</td></tr>
<tr><td><strong>MAP</strong></td><td>â‰¥65â€“70 mmHg</td><td>Cerebral perfusion maintain karo</td></tr>
<tr><td><strong>Glucose</strong></td><td>6â€“10 mmol/L</td><td>Hypoglycaemia devastating for post-arrest brain</td></tr>
<tr><td><strong>Seizures</strong></td><td>Levetiracetam / valproate if occur</td><td>EEG monitoring 24-48h recommended</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-red">
<div class="icon">â±ï¸</div>
<div><strong>Post-ROSC ka "Bundle of Care" â€” Sab Ek Saath:</strong> Temperature control + Haemodynamic optimization + Lung protection + Glucose control + Seizure surveillance + Coronary angiography decision = yeh sab pehle 24h mein karna hai. Fever (â‰¥37.8Â°) post-ROSC bahut harmful hai â€” STRICTLY avoid karo. Paracetamol aur external cooling use karo!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--purple)">Chapter 25</div>
<h2 style="color:var(--purple)">ğŸ§  ICU Delirium &amp; PICS â€” Dimaag Ka ICU!</h2>
<div class="chapter-intro" style="border-color:var(--purple)">
    ICU Delirium â€” 80% tak mechanical ventilated patients mein hoti hai! Ye mortality badhaati hai, ventilator time badhaata hai, costs badhaate hain. PICS (Post-Intensive Care Syndrome) matlab ICU se discharge ke baad bhi suffering. <strong>ABCDEF Bundle = best prevention strategy!</strong> Prevent karo pehle â€” phir treat karo.
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-purple">
<div class="card-icon">ğŸ”¤</div>
<h4>ABCDEF Bundle â€” ICU Liberation!</h4>
<p>A = Assess, prevent, and manage Pain. B = Both Spontaneous Awakening Trials (SAT) + Spontaneous Breathing Trials (SBT). C = Choice of analgesia and sedation. D = Delirium assess, prevent, and manage. E = Early mobility and Exercise. F = Family engagement and empowerment. Yeh bundle ek saath chale!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ“‹</div>
<h4>CAM-ICU â€” Assess Kaise Karein?</h4>
<p>Feature 1: Acute onset + fluctuating course. Feature 2: Inattention (ASE â€” Attention Screening Examination). Feature 3: Altered level of consciousness. Feature 4: Disorganized thinking. Features 1+2 PLUS 3 OR 4 = CAM-ICU positive = Delirium! Daily minimum 2 baar assess karo.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸŒ™</div>
<h4>Sleep in ICU â€” Neglected!</h4>
<p>ICU mein sleep bahut disturbed hoti hai â€” noise, light, procedures, medications. Sleep deprivation = delirium risk badh jaata hai. Noise reduction protocol, dimming lights at night, cluster procedures during day. Melatonin 0.5-10mg consider karo. Dexmedetomidine better sleep quality deta hai!</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸƒ</div>
<h4>Early Mobility â€” Karo Jaldi!</h4>
<p>Patients ventilator pe bhi exercise kar sakte hain! Passive ROM â†’ Active assisted â†’ Sitting at bedside â†’ Standing â†’ Walking. ICU-acquired weakness prevent hoti hai. Delirium risk kam hota hai. Days mein results dikhte hain! Physiotherapist ICU team ka important member hai.</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ’Š</div>
<h4>Delirium Treatment â€” Drugs?</h4>
<p>Non-pharmacological pehle â€” reorientation, family, familiar items, glasses/hearing aids, sleep hygiene. Haloperidol: most used, lekin HOPE trial mein mortality same. Quetiapine: hyperactive delirium mein better tolerated. Dexmedetomidine: sedation while allowing arousal â€” best for delirium in ventilated patients.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ”„</div>
<h4>PICS â€” Post-ICU Syndrome</h4>
<p>ICU discharge ke baad: Cognitive impairment (memory, attention). Physical weakness â€” ICU-acquired myopathy. Psychological â€” PTSD, anxiety, depression (patient aur family dono!). ICU diary helpful hai. Follow-up clinic recommend karo. PICS-F = family members bhi affected hoti hain. Puri family ko support chahiye.</p>
</div>
</div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 400" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg25">
<stop offset="0%" stop-color="#7209b7"></stop>
<stop offset="100%" stop-color="#3a0ca3"></stop>
</radialgradient>
</defs>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="150" y1="200" y2="80"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="750" y1="200" y2="80"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="80" y1="200" y2="200"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="820" y1="200" y2="200"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="150" y1="200" y2="320"></line>
<line opacity=".5" stroke="#7209b7" stroke-width="3" x1="450" x2="750" y1="200" y2="320"></line>
<ellipse cx="450" cy="200" fill="url(#rg25)" rx="110" ry="55"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="450" y="193">DELIRIUM</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="213">Assess + Prevent + Treat!</text>
<rect fill="#f5eeff" height="90" rx="12" stroke="#7209b7" stroke-width="2" width="215" x="30" y="30"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="11" font-weight="800" text-anchor="middle" x="138" y="60">ğŸ“Š Types of Delirium</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="138" y="76">â€¢ Hyperactive: agitated, pulling lines</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="138" y="90">â€¢ Hypoactive: quiet, drowsy â€” MISSED!</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="138" y="104">â€¢ Mixed: dono types baarbaari se</text>
<rect fill="#eef3ff" height="90" rx="12" stroke="#4361ee" stroke-width="2" width="215" x="655" y="30"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="11" font-weight="800" text-anchor="middle" x="762" y="60">âš ï¸ Risk Factors</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="762" y="76">â€¢ Age, dementia, prior delirium</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="762" y="90">â€¢ Benzodiazepines, anticholinergics</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="762" y="104">â€¢ Sleep deprivation, immobility</text>
<rect fill="#eafff6" height="90" rx="12" stroke="#06d6a0" stroke-width="2" width="145" x="5" y="155"></rect>
<text fill="#004d30" font-family="Nunito" font-size="11" font-weight="800" text-anchor="middle" x="78" y="183">âœ… SAT Protocol</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="78" y="199">â€¢ Daily sedation holiday</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="78" y="213">â€¢ Contraindications check</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="78" y="227">â€¢ SBT agar SAT pass</text>
<rect fill="#fff5e6" height="90" rx="12" stroke="#f9c74f" stroke-width="2" width="145" x="750" y="155"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="11" font-weight="800" text-anchor="middle" x="822" y="183">ğŸ¯ Pain-First!</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="822" y="199">â€¢ Pain â†’ sedation cascade</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="822" y="213">â€¢ Analgosedation first</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="822" y="227">â€¢ CPOT/NRS scale use karo</text>
<rect fill="#fff0fa" height="90" rx="12" stroke="#f72585" stroke-width="2" width="215" x="30" y="280"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="11" font-weight="800" text-anchor="middle" x="138" y="308">ğŸ”‘ Non-Pharm Prevention</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="138" y="324">â€¢ Reorientation: time/place/reason</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="138" y="338">â€¢ Familiar items, glasses, hearing aids</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="138" y="352">â€¢ Family involvement zaroori!</text>
<rect fill="#fff0f0" height="90" rx="12" stroke="#e63946" stroke-width="2" width="215" x="655" y="280"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="11" font-weight="800" text-anchor="middle" x="762" y="308">âŒ Avoid in ICU!</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="762" y="324">â€¢ Benzodiazepines â€” delirium â†‘â†‘</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="762" y="338">â€¢ Physical restraints â€” worsen delir</text>
<text fill="#444" font-family="Nunito" font-size="9.5" text-anchor="middle" x="762" y="352">â€¢ Unnecessary catheters/lines</text>
</svg>
</div>
<div class="alert alert-purple">
<div class="icon">ğŸ§ </div>
<div><strong>Delirium = Preventable Hai!</strong> ABCDEF bundle daily follow karo â€” yeh ek systematic approach hai. Benzodiazepines sirf alcohol withdrawal ya seizures mein do ICU mein. Dexmedetomidine co-agitation se better hai â€” patient arousable rehta hai. Hypoactive delirium zyada common hai lekin kam detect hota hai â€” hamesha assess karte raho!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--red)">Chapter 26</div>
<h2 style="color:var(--red)">ğŸ©¸ Haematological Emergencies â€” Khoon Ki Gadbadi!</h2>
<div class="chapter-intro" style="border-color:var(--red)">
    TTP â€” thrombocytopenia + microangiopathic haemolytic anaemia + organ failure â€” plasma exchange se bachti hai jaan! HUS = E. coli ke baad bacchon mein. Neutropenic sepsis â€” ANC &lt;500 + fever = emergency! Sickle cell crisis, hyperleukocytosis â€” yeh sab ICU level emergencies hain. <strong>Haematology consult hamesha karo!</strong>
</div>
<div class="divider"></div>
<div class="cards">
<div class="card g-red">
<div class="card-icon">ğŸ”´</div>
<h4>TTP â€” Thrombotic Thrombocytopenic Purpura</h4>
<p>PLASMIC score use karo diagnosis ke liye. Plasma exchange (PEX) DAILY shuru karo â€” delay = death! Steroids add karo. Rituximab refractory cases mein. Caplacizumab naya option hai. Platelets transfuse MAT KARO â€” thrombosis aur badhta hai! ADAMTS13 activity &lt;10% confirm karta hai diagnosis.</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ¦ </div>
<h4>HUS â€” Haemolytic Uraemic Syndrome</h4>
<p>Typical: E. coli O157:H7 ke baad bacchon mein diarrhoea â†’ HUS. Avoid antibiotics (toxin release â†‘). Supportive care, dialysis agar AKI severe. Atypical HUS (aHUS): complement-mediated, any age â€” Eculizumab treatment of choice. Plasma exchange less effective in aHUS than TTP.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸŒ¡ï¸</div>
<h4>Febrile Neutropenia â€” Emergency!</h4>
<p>ANC &lt;500 cells/Î¼L + single temp â‰¥38.3Â°C ya â‰¥38Â°C Ã— 1h. Blood cultures (2 sets â€” peripheral + CVC). Pip-tazobactam ya meropenem turant â€” within 1 hour! MASCC score &gt;21 = low risk (oral antibiotics). High risk = IV broad-spectrum + antifungal consider karo agar 4-7 din mein fever nahi gayi.</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ§¬</div>
<h4>Hyperleukocytosis â€” WBC &gt;100k!</h4>
<p>Blast crisis mein WBC very high = sludging, respiratory failure, CNS manifestations. Leukapheresis consider karo agar symptomatic. IV fluids, allopurinol ya rasburicase (uric acid). Avoid blood transfusion agar possible (viscosity aur badhti hai!). Hydroxyurea rapidly lower karta hai WBC. Oncology consult STAT.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸŒ™</div>
<h4>Sickle Cell Crisis ICU</h4>
<p>Vaso-occlusive: pain crisis, acute chest syndrome (ACS). ACS = new infiltrate + fever/respiratory symptoms. Exchange transfusion for ACS. Opioid analgesia freely dena â€” undertreating pain bura hai! IV fluids, supplemental Oâ‚‚. Simple transfusion Hb target 9-10 g/dL. Hydroxyurea long-term prevention.</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ’‰</div>
<h4>Massive Transfusion Protocol (MTP)</h4>
<p>1:1:1 ratio PRBC:FFP:Platelets. Calcium dena mat bhoolo â€” citrate chelates CaÂ²âº. Tranexamic acid 1g IV early. Fibrinogen concentrate ya cryo agar fibrinogen &lt;2 g/L. Viscoelastic tests (TEG/ROTEM) targeted therapy ke liye best. Avoid hypothermia â€” warm all products!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#e63946,#9d0208)">
<th>Condition</th><th>Key Lab Finding</th><th>Specific Treatment</th>
</tr></thead>
<tbody>
<tr><td><strong>TTP</strong></td><td>Plt â†“â†“, ADAMTS13 &lt;10%, LDH â†‘</td><td>Daily Plasma Exchange + Steroids + Rituximab</td></tr>
<tr><td><strong>aHUS</strong></td><td>Complement activation, Plt â†“, AKI</td><td>Eculizumab (complement blocker)</td></tr>
<tr><td><strong>HIT</strong></td><td>Plt â†“ 5-14 days post heparin, 4T score</td><td>STOP heparin, start argatroban/fondaparinux</td></tr>
<tr><td><strong>ITP</strong></td><td>Plt â†“ isolated, BMMP negative</td><td>Steroids, IVIG, Romiplostim</td></tr>
<tr><td><strong>Neutropenic Sepsis</strong></td><td>ANC &lt;500, Fever</td><td>Broad-spectrum antibiotics within 1 hour</td></tr>
<tr><td><strong>Sickle ACS</strong></td><td>New infiltrate, Oâ‚‚ saturation â†“</td><td>Exchange transfusion, Incentive spirometry, Analgesics</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-red">
<div class="icon">ğŸ©¸</div>
<div><strong>TTP vs DIC vs HUS â€” Differentiate Karo!</strong> TTP: normal PT/APTT, low ADAMTS13. DIC: elevated PT/APTT + D-dimer + fibrinogen â†“. HUS: similar to TTP but AKI more prominent + typically post-diarrhoeal illness. TTP ka sirf 2-3% mein pentad (all 5 features) hoti hai â€” wait mat karo sab ke liye! Thrombocytopenia + MAHA = start PEX turant!
<div class="cards" style="margin-top:24px;">
<div class="card g-blue">
<div class="card-icon">ğŸ”¬</div>
<h4>HIT â€” Heparin-Induced Thrombocytopenia</h4>
<p>4T Score: Thrombocytopenia timing, Thrombocytopenia nadir, Thrombosis, oTher causes. Score â‰¥6 = high probability. STOP HEPARIN IMMEDIATELY â€” including flushes! Switch to: Argatroban (renal failure agar ho), Bivalirudin (renal failure preferred), Fondaparinux (se avoid agar severe HIT). Platelet transfusion avoid karo â€” thrombosis badhti hai! LMWH bhi cross-react karta hai â€” avoid!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ’‰</div>
<h4>ITP â€” Immune Thrombocytopenic Purpura</h4>
<p>Isolated thrombocytopenia, bone marrow megakaryocytes normal, peripheral smear â€” no schistocytes. Treatment: Plt &gt;30k + no bleeding = observe. Plt &lt;30k ya active bleeding = Prednisolone 1mg/kg/day + IVIG 1g/kg Ã— 2 days (fast response). Thrombopoietin agonists (Romiplostim, Eltrombopag) refractory mein. Rituximab chronic refractory ITP mein. Splenectomy â€” last resort.</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸŒ¡ï¸</div>
<h4>DIC â€” Disseminated Intravascular Coagulation</h4>
<p>Sepsis, trauma, malignancy, obstetric complications. Labs: PT/APTT prolonged, D-dimer elevated, fibrinogen low, schistocytes. ISTH DIC score â‰¥5 = overt DIC. Treatment: UNDERLYING CAUSE treat karo! FFP 15ml/kg agar bleeding + PT/APTT &gt;1.5Ã—. Cryoprecipitate: fibrinogen &lt;1.5 g/L. Platelet: &lt;50k with bleeding. Heparin: only thrombotic dominant DIC (purpura fulminans).</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ§¬</div>
<h4>Transfusion Reactions â€” Pehchano!</h4>
<p>TRALI (Transfusion-Related Acute Lung Injury): ARDS within 6h â€” stop transfusion, support. TACO (Transfusion-Associated Circulatory Overload): Flash pulmonary oedema â€” furosemide. Acute haemolytic: fever, back pain, haemoglobinuria â€” STOP transfusion, fluids, frusemide. Allergic: urticaria â†’ anaphylaxis â€” antihistamine, adrenaline agar severe. Febrile non-haemolytic: paracetamol, leucodepleted blood future mein.</p>
</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ TTP vs DIC vs HUS â€” Differentiate Karo Bhai!</div>
<strong>TTP</strong>: PT/APTT NORMAL, ADAMTS13 &lt;10%, microangiopathy + thrombocytopenia â†’ PEX start karo!<br/>
<strong>DIC</strong>: PT/APTT ELEVATED, D-dimer high, fibrinogen low, underlying cause (sepsis, malignancy) â†’ treat cause!<br/>
<strong>HUS</strong>: Like TTP but AKI more prominent, often post-diarrhoeal (E. coli O157), ADAMTS13 normal â†’ supportive care!<br/><br/>
Yeh differentiation life-saving hai â€” TTP mein PEX karo, DIC mein nahi. Schistocytes dono mein hoti hain â€” confusion mat karo!
</div>
<div class="alert alert-red">
<div class="icon">ğŸ©¸</div>
<div><strong>Platelet Transfusion Thresholds â€” Yaad Karo!</strong> Active major bleeding: &lt;100k â†’ transfuse. ICU â€” general: &lt;10k prophylactic transfuse karo. Pre-procedure (central line): &lt;20k. Pre-surgery: &lt;50k. Neurosurgery: &lt;100k. TTP mein: KABHI NAHI transfuse karo platelets â€” thrombosis aur bhadti hai! HIT mein: avoid unless life-threatening bleeding.</div>
</div>
</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--teal)">Chapter 27</div>
<h2 style="color:var(--teal)">ğŸ’§ Renal Replacement Therapy â€” Gurdey Ki Machine!</h2>
<div class="chapter-intro" style="border-color:var(--teal)">
    ICU mein AKI bahut common hai â€” aur jab kidney fail ho jaaye, RRT chahiye. CRRT (Continuous) ya IHD (Intermittent)? Kab start karein? Dose kitna? Anticoagulation kaise karein? Access kahan lagayein? Yeh sab questions ICU mein roz aate hain â€” inke answers yaad rakhna!
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 500" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg27">
<stop offset="0%" stop-color="#0096c7"></stop>
<stop offset="100%" stop-color="#023e8a"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#0096c7" stroke-width="3" x1="450" x2="185" y1="250" y2="85"></line>
<line opacity=".6" stroke="#0096c7" stroke-width="3" x1="450" x2="715" y1="250" y2="85"></line>
<line opacity=".6" stroke="#0096c7" stroke-width="3" x1="450" x2="65" y1="250" y2="260"></line>
<line opacity=".6" stroke="#0096c7" stroke-width="3" x1="450" x2="835" y1="250" y2="260"></line>
<line opacity=".6" stroke="#0096c7" stroke-width="3" x1="450" x2="185" y1="250" y2="415"></line>
<line opacity=".6" stroke="#0096c7" stroke-width="3" x1="450" x2="715" y1="250" y2="415"></line>
<ellipse cx="450" cy="250" fill="url(#rg27)" rx="115" ry="55"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="450" y="243">RENAL REPLACEMENT</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="262">Kidney Band Hai â€” Machine Chalao!</text>
<rect fill="#eef8ff" height="110" rx="14" stroke="#0096c7" stroke-width="2.5" width="235" x="65" y="30"></rect>
<text fill="#023e8a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="62">ğŸ”„ CRRT â€” Continuous</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="78">â€¢ Haemodynamically unstable patients</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="92">â€¢ Brain injury, ICP high</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="106">â€¢ Dose: 20-25 ml/kg/hr effluent</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="120">â€¢ Citrate anticoagulation preferred</text>
<rect fill="#eafff6" height="110" rx="14" stroke="#06d6a0" stroke-width="2.5" width="235" x="600" y="30"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="62">â±ï¸ IHD â€” Intermittent</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="78">â€¢ Haemodynamically stable patients</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="92">â€¢ Drug overdose (dialyzable toxins)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="106">â€¢ 3-4 hours sessions</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="120">â€¢ Heparin anticoagulation (systemic)</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="175" x="5" y="208"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="237">ğŸ“ Access â€” Kahan?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="253">â€¢ Right IJV = preferred (1st choice)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="267">â€¢ Femoral = infection risk high</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="281">â€¢ Subclavian â€” avoid (stenosis)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="295">â€¢ 13.5 French dual-lumen catheter</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="175" x="720" y="208"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="808" y="237">ğŸ’Š Anticoagulation RRT</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="253">â€¢ Citrate CRRT: preferred â€” regional</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="267">â€¢ Heparin: systemic, monitor APTT</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="281">â€¢ No anticoag: high bleed risk mein</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="295">â€¢ Citrate toxicity: CaÂ²âº check karo!</text>
<rect fill="#fff0f0" height="100" rx="14" stroke="#e63946" stroke-width="2.5" width="235" x="65" y="365"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="394">ğŸš¨ RRT Kab Start Karein?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="410">â€¢ AKIN/KDIGO stage 3</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="424">â€¢ Fluid overload refractory (&gt;10%)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="438">â€¢ Kâº &gt;6.5 ya rising despite treatment</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="452">â€¢ Metabolic acidosis pH &lt;7.15</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="235" x="600" y="365"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="394">ğŸ”¬ RRT Weaning</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="410">â€¢ Urine output badhna = kidney recovery</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="424">â€¢ Creatinine stabilizing/falling</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="438">â€¢ UO &gt;1000 ml/24h off RRT = wean</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="452">â€¢ Recovery may take weeks to months</text>
</svg>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#0096c7,#023e8a)">
<th>Parameter</th><th>CRRT</th><th>IHD</th>
</tr></thead>
<tbody>
<tr><td><strong>Haemodynamics</strong></td><td>Unstable patients tolerate better</td><td>Stable patients ke liye</td></tr>
<tr><td><strong>Solute clearance</strong></td><td>Middle molecules bhi clear hoti hain</td><td>Small molecules main target</td></tr>
<tr><td><strong>Fluid removal</strong></td><td>Slow aur controlled â€” better for brain</td><td>Rapid â€” haemodynamic stress</td></tr>
<tr><td><strong>Anticoagulation</strong></td><td>Citrate preferred (regional)</td><td>Heparin (systemic)</td></tr>
<tr><td><strong>Drug dosing</strong></td><td>Continuous removal â€” dose adjust karo</td><td>Post-dialysis dosing ka dhyan rakho</td></tr>
<tr><td><strong>Cost</strong></td><td>More expensive</td><td>Less expensive</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-blue">
<div class="icon">ğŸ’§</div>
<div><strong>AKIKI Trial â€” Early vs Standard RRT:</strong> Early RRT start karne se outcomes improve nahi hue â€” spontaneous recovery ka chance dono groups mein same tha. STARRT-AKI trial bhi same conclusion! Isliye wait for definitive indications: refractory fluid overload, K+ crisis, severe acidosis, uraemic complications. But jab indication aaye â€” delay mat karo!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--green)">Chapter 28</div>
<h2 style="color:var(--green)">ğŸ”¬ POCUS in Critical Care â€” Ultrasound ICU Ka Stetho Hai!</h2>
<div class="chapter-intro" style="border-color:var(--green)">
    Point-Of-Care UltraSound (POCUS) ab ICU ka standard of care ban gaya hai! Lung, Heart, FAST, DVT â€” sab kuch bedside pe dekh sakte ho bina patient ko hilaye. <strong>"Stethoscope replace nahi karta POCUS â€” POCUS stethoscope ko upgrade karta hai!"</strong> Real-time information â†’ better decisions â†’ better outcomes!
  </div>
<div class="divider"></div>
<div class="cards">
<div class="card g-green">
<div class="card-icon">ğŸ«</div>
<h4>Lung USS â€” Kya Dekho?</h4>
<p>A-lines: normal air-filled lung = sliding present. B-lines (â‰¥3/view): pulmonary oedema ya pneumonitis. Absent lung sliding: pneumothorax? (confirm with lung point). Consolidation: hepatization of lung â€” pneumonia ya atelectasis. Effusion: anechoic space. BLUE protocol acute dyspnoea mein use karo!</p>
</div>
<div class="card g-teal">
<div class="card-icon">â¤ï¸</div>
<h4>Cardiac ECHO â€” FATE Protocol</h4>
<p>Focus Assessed TransThoracic Echo. 4 views: subcostal, PLAX, PSAX, apical 4-chamber. Assess: LV function (qualitative), RV size, pericardial effusion, IVC collapsibility. IVC &lt;2cm + collapsing &gt;50% = fluid responsive. Tamponade: diastolic RV collapse. RUSH protocol shock mein use karo!</p>
</div>
<div class="card g-blue">
<div class="card-icon">ğŸ©º</div>
<h4>FAST Exam â€” Trauma</h4>
<p>Focused Assessment with Sonography in Trauma. 4 windows: RUQ (Morrison's pouch), LUQ (splenorenal recess), Pelvic (bladder), Pericardial. Free fluid = echogenic material ko track karo. E-FAST: bilateral lung scanning bhi add karo for pneumothorax. â‰¥200ml fluid detect ho sakta hai.</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ¦µ</div>
<h4>DVT Assessment â€” Compressibility</h4>
<p>Non-compressibility of vein = DVT! Proximal leg (common femoral â†’ popliteal): compress karo probe se. Normal: vein completely collapses. DVT: thrombus dikhta hai ya vein compress nahi hoti. 2-point compression: CFV aur popliteal vein. Sensitivity 95% for proximal DVT â€” good for ICU!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ’‰</div>
<h4>Guided Procedures â€” USS Se!</h4>
<p>CVC insertion: IJV aur subclavian real-time guidance se â€” complication â†“â†“. Arterial line: radial artery USS guided. Thoracocentesis: USS mark ya real-time. Paracentesis: real-time guidance. Lumbar puncture: USS for difficult patients. PICC insertion bhi. USS-guided procedures = safest procedures!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ”</div>
<h4>RUSH Protocol â€” Shock Mein!</h4>
<p>Rapid Ultrasound in Shock: Pump (cardiac) + Tank (IVC/volume) + Pipes (aorta, IVC). Pump: LV/RV function, tamponade. Tank: IVC, bilateral pleural/peritoneal. Pipes: aortic dissection/aneurysm. Yeh sab 5 minutes mein ho sakta hai â€” shock ka cause identify karo bedside pe!</p>
</div>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#0096c7)">
<th>USS Finding</th><th>Matlab Kya Hai?</th><th>Action</th>
</tr></thead>
<tbody>
<tr><td><strong>B-lines bilateral diffuse</strong></td><td>Pulmonary oedema (cardiogenic)</td><td>Diuresis, CPAP, treat underlying cause</td></tr>
<tr><td><strong>B-lines unilateral</strong></td><td>Pneumonia ya contusion</td><td>Antibiotics + chest physiotherapy</td></tr>
<tr><td><strong>Absent lung sliding</strong></td><td>Possible pneumothorax</td><td>Confirm lung point, chest drain agar symptomatic</td></tr>
<tr><td><strong>IVC &lt;2cm, collapsing</strong></td><td>Fluid responsive</td><td>Fluid bolus do</td></tr>
<tr><td><strong>IVC &gt;2.5cm, fixed</strong></td><td>Fluid overloaded ya RHF</td><td>Avoid fluid, assess cardiac function</td></tr>
<tr><td><strong>RV dilation + D-sign</strong></td><td>Acute cor pulmonale (PE?)</td><td>CT-PA, thrombolysis if massive PE</td></tr>
</tbody>
</table>
</div>
<div class="alert alert-green">
<div class="icon">ğŸ”¬</div>
<div><strong>POCUS Learn Karna Kyun Zaroori Hai?</strong> Bedside, real-time, no radiation, repeatable, dynamic assessment. Shock management, dyspnoea workup, procedure guidance, daily monitoring â€” sab mein POCUS help karta hai. Critical care ultrasound course karo aur practice karo â€” skill aata hai sirf practice se! "See one, do one, teach one" â€” but ultrasound mein "see many, do many" zyada safer hai.
<div class="tbl-wrap" style="margin-top:24px;">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#023e8a)">
<th>POCUS Application</th><th>Views / Windows</th><th>What to Look For</th><th>Clinical Use</th>
</tr></thead>
<tbody>
<tr><td><strong>Lung USS</strong></td><td>6-8 zones bilateral</td><td>A-lines, B-lines, consolidation, effusion, absent sliding</td><td>BLUE protocol: dyspnoea workup in 5 min</td></tr>
<tr><td><strong>Cardiac (FATE)</strong></td><td>Subcostal, PLAX, PSAX, Apical 4C</td><td>LVEF, RV size, effusion, IVC collapsibility</td><td>Shock differentiation: RUSH protocol</td></tr>
<tr><td><strong>FAST Exam</strong></td><td>RUQ, LUQ, Pelvis, Pericardial</td><td>Free fluid (anechoic), haemopericardium</td><td>Trauma: haemoperitoneum detect karo</td></tr>
<tr><td><strong>DVT Assessment</strong></td><td>CFV, SFV, Popliteal</td><td>Non-compressibility = thrombosis</td><td>PE workup, VTE diagnosis</td></tr>
<tr><td><strong>IVC Assessment</strong></td><td>Subcostal long axis</td><td>Diameter + collapsibility index</td><td>Fluid responsiveness: &lt;2cm collapsing &gt;50% = responsive</td></tr>
<tr><td><strong>Guided Procedures</strong></td><td>Real-time or mark</td><td>Target structure visualize karo</td><td>CVC, art line, thoracentesis, paracentesis</td></tr>
</tbody>
</table>
</div>
<div class="cards" style="margin-top:0">
<div class="card g-green">
<div class="card-icon">ğŸ«</div>
<h4>BLUE Protocol â€” Dyspnoea in 5 Minutes!</h4>
<p>A-lines bilateral + normal sliding = normal lungs OR PE (check IVC + DVT). B-lines bilateral (â‰¥3) = pulmonary oedema (left heart failure) OR ARDS/pneumonitis. Unilateral B-lines = pneumonia. Absent lung sliding unilaterally = pneumothorax (confirm with lung point sign). Consolidation = pneumonia ya atelectasis. BLUE protocol accuracy &gt;90% for dyspnoea cause!</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ”´</div>
<h4>RUSH Protocol â€” Shock Workup!</h4>
<p>"HI-MAP": Heart (FATE) â†’ IVC (preload) â†’ Morrison's pouch (free fluid) â†’ Aorta (AAA) â†’ Pneumothorax. Hypo shock: flat IVC + small heart â†’ fluid. Distributive: hyperdynamic LV + collapsing IVC â†’ vasopressor. Cardiogenic: poor LV + dilated IVC â†’ inotrope. Obstructive: RV dilatation (PE) ya tamponade â†’ decompress. RUSH = diagnosis in 5 minutes!</p>
</div>
<div class="card g-teal">
<div class="card-icon">â¤ï¸</div>
<h4>Cardiac POCUS â€” What Matters</h4>
<p>LV Function qualitative: Normal (&gt;55%), Mildly reduced (40-55%), Moderately reduced (30-40%), Severely reduced (&lt;30%) â€” eyeballing. RV:LV ratio &gt;1 = RV strain (PE, PHTN, RV MI). Pericardial effusion: &gt;1cm significant. Tamponade: diastolic RV collapse + IVC plethora + haemodynamic compromise. TAPSE &lt;17mm = RV dysfunction. 3 minute sono = enough for decisions!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ’‰</div>
<h4>US-Guided CVC â€” Standard of Care!</h4>
<p>USS guidance reduces: pneumothorax (RR 0.32), arterial puncture (RR 0.22), failures (RR 0.14). IJV approach: visualize under needle, confirm wire in vein. Static marking vs real-time: real-time better. Confirm: cannula in vein before dilating! Short axis (cross-section) vs long axis (in-plane) â€” practise both. NICE guidelines: USS mandatory for IJV CVC. Skill pe invest karo!</p>
</div>
</div>
<div class="tip-box">
<div class="t-head">ğŸ’¡ POCUS Learning â€” Kaise Seekho!</div>
Start karo basics se: Normal anatomy + 5 pathological patterns. Learn FATE (cardiac) + BLUE (lung) protocols first â€” yeh sab se zyada use hote hain ICU mein.<br/><br/>
Certification: EDEC (European), FICE (UK), WINFOCUS Basic Critical Care USS. Training: 30 supervised scans cardiac + 20 lung = basic competence. Each day ICU mein: apne patients pe scan karo aur clinical findings se compare karo â€” yahi asli learning hai!
</div>
</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--blue)">Chapter 29</div>
<h2 style="color:var(--blue)">ğŸ¥ Surgical Critical Care â€” Operation Ke Baad Ka Drama!</h2>
<div class="chapter-intro" style="border-color:var(--blue)">
    Post-op patient ICU mein jaata hai â€” aur wahan naye complications shuru hote hain! Anastomotic leak, intra-abdominal abscess, abdominal compartment syndrome, fistula, wound dehiscence â€” yeh sab surgical ICU ki daily life hai. Surgeon aur intensivist ka coordination bahut zaroori hai. <strong>"When in doubt, take them back to theatre!"</strong>
</div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 500" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg29">
<stop offset="0%" stop-color="#4361ee"></stop>
<stop offset="100%" stop-color="#3a0ca3"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#4361ee" stroke-width="3" x1="450" x2="185" y1="250" y2="85"></line>
<line opacity=".6" stroke="#4361ee" stroke-width="3" x1="450" x2="715" y1="250" y2="85"></line>
<line opacity=".6" stroke="#4361ee" stroke-width="3" x1="450" x2="65" y1="250" y2="260"></line>
<line opacity=".6" stroke="#4361ee" stroke-width="3" x1="450" x2="835" y1="250" y2="260"></line>
<line opacity=".6" stroke="#4361ee" stroke-width="3" x1="450" x2="185" y1="250" y2="415"></line>
<line opacity=".6" stroke="#4361ee" stroke-width="3" x1="450" x2="715" y1="250" y2="415"></line>
<ellipse cx="450" cy="250" fill="url(#rg29)" rx="115" ry="55"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="450" y="243">SURGICAL ICU</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="263">Post-Op Complications â€” Pehchano!</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="235" x="65" y="30"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="63">ğŸ’§ Anastomotic Leak</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="79">â€¢ Day 3-7 post-op fever + deterioration</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="93">â€¢ Drain amylase high (bowel leak)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="107">â€¢ CT abdomen with contrast confirm</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="121">â€¢ Percutaneous drain ya re-operation</text>
<rect fill="#fff0f0" height="110" rx="14" stroke="#e63946" stroke-width="2.5" width="235" x="600" y="30"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="63">ğŸ«ƒ Abdominal Compartment Syndrome</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="79">â€¢ IAP &gt;12 mmHg = intra-abdominal HT</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="93">â€¢ ACS = IAP &gt;20 + new organ failure</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="107">â€¢ Bladder pressure surrogate IAP</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="121">â€¢ Decompressive laparotomy = definitive</text>
<rect fill="#eafff6" height="100" rx="14" stroke="#06d6a0" stroke-width="2.5" width="175" x="5" y="208"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="93" y="237">ğŸ•³ï¸ Enteric Fistula</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="253">â€¢ Bowel output from wound/drain</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="267">â€¢ High output &gt;500 ml/day = manage</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="281">â€¢ Octreotide reduce karta hai output</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="93" y="295">â€¢ TPN agar EN possible nahi</text>
<rect fill="#fffbea" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="175" x="720" y="208"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="808" y="237">ğŸ©º Post-Op Fever â€” Causes</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="253">â€¢ Day 1-2: Wind (atelectasis)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="267">â€¢ Day 3-5: Water (UTI), Wound</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="281">â€¢ Day 5-7: Walk (DVT/PE)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="808" y="295">â€¢ Day 5+: Wonder drugs (drug fever)</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f4a261" stroke-width="2.5" width="235" x="65" y="365"></rect>
<text fill="#7a3000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="393">ğŸ“ˆ Enhanced Recovery (ERAS)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="409">â€¢ Pre-op carbohydrate loading</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="423">â€¢ Minimal opioids â€” regional analgesia</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="437">â€¢ Early oral feeding + mobilization</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="451">â€¢ Goal-directed fluid therapy</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="235" x="600" y="365"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="393">ğŸ”ª Re-Laparotomy â€” Kab?</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="409">â€¢ Peritoneal signs + sepsis = go back!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="423">â€¢ CT-proven collection/leak</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="437">â€¢ Deteriorating despite antibiotics</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="451">â€¢ Planned re-look open abdomen</text>
</svg>
</div>
<div class="cards">
<div class="card g-blue">
<div class="card-icon">ğŸ©º</div>
<h4>Post-Op Respiratory Failure â€” Why?</h4>
<p>Upper abdominal surgery ke baad: diaphragm dysfunction, pain se splinting, atelectasis. Lung expansion encourage karo â€” incentive spirometry, physiotherapy, epidural analgesia. CPAP/BiPAP early agar deteriorating. NIV post-extubation reduces re-intubation rate! Position upright rakho hamesha.</p>
</div>
<div class="card g-red">
<div class="card-icon">ğŸ’Š</div>
<h4>Post-Op Analgesia â€” Multimodal!</h4>
<p>Opioid-sparing approach: paracetamol + NSAIDs (agar no contraindication) + regional techniques (epidural, wound catheter, TAP block, erector spinae block). PCA opioid agar others fail. Gabapentinoids reduce opioid requirements. Opioid dependence risk real hai â€” minimize karo exposure!</p>
</div>
<div class="card g-orange">
<div class="card-icon">ğŸ«ƒ</div>
<h4>Open Abdomen Management</h4>
<p>Temporary closure with BogotÃ¡ bag ya negative pressure wound therapy (ABThera). Daily irrigation + inspection. Close when: source controlled, oedema resolved, haemodynamically stable. Fascia close karo primary â€” delayed primary closure better than skin grafting. Enteroatmospheric fistula ka risk â€” protect bowel always!</p>
</div>
<div class="card g-green">
<div class="card-icon">ğŸ”¬</div>
<h4>Pancreatic Surgery ICU</h4>
<p>Pancreaticoduodenectomy (Whipple) ke baad: delayed gastric emptying (DGE) common. Pancreatic fistula: drain amylase &gt;3Ã— serum amylase on day 3. Grade A-C classification. Octreotide helps prevention. Post-pancreatectomy haemorrhage = surgical emergency â€” back to theatre immediately!</p>
</div>
<div class="card g-purple">
<div class="card-icon">ğŸ’‰</div>
<h4>VTE Prophylaxis Post-Surgery</h4>
<p>LMWH start karo 12-24h post-op (lower risk) ya 48h (high bleeding risk). Mechanical compression hamesha. High-risk: extended prophylaxis 28-35 days (colorectal cancer, ortho major surgery). Spinal/epidural catheter ke saath: timing crucial â€” 12h before/after LMWH dose for catheter removal.</p>
</div>
<div class="card g-teal">
<div class="card-icon">ğŸ§ª</div>
<h4>Post-Transplant ICU</h4>
<p>Immunosuppression: tacrolimus, mycophenolate, steroids. CMV prophylaxis (ganciclovir/valganciclovir). Rejection signs: organ dysfunction + biopsy. Drug levels monitor closely â€” tacrolimus narrow therapeutic window. Fungal infections common â€” fluconazole prophylaxis. Avoid nephrotoxic drugs with calcineurin inhibitors!</p>
</div>
</div>
<div class="alert alert-blue">
<div class="icon">ğŸ¥</div>
<div><strong>Surgical ICU Ka Golden Principle:</strong> "Source Control" â€” infection ke source ko surgical ya percutaneous method se control karo bina deri ke. Antibiotics infection treat nahi kar sakte agar undrained abscess ya anastomotic leak hai. Intensivist + Surgeon = team approach. CT abdomen liberal use karo diagnostically â€” doubt pe scan, scan pe act!</div>
</div>
</div>`,
`<div class="chapter">
<div class="chapter-label" style="color:var(--green)">Chapter 30</div>
<h2 style="color:var(--green)">ğŸ“Š ICU Scoring &amp; Prognostication â€” Numbers Se Kya Pata Chalta Hai!</h2>
<div class="chapter-intro" style="border-color:var(--green)">
    APACHE, SOFA, SAPS, APACHE II â€” yeh sab scores kyun hain? Research, quality improvement, resource allocation â€” aur families ko realistic expectations dena! Lekin yaad rakhna: <strong>koi bhi score individual patient ko predict nahi karta perfectly.</strong> Score tool hai, oracle nahi! Clinical judgement hamesha first.
  </div>
<div class="divider"></div>
<div class="mindmap-wrap">
<svg style="max-width:900px" viewbox="0 0 900 490" width="100%">
<defs>
<radialgradient cx="50%" cy="50%" id="rg30">
<stop offset="0%" stop-color="#06d6a0"></stop>
<stop offset="100%" stop-color="#0096c7"></stop>
</radialgradient>
</defs>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="185" y1="245" y2="80"></line>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="715" y1="245" y2="80"></line>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="65" y1="245" y2="255"></line>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="835" y1="245" y2="255"></line>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="185" y1="245" y2="410"></line>
<line opacity=".6" stroke="#06d6a0" stroke-width="3" x1="450" x2="715" y1="245" y2="410"></line>
<ellipse cx="450" cy="245" fill="url(#rg30)" rx="115" ry="55"></ellipse>
<text fill="#fff" font-family="Nunito" font-size="14" font-weight="800" text-anchor="middle" x="450" y="237">ICU SCORING</text>
<text fill="rgba(255,255,255,.85)" font-family="Nunito" font-size="10" text-anchor="middle" x="450" y="258">Numbers â€” Research + Quality Tool!</text>
<rect fill="#eafff6" height="110" rx="14" stroke="#06d6a0" stroke-width="2.5" width="235" x="65" y="25"></rect>
<text fill="#004d30" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="57">ğŸ“Š APACHE II â€” ICU Classic!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="73">â€¢ Acute Physiology + Age + Chronic</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="87">â€¢ 12 physiological variables (worst 24h)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="101">â€¢ Score &gt;25 = high mortality risk</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="115">â€¢ Most widely used research tool</text>
<rect fill="#eef3ff" height="110" rx="14" stroke="#4361ee" stroke-width="2.5" width="235" x="600" y="25"></rect>
<text fill="#1a0080" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="57">ğŸ¥ SOFA Score â€” Organ Failure!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="73">â€¢ 6 organ systems (0-4 each)</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="87">â€¢ Respiratory, Coagulation, Liver</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="101">â€¢ Cardiovascular, CNS, Renal</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="115">â€¢ Sepsis-3 definition mein used!</text>
<rect fill="#fff5e6" height="100" rx="14" stroke="#f9c74f" stroke-width="2.5" width="170" x="5" y="203"></rect>
<text fill="#7a5000" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="90" y="232">âš¡ qSOFA â€” Bedside!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="248">â€¢ RR â‰¥22, AMS, SBP â‰¤100</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="262">â€¢ â‰¥2 = sepsis suspect</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="276">â€¢ No labs needed!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="90" y="290">â€¢ Best for outside ICU</text>
<rect fill="#fff0fa" height="100" rx="14" stroke="#f72585" stroke-width="2.5" width="170" x="725" y="203"></rect>
<text fill="#8a003a" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="810" y="232">ğŸ“ˆ SAPS II</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="248">â€¢ Simplified Acute Physiology</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="262">â€¢ 17 variables, age-adjusted</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="276">â€¢ Predicts hospital mortality</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="810" y="290">â€¢ European ICUs mein popular</text>
<rect fill="#f5eeff" height="100" rx="14" stroke="#7209b7" stroke-width="2.5" width="235" x="65" y="360"></rect>
<text fill="#3a0ca3" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="183" y="388">ğŸ©º Disease-Specific Scores</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="404">â€¢ CURB-65: pneumonia severity</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="418">â€¢ Child-Pugh / MELD: liver disease</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="432">â€¢ TISS-28: nursing workload</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="183" y="446">â€¢ Ranson's: pancreatitis severity</text>
<rect fill="#fff0f0" height="100" rx="14" stroke="#e63946" stroke-width="2.5" width="235" x="600" y="360"></rect>
<text fill="#c1121f" font-family="Nunito" font-size="12" font-weight="800" text-anchor="middle" x="718" y="388">âš ï¸ Scoring Limitations</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="404">â€¢ Population data, not individual!</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="418">â€¢ Context matters â€” comorbidities</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="432">â€¢ High score â‰  treatment withdraw</text>
<text fill="#444" font-family="Nunito" font-size="10" text-anchor="middle" x="718" y="446">â€¢ Treat the patient, not the number!</text>
</svg>
</div>
<div class="tbl-wrap">
<table>
<thead><tr style="background:linear-gradient(90deg,#06d6a0,#0096c7)">
<th>Score</th><th>Variables</th><th>Best Use</th>
</tr></thead>
<tbody>
<tr><td><strong>APACHE II</strong></td><td>12 physio vars + age + chronic health</td><td>ICU admission severity; research benchmarking</td></tr>
<tr><td><strong>SOFA</strong></td><td>6 organ systems, 0-4 each (max 24)</td><td>Sepsis definition; daily organ failure tracking; trend monitoring</td></tr>
<tr><td><strong>qSOFA</strong></td><td>RR, GCS, SBP â€” 3 variables only</td><td>Rapid bedside screening for sepsis outside ICU</td></tr>
<tr><td><strong>SAPS II</strong></td><td>17 variables including diagnoses</td><td>Hospital mortality prediction; European ICU data</td></tr>
<tr><td><strong>GCS</strong></td><td>Eye, verbal, motor (3-15)</td><td>Neurological status â€” serial assessments; intubation decision (GCS â‰¤8)</td></tr>
<tr><td><strong>MELD Score</strong></td><td>INR, Bilirubin, Creatinine, Na</td><td>Liver disease severity; transplant listing priority</td></tr>
</tbody>
</table>
</div>
<div class="tip-box">
<div class="t-head">ğŸ“Š Scoring Ka Sahi Istemal â€” Yeh Jaanna Zaroori Hai!</div>
<p>Scores are descriptive, not prescriptive. Yeh batate hain ki kitne sick hain â€” nahi batate ki kya karna chahiye. Daily SOFA trend zyada important hai single value se. Improving SOFA = good prognosis. Worsening despite treatment = poor. But always treat individual â€” outliers hamesha hote hain! "Numbers guide, clinicians decide."</p>
</div>
<div class="alert alert-green">
<div class="icon">ğŸ“ˆ</div>
<div><strong>SOFA Score â€” ICU Mein Daily Use Karo!</strong> SOFA score &gt;2 (organ dysfunction) + suspected infection = Sepsis definition (Sepsis-3). Lactate &gt;2 mmol/L + SOFA â‰¥2 + vasopressor required = Septic Shock. Daily SOFA tracking se patient trajectory samajhta hai â€” haemodynamics improve ho rahe hain ya deteriorate? Yeh conversations families ke saath bhi easy hoti hain numbers se.</div>
</div>
</div>`];

const CHAPTER_TITLES = [['ğŸ«', 'Airway â€” Saans Ki Nali Ko Sambhalo!', 1], ['ğŸ”§', 'Mechanical Ventilation â€” Machine Se Saans!', 1], ['ğŸ’”', 'Shock â€” Jab BP Gir Jaaye!', 1], ['ğŸ¦ ', 'Sepsis â€” Infection Ka Toofan!', 1], ['ğŸ«', 'ARDS â€” Phaephde Ka Crisis!', 1], ['ğŸ«˜', 'AKI â€” Gurde Ka Achanak Dhoka!', 1], ['ğŸ’¤', 'Dard Aur Neend â€” Sedation, Analgesia, Delirium', 1], ['â¤ï¸', 'Dil Ki Emergency â€” Cardiac Emergencies in ICU', 1], ['ğŸ§ ', 'Dimag Ki Emergency â€” Neurological Emergencies!', 1], ['ğŸ¥—', 'ICU Mein Khaana Peena â€” Nutrition!', 1], ['ğŸ©¸', 'GI Bleeding â€” ICU Mein Manage Karo!', 2], ['ğŸ”´', 'DIC â€” Disseminated Intravascular Coagulation!', 2], ['ğŸ’‰', 'ICU Infections & Antibiotics â€” Antimicrobial Stewardship!', 2], ['ğŸ«€', 'Acute Liver Failure â€” Khatarnak Hai!', 2], ['ğŸ«', 'Pulmonary Embolism â€” Massive PE Bachao!', 2], ['â˜ ï¸', 'Toxicology & Poisoning â€” ICU Mein!', 2], ['ğŸš‘', 'Trauma ICU â€” Maut Se Ladte Hain!', 2], ['ğŸŒ¬ï¸', 'Ventilator Weaning â€” Kab Nikaalo?', 2], ['âš™ï¸', 'ECMO â€” Jab Sab Fail Ho Jaaye!', 2], ['ğŸ™', 'End of Life Care in ICU â€” Izzat Se Jaana!', 2], ['ğŸ©º', 'Endocrine Emergencies â€” Hormones Pagal Ho Gaye!', 3], ['ğŸ”¥', 'Burns ICU â€” Aag Ka Ilaj!', 3], ['ğŸ¤°', 'Obstetric Critical Care â€” Do Zindagiyaan Bachao!', 3], ['â¤ï¸', 'Cardiac Arrest & Post-Resuscitation Care â€” ROSC Ke Baad!', 3], ['ğŸ§ ', 'ICU Delirium & PICS â€” Dimaag Ka ICU!', 3], ['ğŸ©¸', 'Haematological Emergencies â€” Khoon Ki Gadbadi!', 3], ['ğŸ’§', 'Renal Replacement Therapy â€” Gurdey Ki Machine!', 3], ['ğŸ”¬', 'POCUS in Critical Care â€” Ultrasound ICU Ka Stetho Hai!', 3], ['ğŸ¥', 'Surgical Critical Care â€” Operation Ke Baad Ka Drama!', 3], ['ğŸ“Š', 'ICU Scoring & Prognostication â€” Numbers Se Kya Pata Chalta Hai!', 3]];

let currentChapter = 0;
let isUnlocked = false;

// Check sessionStorage for unlock status (works with file:// protocol)
function checkUnlock() {
  try {
    const code = sessionStorage.getItem('icu_access_code');
    if (code && ['DRVARUN2025','ICU499','VARUN_FULL'].includes(code)) {
      isUnlocked = true;
    }
  } catch(e) {}
}
checkUnlock();

// â”€â”€ ORIGINAL BOOK CSS injected into modal â”€â”€
const BOOK_CSS = `
  @import url('https://fonts.googleapis.com/css2?family=Nunito:wght@300;400;600;700;800;900&family=Playfair+Display:ital,wght@0,700;1,600&display=swap');

  :root {
    --red:    #e63946;
    --orange: #f4a261;
    --yellow: #f9c74f;
    --green:  #06d6a0;
    --teal:   #0096c7;
    --blue:   #4361ee;
    --purple: #7209b7;
    --pink:   #f72585;
    --dark:   #1a1a2e;
    --light:  #f8f9ff;
  }

  * { box-sizing: border-box; margin: 0; padding: 0; }
  body { font-family: 'Nunito', sans-serif; background: var(--light); color: var(--dark); }

  /* â”€â”€ WATERMARK â”€â”€ */
  .watermark-fixed {
    position: fixed;
    top: 0; left: 0;
    width: 100vw; height: 100vh;
    pointer-events: none;
    z-index: 9999;
    overflow: hidden;
  }
  .watermark-fixed::before,
  .watermark-fixed::after {
    content: 'DR VARUN KUMAR';
    position: absolute;
    font-family: 'Nunito', sans-serif;
    font-size: 42px;
    font-weight: 900;
    color: rgba(114, 9, 183, 0.07);
    letter-spacing: 4px;
    white-space: nowrap;
    transform: rotate(-38deg);
    transform-origin: center;
    left: 50%;
    top: 50%;
  }
  .watermark-fixed::before {
    transform: translate(-50%, -130%) rotate(-38deg);
  }
  .watermark-fixed::after {
    transform: translate(-50%, 30%) rotate(-38deg);
  }
  /* Watermark repeat pattern via pseudo on body */
  body::before {
    content: '';
    position: fixed;
    inset: 0;
    z-index: 9997;
    pointer-events: none;
    background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='480' height='220'%3E%3Ctext x='50%25' y='50%25' text-anchor='middle' dominant-baseline='middle' transform='rotate(-38 240 110)' font-family='Arial' font-size='24' font-weight='900' fill='rgba(114%2C9%2C183%2C0.05)' letter-spacing='4'%3EDR VARUN KUMAR%3C/text%3E%3C/svg%3E");
    background-repeat: repeat;
  }
  /* Watermark tile for print / scroll */
  .watermark-tile {
    position: fixed;
    top: 0; left: 0;
    width: 100vw; height: 100vh;
    pointer-events: none;
    z-index: 9998;
  }

  /* â”€â”€ COVER â”€â”€ */
  .cover {
    height: 100vh; min-height: 700px;
    background: linear-gradient(135deg, #0f0c29, #302b63, #24243e);
    display: flex; flex-direction: column; align-items: center; justify-content: center;
    text-align: center; padding: 40px; position: relative; overflow: hidden;
  }
  .cover::before {
    content: ''; position: absolute; inset: 0;
    background: radial-gradient(ellipse at 30% 70%, rgba(114,9,183,.4) 0%, transparent 60%),
                radial-gradient(ellipse at 70% 30%, rgba(67,97,238,.4) 0%, transparent 60%);
  }
  .cover-badge {
    background: linear-gradient(90deg, var(--pink), var(--orange));
    color: #fff; border-radius: 30px; padding: 6px 22px;
    font-size: 13px; letter-spacing: 2px; text-transform: uppercase; font-weight: 700;
    margin-bottom: 24px; position: relative;
  }
  .cover h1 {
    font-family: 'Playfair Display', serif; font-size: clamp(2.2rem, 6vw, 4.5rem);
    color: #fff; line-height: 1.15; position: relative; margin-bottom: 16px;
    text-shadow: 0 4px 30px rgba(247,37,133,.5);
  }
  .cover h1 span { color: var(--yellow); }
  .cover-sub {
    font-size: clamp(.95rem, 2.5vw, 1.3rem); color: rgba(255,255,255,.75);
    max-width: 680px; line-height: 1.7; position: relative; margin-bottom: 40px;
  }
  .cover-author {
    position: relative; border-top: 1px solid rgba(255,255,255,.2);
    padding-top: 24px; color: #fff;
  }
  .cover-author .name {
    font-size: 1.3rem; font-weight: 800; letter-spacing: 1px;
    background: linear-gradient(90deg, var(--green), var(--teal));
    -webkit-background-clip: text; -webkit-text-fill-color: transparent;
  }
  .cover-author .cred { font-size: .95rem; color: rgba(255,255,255,.6); margin-top: 4px; }
  .bubble {
    position: absolute; border-radius: 50%; opacity: .15;
    animation: float 8s ease-in-out infinite;
  }
  @keyframes float {
    0%,100% { transform: translateY(0) rotate(0deg); }
    50% { transform: translateY(-30px) rotate(180deg); }
  }

  /* â”€â”€ CHAPTER â”€â”€ */
  .chapter {
    padding: 60px 40px 40px;
    max-width: 1100px; margin: 0 auto;
  }
  .chapter-label {
    font-size: .8rem; letter-spacing: 3px; text-transform: uppercase;
    font-weight: 700; margin-bottom: 8px;
  }
  .chapter h2 {
    font-family: 'Playfair Display', serif;
    font-size: clamp(1.8rem, 4vw, 2.8rem); line-height: 1.2; margin-bottom: 16px;
  }
  .chapter-intro {
    font-size: 1.05rem; line-height: 1.9; color: #444;
    max-width: 760px; margin-bottom: 40px;
    border-left: 5px solid; padding-left: 18px;
  }

  /* â”€â”€ MIND MAP â”€â”€ */
  .mindmap-wrap {
    background: #fff; border-radius: 24px;
    box-shadow: 0 8px 40px rgba(0,0,0,.1);
    padding: 24px; margin-bottom: 48px; overflow-x: auto;
  }
  .mindmap-wrap svg { display: block; margin: 0 auto; }

  /* â”€â”€ CARDS â”€â”€ */
  .cards {
    display: grid; grid-template-columns: repeat(auto-fill, minmax(250px, 1fr));
    gap: 20px; margin-bottom: 48px;
  }
  .card {
    border-radius: 18px; padding: 22px 20px;
    color: #fff; position: relative; overflow: hidden;
  }
  .card::after {
    content: ''; position: absolute; bottom: -20px; right: -20px;
    width: 100px; height: 100px; border-radius: 50%;
    background: rgba(255,255,255,.12);
  }
  .card h4 { font-size: 1rem; font-weight: 800; margin-bottom: 8px; }
  .card p  { font-size: .87rem; line-height: 1.65; opacity: .92; }
  .card-icon { font-size: 1.8rem; margin-bottom: 10px; }

  /* â”€â”€ TABLE â”€â”€ */
  .tbl-wrap { overflow-x: auto; margin-bottom: 48px; }
  table { width: 100%; border-collapse: collapse; font-size: .92rem; }
  th { padding: 12px 16px; color: #fff; text-align: left; }
  td { padding: 11px 16px; border-bottom: 1px solid #eee; vertical-align: top; }
  tr:nth-child(even) td { background: #fafafa; }
  tr:hover td { background: #f0f4ff; }

  /* â”€â”€ DIVIDER â”€â”€ */
  .divider {
    height: 6px; border-radius: 3px; margin: 0 0 48px;
    background: linear-gradient(90deg, var(--pink), var(--blue), var(--green));
  }

  /* â”€â”€ ALERT â”€â”€ */
  .alert {
    border-radius: 14px; padding: 18px 22px; margin-bottom: 30px;
    display: flex; gap: 14px; align-items: flex-start;
    font-size: .95rem; line-height: 1.75;
  }
  .alert .icon { font-size: 1.5rem; flex-shrink: 0; }
  .alert-red    { background: #fff0f0; border-left: 5px solid var(--red);    color: #7a0000; }
  .alert-yellow { background: #fffbea; border-left: 5px solid var(--yellow); color: #5a4000; }
  .alert-green  { background: #eafff6; border-left: 5px solid var(--green);  color: #004d30; }
  .alert-blue   { background: #eef3ff; border-left: 5px solid var(--blue);   color: #001a80; }
  .alert-purple { background: #f5eeff; border-left: 5px solid var(--purple); color: #3a0063; }

  /* â”€â”€ TOC â”€â”€ */
  .toc {
    background: #fff; border-radius: 20px; padding: 36px 40px;
    box-shadow: 0 6px 30px rgba(0,0,0,.08); max-width: 800px; margin: 60px auto;
  }
  .toc h3 { font-size: 1.5rem; font-weight: 800; margin-bottom: 24px; }
  .toc ol { list-style: none; counter-reset: toc; }
  .toc li {
    counter-increment: toc; display: flex; align-items: center; gap: 12px;
    padding: 10px 0; border-bottom: 1px dashed #e0e0e0; font-weight: 600; font-size: 1rem;
  }
  .toc li::before {
    content: counter(toc, decimal-leading-zero);
    font-size: .8rem; font-weight: 800; color: #fff;
    background: var(--blue); border-radius: 8px; padding: 2px 8px; flex-shrink: 0;
  }
  .toc li span { color: #888; margin-left: auto; font-weight: 400; font-size: .85rem; }

  /* â”€â”€ FOOTER â”€â”€ */
  .page-footer {
    text-align: center; padding: 30px; background: var(--dark); color: rgba(255,255,255,.5);
    font-size: .85rem; margin-top: 80px;
  }
  .page-footer strong { color: var(--green); }

  /* Gradients */
  .g-red    { background: linear-gradient(135deg, #e63946, #c1121f); }
  .g-orange { background: linear-gradient(135deg, #f4a261, #e76f51); }
  .g-yellow { background: linear-gradient(135deg, #f9c74f, #f8961e); color:#2a1a00!important; }
  .g-yellow h4, .g-yellow p { color:#2a1a00!important; }
  .g-green  { background: linear-gradient(135deg, #06d6a0, #0096c7); }
  .g-teal   { background: linear-gradient(135deg, #0096c7, #023e8a); }
  .g-blue   { background: linear-gradient(135deg, #4361ee, #3a0ca3); }
  .g-purple { background: linear-gradient(135deg, #7209b7, #560bad); }
  .g-pink   { background: linear-gradient(135deg, #f72585, #b5179e); }

  /* Hinglish highlight */
  .hi { color: var(--pink); font-weight: 700; }
  .tip-box {
    background: linear-gradient(135deg,#fff0fa,#eef3ff);
    border-radius:14px; padding:18px 22px; margin-bottom:30px;
    border:2px dashed var(--purple); font-size:.95rem; line-height:1.8;
  }
  .tip-box .t-head { font-weight:800; color:var(--purple); margin-bottom:6px; font-size:1rem; }
`;

function getChapterStyle() {
  return `<style>
    ${BOOK_CSS}
    .watermark-fixed { display: block !important; }
    .watermark-tile { display: none !important; }
    body::before { display: block !important; }
    .chapter { padding: 40px 32px; max-width: 100%; }
    @media(max-width:600px) { .chapter { padding: 24px 16px; } }
  </style>`;
}

function openChapter(idx) {
  currentChapter = idx;
  renderChapter();
  document.getElementById('chapterModal').classList.add('active');
  document.body.style.overflow = 'hidden';
}

function renderChapter() {
  const modal = document.getElementById('chapterModal');
  const content = document.getElementById('modalContent');
  const titleEl = document.getElementById('modalTitle');
  const [emoji, title, part] = CHAPTER_TITLES[currentChapter];
  
  titleEl.textContent = `Ch.${String(currentChapter+1).padStart(2,'0')} â€” ${title}`;
  
  const isFree = currentChapter === 0;
  
  if (isFree || isUnlocked) {
    content.innerHTML = getChapterStyle() + CHAPTERS_HTML[currentChapter];
    content.scrollTop = 0;
    modal.scrollTop = 0;
  } else {
    content.innerHTML = `
      <div class="lock-screen">
        <div class="lock-icon">ğŸ”’</div>
        <h3>Yeh Chapter Locked Hai</h3>
        <p>Saare 30 chapters padne ke liye full book unlock karo. Ek baar payment, lifetime access!</p>
        <div class="lock-price"><small>sirf</small> â‚¹499</div>
        <button class="btn-unlock" onclick="closeModal(); showPayModal()">
          ğŸ”“ Abhi Unlock Karo â€” â‚¹499
        </button>
        <button class="btn-razorpay" onclick="openChapter(0)">
          ğŸ‘€ Pehle Chapter 1 Free Padho
        </button>
      </div>`;
  }
}

function closeModal() {
  document.getElementById('chapterModal').classList.remove('active');
  document.body.style.overflow = '';
}

function nextChapter() {
  if (currentChapter < CHAPTERS_HTML.length - 1) {
    currentChapter++;
    renderChapter();
    document.querySelector('.modal-box').scrollTop = 0;
  }
}

function prevChapter() {
  if (currentChapter > 0) {
    currentChapter--;
    renderChapter();
    document.querySelector('.modal-box').scrollTop = 0;
  }
}

// Close modal on overlay click
document.getElementById('chapterModal').addEventListener('click', function(e) {
  if (e.target === this) closeModal();
});

// â”€â”€ PAYMENT â”€â”€
function showPayModal() {
  document.getElementById('payModal').classList.add('active');
}
function closePayModal() {
  document.getElementById('payModal').classList.remove('active');
}
document.getElementById('payModal').addEventListener('click', function(e) {
  if (e.target === this) closePayModal();
});

function copyUPI() {
  var upiId = '9045477253@hdfc';
  var msg = 'UPI ID copy ho gaya!\n\n' + upiId + '\n\nPhonePe / GPay / Paytm mein paste karein aur Rs.499 send karein.';
  if (navigator.clipboard && navigator.clipboard.writeText) {
    navigator.clipboard.writeText(upiId).then(function() { alert(msg); }).catch(function() { prompt('Manually copy karein:', upiId); });
  } else {
    prompt('Manually copy karein:', upiId);
  }
}

function verifyCode() {
  const code = document.getElementById('accessCodeInput').value.trim().toUpperCase();
  const validCodes = ['DRVARUN2025', 'ICU499', 'VARUN_FULL'];
  
  if (validCodes.includes(code)) {
    try { sessionStorage.setItem('icu_access_code', code); } catch(e) {}
    isUnlocked = true;
    closePayModal();
    alert('âœ… Code verified! Saare chapters unlock ho gaye. Enjoy!');
  } else {
    alert('âŒ Invalid code. Payment ke baad jo code mila hai woh enter karein.\n\nHelp: drvarunvarshney@gmail.com');
  }
}

// Keyboard shortcut
document.addEventListener('keydown', e => {
  if (e.key === 'Escape') { closeModal(); closePayModal(); }
  if (e.key === 'ArrowRight') currentChapter < CHAPTERS_HTML.length - 1 ? (currentChapter++, renderChapter()) : null;
  if (e.key === 'ArrowLeft') currentChapter > 0 ? (currentChapter--, renderChapter()) : null;
});

checkUnlock();
</script>
</body>
</html>
